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The Spatial and Temporal Anatomy of Seasonal Influenza in the United States, 1968-2008 
Bianca Malcolm 
Seasonality has a major effect on the spatiotemporal dynamics of natural systems and 
their populations and is a driving force behind the transmission of influenza in temperate regions. 
Although the seasonality of influenza in temperate countries is widely recognized, inter-state 
spread of influenza in the United States has not been well characterized. This dissertation 
characterized the seasonality of influenza throughout the United States by using monthly 
pneumonia and influenza (P&I) mortality to model inter-state movement of seasonal influenza in 
the continental United States between 1968 and 2008. The first chapter summarizes the current 
knowledge of the burden, morphology, and geography of influenza as well as limitations of prior 
studies. In the second chapter, weekly data on laboratory-confirmed influenza isolates from a 
national viral surveillance system (considered the “gold standard”) is compared with weekly 
pneumonia and influenza (P&I) mortality data from a national mortality surveillance system in 
order to determine if the timing of mortality data correlated well with the timing of viral 
surveillance data and was, therefore, a good measurement for determining the timing of annual 
influenza epidemics. Sufficient viral surveillance data for influenza is not available for the 
majority of the study period and its quality most likely varies geographically. This made it 
necessary for this study to use mortality data as a substitute. It was, therefore, critical for this 
dissertation to assess the reliability of mortality data as a measurement to determine the timing of 
annual influenza waves. In the third chapter, an analysis of monthly P&I mortality data was 
conducted to identify an average underlying wave of seasonal influenza spread in the United 
States, the spatial and temporal patterns of seasonal influenza in the U.S. from 1968 to 2008, and 
  
the dependence of the timing and spread of influenza on the dominant circulating influenza type 
or subtype in a given influenza season. Source locations of influenza transmission in the U.S. 
were also identified. The dependence of the spread process of seasonal influenza in the U.S. on 
distance and/or population was assessed in chapter four. Additionally, spatial clusters of P&I 
mortality rates at different phases of an average influenza wave were identified. An assessment 
of the effect of the introduction or reintroduction of a novel influenza virus subtype on the 
spatio-temporal dynamics of influenza spread in the U.S. was performed in the fifth chapter. In 
the sixth and final chapter, I conclude by summarizing the findings of these four studies. This 
research found that P&I mortality was a valid measure used to assess the timing of influenza 
epidemics. Additionally, seasonal influenza in the U.S. typically began in November, peaked in 
February, and ceased in May. Annual influenza epidemics lasted an average of 6.7 months and 
produced a small, but significant southward traveling wave of influenza across the United States, 
originating from northern states in September-October and moving toward southern states over a 
4-month period. H3N2-prominent seasons were significantly shorter and faster in progression 
than H1N1-prominent seasons. Moreover, influenza waves in the contiguous U.S. followed a 
general spatial contagion model, particularly at their peak, with high clusters of P&I rates found 
in Midwestern (North Dakota, Minnesota, South Dakota, Iowa, Nebraska, Kansas, Missouri, 
Arkansas, and Oklahoma), Southeastern (Kentucky, Tennessee, and West Virginia) and 
Northeastern States (New York, Vermont, Massachusetts, and Connecticut) at every phase of an 
epidemic. Finally, influenza waves that directly followed seasons that introduced or reintroduced 
a novel influenza subtype were significantly longer and slower in progression than the waves that 
introduced/reintroduced the novel virus. Identifying spatiotemporal patterns could improve 
epidemic prediction and prevention. This research determined the spatial and temporal 
  
characteristics of seasonal influenza in the U.S. and showed that these characteristics differed by 
dominant influenza subtype. Results of this research should aid public health professionals in 
refining influenza intervention strategies that include better placement and distribution of 
vaccines and other medicines.
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The Burden of Influenza 
Influenza is a contagious, but short-lived infection and represents a leading cause of 
morbidity and mortality in the United States and around the world (1). It affects millions of 
people in the United States on an annual basis and (combined with pneumonia) is the eighth 
leading cause of death in the U.S. Indeed, influenza causes symptoms in 5-20% of U.S. residents, 
500,000 hospitalizations from influenza-related complications, and approximately 24,000 deaths 
in an average year, most of which occurs in persons 65 years of age or older (2-3). Influenza also 
takes a toll on the population in the form of lost productivity from workplace absenteeism and 
excessive health resource consumption (4). In a non-pandemic year, influenza results in the loss 
of 3.5 effective days per person in the U.S. (5). These costs may skyrocket during a pandemic. 
 Persons who suffer from influenza-like illness (ILI) may experience fever and cough or 
sore throat. They may also suffer from runny or stuffy nose, muscle or body aches, headaches, 
fatigue, vomiting and diarrhea (2). Complications from flu infection include bacterial pneumonia, 
ear infections, sinus infections and dehydration. Persons at the greatest risk of influenza 
complications are the elderly (≥65 years), the very young (<5 years), pregnant women, and 
persons who have chronic underlying medical conditions, such as asthma, heart disease, blood, 
kidney, and liver disorders, and weakened immune systems due to disease (e.g. cancer). Chronic 
underlying medical conditions may worsen from influenza infection. Persons at greatest risk for 
influenza-related complications are most in need for annual flu vaccinations (2). 
The influenza virus 
Influenza belongs to the Orthomyxovirdae family and consists of three types, A, B, and C. 
They are closely related in structure, chemical composition, and biological activity.  All 





major structural proteins, and three proteins with RNA replicase and transcriptase activity. The 
influenza virus also contains 6 to 8 segments of linear negative-sense single stranded RNA (1, 6). 
Only influenza types A and B cause annual influenza epidemics and only influenza type A 
viruses have been known to cause pandemics. Type C is rarely reported in humans at all. 
Influenza A viruses are further separated into subtypes, which are based on two surface 
antigens, hemagglutinin (H or HA) and neuraminidase (N or NA).  They are the major 
components of influenza and differ in morphology and the mean ratio of HA:NA is 5:1 (1). 
Hemagglutinin is responsible for binding the virus to red blood cells and host cells and for fusing 
the virion envelope to the host cell.  Antibodies to the hemagglutinin spike form after infection in 
order to prevent reinfection with the same strain of influenza virus.  These spikes can undergo 
antigenic variation (7).  Neuraminidase is an enzyme that cuts sialic acid residues from 
glycoproteins and glycolipids in order to assist the spread of the virus from one cell to another 
and the release of progeny virus from infected cells (8-9).  Antibodies are also formed to the 
neuraminidase antigen after influenza infection; however they are less important in creating 
protection from reinfection than antibodies to the hemagglutinin spike.  Indeed, the HA protein is 
indispensable for influenza virus infectivity and viral pathogenicity is mainly dependent on it. 
The exceptionally high pathogenicity of the 1918 influenza virus was largely the result of the HA 
protein (7, 10-11). Additionally, neuraminidase antigens also undergo antigenic variation, but are 
less variable than hemagglutinin antigens.  The highly variable nature of both hemagglutinin and 
neuraminidase proteins, as well as antibodies to these proteins, distinguishes strains of influenza 
virus.  This antigenic variation leads to new strains, subtypes, and variants of the influenza virus 





Another cause of the development of new strains, subtypes, and variants of influenza 
viruses is the segmentation of the ribonucleic acid, RNA, in the ribonucleoprotein core (13).  The 
segmentation of the RNA in influenza viruses allows genetic recombination, or reassortment, to 
occur readily during mixed infection with different influenza A strains.  This recombination of 
RNA is a major component for major antigenic variations of influenza viruses (13).  
Influenza undergoes two kinds of antigenic variation, minor change, or antigenic drift, 
and major antigenic change, or antigenic shift.  Antigenic drift comprises slight variations of the 
amino acid sequences of the surface antigens, H and N, which can alter the immunological 
characteristics of the virus. It occurs on an annual basis and is the result of the influenza virus 
being put under evolutionary pressure to evade immune system responses (14).  Major antigenic 
changes, antigenic shifts, are caused by sudden and total change in either or both of the surface 
antigens, H and N.  They produce “new” viruses to which the population has little or no 
immunity.  For this reason, these viruses also can cause major influenza pandemics (15).  Indeed, 
novel influenza A viruses contain surface antigens that are so different from those of previously 
circulating viruses that they are designated as new subtypes.  Mostly, these new viruses are not 
merely from mutation of the previously prevalent virus; instead, they are most likely from 
genetic reassortment between influenza A viruses of human or nonhuman hosts or the 
reappearance of a virus after a prolonged absence in humans (16). 
Influenza pandemics 
The term “pandemic” literally means an epidemic that involves all people.  More 
specifically, it is often defined as an epidemic of unusually severe (more than usual) disease that 
is pervasive within a relatively short period (1 or 2 years) of time (1).  Influenza pandemics occur 





between one-third to two-thirds) (15).  They usually have four distinct characteristics: 1) major 
change in the HA antigen of the new virus; 2) rapid replacement of the preexisting influenza 
subtype virus variants; 3) susceptibility of all (or most) members of the population to the new 
virus; and 4) significant excess mortality (1).  This last characteristic is often up for debate since 
influenza is a relatively mild disease where a full recovery is expected and in which the case 
fatality rate rarely exceeds 0.01% (1).  Due to high morbidity during an influenza pandemic, 
large numbers of people are killed and are then recorded as “excess mortality.”  Excess mortality 
was a major determinant of definitive influenza pandemics, such as 1918 and 1957.  However, 
mortality from influenza in the 1968-69 pandemic did not much exceed mortality during a non-
pandemic (which will be discussed later) and many consider the 1947 epidemic a pandemic even 
though its mortality did not even exceed that of the 1943-44 epidemic (1; 18). 
Some believe that it is neither a rise in lethality nor a rise in the proportion of cases 
resulting in death that defines an epidemic or pandemic of influenza.  Instead, they believe a 
pandemic is defined by the rapid occurrence of many cases throughout the world within a short 
interval of time.  The case fatality rate of pandemic influenza may not differ much from that of 
interpandemic influenza, but total excess mortality reflects the immediate increase of total cases 
(19)   On the subject of whether mass mortality defines an influenza pandemic, Kilbourne (19) 
said “A pandemic virus is dangerous and should be curtailed because it infects, sickens, and 
acutely incapacitates millions and millions of people.  Even if case fatality rates are low – as they 
have been in recent epidemics – total excess mortality will increase substantially beyond that 
occasioned by any other human condition” (19).  From this, one can assume that overall 





be dying directly from influenza or pneumonia (i.e. case fatality may remain relatively normal).  
However, the amount of excess mortality varies from pandemic to pandemic. 
Pandemics also are often independent of seasonality, cyclical in nature, and have 
successive waves (20).  However these characteristics are sufficient but not necessary 
components of pandemics.  Indeed, some nonpandemic influenza seasons, such as 1943 and 
1950-51, have had early summer outbreaks of influenza (21). 
While there are three types of influenza (e.g. A, B, C) circulating, influenza pandemics 
have only been caused by influenza A viruses.  These viruses then underwent significant 
antigenic change that was sufficient to escape and evade community immunity by rapidly 
infecting all susceptible members of the population before burning itself out to leave room for 
the next variant.  These antigenic changes, which are the major component of influenza 
pandemics, were also sufficient to completely replace preexisting influenza subtypes (1).  The 
1918 pandemic may have had the best and most efficient major antigenic change in that the 
H1N1 virus circulated undisturbed for nearly 40 years. 
Since 1889, there have been 5 influenza pandemics (e.g. 1889-90, 1918-19, 1957-58, 
1968-69, and 2009-10).  Each epidemic, except 2009-10, was also characterized by a high case 
incidence and unusually high mortality in young, healthy individuals between 20 and 40 years 
old, which distinguished them from other pandemics (1, 22).  The 1918-20 H1N1 pandemic was 
unique for an influenza epidemic.  It was by far the most lethal and largest outbreak in recorded 
history, having claimed between 20 and 100 million lives in a relatively short period of time (23-
24). In the U.S. alone, the pandemic caused between 500,000 and 675,000 deaths (25-26).  And, 
as previously noted, it mostly claimed the young and healthy while, seemingly, the old were 





 Nearly 40 years passed before the next pandemic of the 20
th
 century arrived in the U.S.  
The 1957-58 H2N2 pandemic was the first “indisputable pandemic of the virologic era (19).” It 
was also the first indication that an influenza virus could still cause a pandemic, which caused 
extensive morbidity and excess mortality, during a time when the virus was easily identifiable 
through conventional techniques.  This “Asian” influenza produced significant mortality in its 
later waves, but its total mortality (70,000 U.S. deaths) was only a fraction of that seen in earlier 
pandemics (19, 27). 
 Only 11 years after the second pandemic of the 20
th
 century, the “Hong Kong influenza” 
H3N2 virus supplanted the H2N2 virus of the 1957 pandemic.  Like its recent predecessor, the 
1968-69 pandemic originated in southeastern China in early summer and then spread rapidly 
throughout the East (19). The 1968-69 pandemic was much more subdued than prior pandemics. 
Only 34,000 deaths were caused in the U.S. during this pandemic (19).  The muted mortality of 
the 1968 pandemic was possibly the result of the virus which caused the epidemic.  The 
hemagglutinin of the Hong Kong influenza virus was new (H3), but its neuraminidase (N2) was 
that of the Asian subtype viruses of the 1957 pandemic (28).  Perhaps, the less than novel virus 
of the 1968 pandemic blunted its impact (19). 
The 2009-10 pandemic covered the globe in a matter of weeks and was the first influenza 
pandemic in over 40 years (29). This pandemic was very much unlike the past pandemics. For 
one, the 2009 pandemic virus did not represent a major shift in the influenza A virus subtype. 
Instead, it was a distant variant of the circulating seasonal H1 viruses (30-32). Furthermore, the 
2009 H1N1 pandemic virus did not result in any excess mortality (unpublished observation). 
Indeed, it produced fewer deaths than recent seasonal epidemics (33-35). The stunted impact of 





the case for past pandemics.  Although the 2009 H1N1 virus is antigenically different from 
circulating seasonal H1 viruses, it is also very similar to H1N1 viruses that circulated during the 
early 20
th
 century (32, 36). Shared antigenic properties between pandemic strains may have also 
lessened the impact of the 1968 H3N2 pandemic.  
Nonpandemic (seasonal) influenza 
Nonpandemic (i.e. seasonal) influenza is a global endemic disease whose seasons occur 
between influenza pandemics.  Smaller annual epidemics often succeed pandemics and involve 
drift variants of the current pandemic strain (17). The persistence and characteristics of 
nonpandemic influenza are quite different from pandemic influenza. For one, while pandemic 
influenza is largely independent of season, often beginning in the summer months, nonpandemic 
influenza is cyclical and season-dependent (1).  In general, influenza has a low incidence in 
summer months and a high incidence in winter months.  It peaks in winter, which leads to an 
oscillation of influenza activity between the northern and southern hemispheres at an 
approximately six-month interval (17).  Moreover, because of the seasonal dependency (and the 
co-dependence of climate and season) of influenza, it operates differently in climate zones.  In 
temperate zones, influenza is usually a seasonal winter-time disease, while, in tropical zones, 
influenza circulates yearly and incidence increases during monsoons or rainy seasons.  Low 
relative humidity and indoor crowding due to inclement weather in the winter months of 
temperate zones appears to be driving the seasonality of influenza (1).  Yet, mouse studies have 
shown that even when mice were put in controlled environments that yielded identical conditions 






Seasonality is a major driving force in the circulation of influenza in temperate zones 
because of its effect on population dynamics. Year to year pandemics of childhood infectious 
diseases, such as measles, mumps, and chickenpox are largely controlled by seasonally changing 
contact rate between children, which increases sharply at the start of each school year. Influenza 
is probably not any different from these childhood infectious diseases in that the pattern of 
disease transmission is greatly dependent on the population’s periodically changing annual 
contact rate (37). Influenza virus infection can be asymptomatic and asymptomatic individuals 
are a key to the spread of influenza.  The survival of the influenza virus between pandemics 
appears to be the result of continual person-to-person transmission at a level below the epidemic 
threshold (1; 38-39). Studies of the 2009 H1N1 pandemic virus showed immunity waned 
significantly after 30 days and less than half of infected or vaccinated persons still had antibodies 
to the pandemic strain six months after initial infection/vaccination (40). Partial immunity to a 
pandemic strain may prevent a large portion of the population from being infected with the 
seasonal virus variant of the pandemic virus, but it will not prevent a subsequent influenza 
epidemic. 
The geography of influenza 
The effect of space on the spread of epidemics has been very much explored. Specifically, 
there is some evidence that the spatial waves of epidemics originate at an initial center (17; 41-
44).  Moreover, it has been suggested that the local dynamics of an epidemic, such as its force of 
infection or basic reproduction number, have a complex dependency on the heterogeneities in 
population density (38, 45).  
Cliff, Haggett, and Ord (17) believed that the spread of seasonal influenza is led through 





centers next in rank follow. This order would soon be stopped and superceded by the 
neighborhood effect, which would dominate over the pure size succession.  Therefore, in the 
beginning stages of an epidemic, influenza would spread through the urban population size 
hierarchy to less populous regional centers.  Then, this hierarchical spread would be replaced by 
localized diffusion (or the neighborhood effect) as the epidemic continues (17).  Onozuka and 
Hagihara (46) also found an urban hierarchy to the spread of influenza outbreaks in Japan. Here, 
influenza outbreaks increased within urban areas before spreading along main roadways and 
railways to initiate large outbreaks in rural areas throughout Fukuoka Prefecture (46). This 
characteristic of influenza epidemics, beginning in more densely populated areas and then 
moving to less populated areas, would be consistent with its mode of transmission, person to 
person (17). 
Still, the density-dependence of epidemic influenza may only play a role in the vicinity of 
the epidemic’s peak. Bonabeau et al (47) found that although the number of cases in a region 
increases when that region becomes infected, the spread of the epidemic is more rapid than its 
microscopic dynamics. Therefore, the mean-field regime is reached before local dynamic 
heterogeneities can dominate. Indeed, local heterogeneities are only relevant when the epidemic 
reaches its peak because of the build-up of the epidemic within densely populated infected 
patches. And influenza illness possibly diffuses quickly across the country in step with the 
occurrence of homogeneous global mixing before local epidemics peaked (47). 
These changing spread dynamics may be the direct result of the changing nature of 
transportation networks over the past four decades, which may have amplified the diffusion of 
the influenza virus to the point where the time-scale of global mixing is so short that it dominates 





network of interconnected cities and took less than two years to diffuse globally whereas the 
2009 H1N1 pandemic took a few weeks to spread globally through its own interconnected 
system (48-49). Changes in the global transportation systems have not only promoted exchanges 
among countries, but also within countries (47). This may explain variation in the temporal 
profile of influenza epidemics over the years, but it does not necessarily explain variations in the 
spatial profile of these annual occurrences. 
 There have been many other descriptive studies that have sought to identify the 
spatiotemporal patterns of influenza. Viboud et al (50) found a high correlation between 
epidemic synchrony and the timing of influenza epidemics in France and the United States. 
Mugglin et al (51) identified two clusters of influenza in high-population centers in the northern 
and southern regions of Scotland in 1989-1990. Paget et al’s (52) results indicated influenza 
spread in a west-to-east direction across 20 European countries in 3 of 5 winters between 1999 
and 2004. And a study by Sakai et al (53) suggested influenza-like illness in Japan from 1992 to 
1999 spread in concentric circles from western-central to eastern regions. 
Still, the transmission dynamics of seasonal influenza epidemics are dependent on two 
factors: seasonality and the population of susceptibles. Indeed, annual epidemics in humans 
cannot continue without the continuous birth and recruitment of new susceptible persons into the 
population (38, 54-56). The number of susceptibles increases as an outbreak proceeds on. This 
number drops to a minimum level during an epidemic and then rises as the birth process 
dominates once again (37). This wave of availability of susceptible individuals may be able to 
explain the spatiotemporal dynamics of annual influenza waves and the behavior of influenza 





For one, if an infected individual initiates an epidemic early in a typical influenza season, 
ample time is provided for the creation of a full-scale epidemic. This early introduction of an 
infected individual may lead to a lengthy influenza season, exhausting the susceptible pool, and 
creating a shortened or less intense subsequent influenza season. On the other hand, if an 
infected individual made contact with the susceptible pool late in a typical influenza season, 
there would be very little time for a full-scale epidemic to develop. This, in turn, would produce 
a shortened season and a large pool of susceptible persons. The large number of susceptible 
persons from the prior shortened influenza season would possibly create a large outbreak in the 
following year. This could possibly mean that the entry of infected individuals into a susceptible 
population (i.e. the start of an influenza season) may be directly correlated with the impact of an 
epidemic. Moreover, epidemics that begin early in a season are more likely to be followed by 
shortened, smaller seasons (37). This may explain why influenza seasons that immediately 
follow influenza pandemics are much smaller in nature than pandemic seasons. If the 
introduction of a novel virus into a susceptible pool creates a pandemic, the prior influenza strain 
is usurped by the pandemic strain. Furthermore, the pool of susceptibles to the novel influenza 
virus has been exhausted during the pandemic, which would decrease the likelihood of a long, 
large-scale epidemic the following year (1). However, large-scale epidemics are not always 
followed by shortened smaller seasons and some outbreaks may be able cause high morbidity 
even if they occur relatively late in the season (37). It is also unclear if influenza seasons that 
begin early in the fall months are then followed by seasons that begin later in the winter.  
It would make logical sense that large-scale outbreaks that begin early in the season 
would produce a late-starting subsequent season because the pool of susceptible people was 





persons the previous season would then lead to shorter, smaller epidemics the following season. 
These smaller epidemics are more likely to begin later in the season since the smaller susceptible 
population would need more time to create an epidemic. However, influenza seasons are driven 
by three subtypes/types (e.g. A/H3N2, A/H1N1, B) and there may not be a lot of cross-protection 
between them. The dominant subtype/type for one influenza season may not be the dominant 
subtype/type for the subsequent season. So, the temporal characteristics and impact of influenza 
seasons may not be controlled by those of the prior season. It may not matter if an influenza 
season with A/H3N2 as the dominant subtype was large and exhausted the pool of susceptibles if 
A/H1N1 is the dominant subtype the following year. The size of the susceptible population for 
the A/H1N1-dominant season is not dependent on the size of the susceptible population for the 
A/H3N2-dominant season because there is very little cross-protection between these two 
subtypes. So, a person who was susceptible to A/H3N2 at the beginning of that season and 
became infected with A/H3N2 during that season will also be a part of the susceptible pool for 
the A/H1N1-season. Moreover, influenza strains are constantly changing within a subtype, 
reassorting to create major antigenic changes in A/H3N2 and A/H1N1 and immunity is not 
permanent. Partial susceptibility to new variants of the influenza virus usually occurs within a 
few years of initial infection, so there may be a lot of overlap between the susceptible 
populations of two consecutive influenza seasons that share the same general influenza subtype 
(36, 57-59). 
Previous studies have been unable to predict the shape of influenza seasons based on past 
epidemic patterns. Influenza studies conducted in Tecumseh, Michigan in the 1960s and 1970s 
found that the months of the annual influenza A outbreak did not follow a pattern predictable by 





the ones launching the successive season’s outbreak (60-61). Carryover immunity and the effect 
introduction of a pandemic strain has on subsequent seasonal strains is addressed in Chapter 5. 
Limitations of previous studies 
Seasonality has a great effect on the timing of influenza epidemics, but the cause of this 
effect is unknown. The problem with describing the seasonal pattern of influenza is that the 
initiation and termination of the transmission cycle in a population is unknown. Many propose 
that influenza epidemics mainly begin in the winter because of indoor crowding, drier indoor 
conditions, colder outdoor temperatures, ultraviolet inactivation of the virus or reduced levels. 
However, environmental factors have shown to have only a minimal effect on the spatiotemporal 
patterns of influenza spread (62). If environmental factors were the driving force behind 
influenza epidemics, earlier epidemics would occur in the northern cities of the U.S. And while 
latitude has been shown to be associated with patterns of influenza spread, earlier epidemics 
have been seen to occur in southern cities in the U.S (55, 62-64). Furthermore, on a global scale, 
earlier epidemics have more frequently been observed in countries closer to the equator than in 
countries farther from the equator (63). Although countries closer to the equator have year-round 
influenza transmission, countries farther from the equator have clearly defined influenza seasons, 
where influenza seasons circulate at high levels during the winter months. Potential drivers of 
seasonality may be different from the factors most responsible for the variability in seasonal 
patterns. This study examines the direction of seasonal influenza in the U.S. at different phases 
of an influenza wave and for different characteristics. 
Past studies that sought to predict the shape of influenza seasons based on past epidemic 
patterns assumed that the spread process of seasonal influenza is constant over the epidemic 





spatiotemporal characteristics between subtypes and the year-to-year variation in epidemic 
timing. The spatial make-up of seasonal influenza at different points in an epidemic wave is also 
examined. Prior studies have also suffered from methodological limitations, such as the use of 
annualized monthly aggregations and short time periods, which obscures year to year variations 
and trends over time (65-66). This study addresses those limitations by employing 
comprehensive time series techniques to examine population-based data over a 40-year study 
period for pneumonia and influenza. 
Finally, while several studies have analyzed the spatial and temporal properties of 
epidemic cycles (17, 67-70), only Viboud and colleagues (71) even attempted to ascertain the 
seeding locations of annual waves. They theorized that California initiated seasonal influenza in 
the U.S. because of its large population size and many connections to other States (71). However, 
the Viboud study (71) only looked at the 10 most populous States in the U.S. as sources of 
influenza infection. It is possible that large, populous States do not initiate influenza infection in 
this country. This study will not only determine the seeding locations of epidemic waves in the 
nation, but will also analyze if these seeding locations vary over time and by influenza subtype. 
Additionally, I will look at all continental States as potential seeding locations for influenza.  
Knowledge of the geographical variation in infectious diseases has significantly added to 
our understanding of disease distribution and diffusion, as well as the causal factors and 
mechanisms associated with the risk of infection or developing the disease (17, 67-70). However, 
our understanding of the geographic variability of pneumonia and influenza is limited and does 
not take into account circulating influenza subtype, State-level variability, phases of an influenza 
wave, spatial clustering of rates, or virus novelty (18, 38, 47-48, 50). Current prevention 





despite evidence that suggests spatial heterogeneity of rates. Through the examination of 
geographic variability of pneumonia and influenza mortality in the U.S., this study provides 
information required for the development of geographically focused programs and policies. 
Conceptual Framework 
Time and space form an inseparable combination in all human activity. Furthermore, 
influenza subtype or novelty may directly or indirectly affect the likelihood of exposure, 
infection, or transmission of pneumonia or influenza and the biological or behavioral response to 
infection. In this dissertation, I explore the variation of pneumonia and influenza mortality over 
space and time and how it links back to subtype and virus novelty. 
 
Figure 1.1: Conceptual framework 
 
Aims of the dissertation  
The objective of this dissertation is to further the understanding of space and time in the 
spread of seasonal influenza in the U.S. It is not intended to identify the mechanisms behind 
variability in influenza epidemic patterns, but rather to explore time-space patterns of influenza 
mortality and relate State mortality patterns to influenza subtype. Firstly, the reliability of 













(Chapter 2). Then, using population-based administrative data, the spatial and temporal 
variability in pneumonia and influenza mortality is analyzed as it relates to influenza subtype 
(Chapter 3). Then, the role of space in influenza epidemics is further examined through an 
analysis of the contribution of distance and population to the variation in the geography of 
seasonal influenza (Chapter 4). Additionally, the impact a novel virus has on the spatial and 
temporal features of epidemic influenza is explored (Chapter 5). Finally, the results of this 
research and their implications are summarized in the concluding chapter (Chapter 6). 
Hypotheses 
Pneumonia and influenza mortality is theorized as being a representative measure for the 
timing of influenza spread in Chapter 2. In the third chapter, it is hypothesized that there are 
discernible spatiotemporal patterns in U.S. pneumonia and influenza mortality, and that these 
patterns differ by circulating influenza subtype. Specifically, influenza seasons where H3N2 
either dominates or co-dominates with type B will be significantly shorter and have a faster wave 
velocity than influenza seasons where H1N1 either dominates or co-dominates with type B. The 
hypothesis being tested in the fourth chapter is that seasonal influenza in the U.S. will 
demonstrate a dominant contagious (distance-dependence) diffusion process. In the fifth chapter, 
the prevailing hypothesis is that spatiotemporal patterns in U.S. pneumonia and influenza 
mortality will differ between pandemic (or novel) and epidemic influenza waves. Successive 
seasons of novel waves (seasons where a novel influenza subtype is either introduced or 
reintroduced into the population) will be significantly longer and slower in progression than the 
pandemic season that introduced the novel virus. The spatial course of influenza seasons that 
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CHAPTER 2:  








Estimating influenza-associated deaths and the timing of seasonal influenza waves has long been 
considered difficult and reliable data hard to find. Consequently, a wide range of methods have 
been used. However, direct comparisons of the reliability of two widely used data sources, U.S. 
pneumonia and influenza (P&I) mortality data and influenza laboratory data (the “gold 
standard”), for the timing of seasonal influenza waves have not been conducted. This study 
compared the temporal estimates of U.S. P&I deaths with that of U.S. influenza laboratory data 
through five different models. U.S. mortality data from the 1997-98 through 2007-08 influenza 
seasons and viral surveillance data from a network of 80 World Health Organization 
Collaborating Laboratories and 60 National Respiratory and Enteric Virus Surveillance System 
laboratories were used to estimate the timing of U.S. influenza seasons. Five methods were used 
on the viral surveillance data: (i) normalization (total number of positive isolates and percent of 
positive isolates), (ii) 5% moving average, (iii) 10% total tested, (iv) first and last isolate, (v) 5% 
total season. Annual estimates of the start of influenza seasons using viral surveillance data were 
highly and positively correlated between each method. The start of influenza seasons using 
mortality data were significantly correlated with the lab data, but the end and length of influenza 
seasons were weakly and insignificantly correlated. This study showed that the timing of 
seasonal influenza using different timing methods and viral surveillance was not significantly 
different than the timing of influenza seasons using mortality data. Future studies could feel 
confident knowing that using mortality data to assess the timing of annual influenza seasons is a 
suitable approach. 
 






In North America, influenza typically begins in November and ends in April, but the 
exact start and stop dates vary annually. Because periods of circulating influenza are not fixed on 
both an annual and regional basis, careful definitions of exposure are needed when analyzing the 
impact on outcomes such as hospitalization and deaths (1). Estimates of influenza-associated 
deaths for both pandemic and epidemic periods have varied and depend on the outcomes 
modeled and the specific statistical methods used. However, there is not a consensus about 
exactly how the influenza season should be defined in studies assessing influenza-attributable 
risk. Different methods can produce very different results for the expected contribution of 
influenza to all-cause mortality even when applied to identical data (2). 
The CDC uses a 5% moving average of positive influenza specimens obtained from 
weekly national surveillance testing to determine the beginning and end of an influenza season 
(1). Other studies have used 5% of the total number of positive isolates obtained for the whole 
season (3-4), the first and last positive isolate identified (5-9), the "winter season" (10-11), and 
when positive isolates exceed 10% of total tested (12-13) to define the timing and length of 
influenza seasons. The definition of an influenza season may have a significant and differential 
impact on estimates of association when evaluating influenza-attributable risk, depending on the 
outcome being considered. This may be due to the differing time intervals associated with each 
method. For instance, outcomes will be higher when a liberal approach to estimates, such as the 
5% moving average method, is used because this method creates a larger period of time for the 
influenza season. When using a more conservative or restrictive method, such as the 10% of total 






There have not been any published studies comparing the timing of annual influenza 
seasons using different methods for either viral surveillance or mortality data. This paper details 
a comparison of seven different methods to define the influenza season. The intent is to examine 
the reliability of mortality data to estimate influenza activity in the U.S. as well as the similarities 
in temporal measures between different timing methods used on viral surveillance data. 
Methods 
Data and Analyses 
United States viral surveillance for influenza viruses was conducted from October 
through mid-May for influenza seasons between 1997-1998 and 1999-2000 (calendar week 40 of 
the first influenza year of the season through week 20 of the second influenza year of the season; 
e.g. calendar week 40 of 1997 through calendar week 20 of 1998). Viral surveillance was 
conducted year-round for influenza seasons 2000-2001 to 2007-2008 (calendar week 40 of the 
first influenza year of the season to calendar week 39 of the second influenza year of the season; 
e.g. week 40 of 2000 to week 39 of 2001). Weekly influenza test results were obtained from 
approximately 80 U.S. World Health Organization (WHO) collaborating laboratories and 60 
National Respiratory and Enteric Virus Surveillance System (NREVSS) laboratories located 
throughout the United States. The laboratories reported weekly numbers of total respiratory 
specimens tested for influenza and the number of positive influenza tests by virus type and 
subtype to the U.S. virologic surveillance system (14). 
National P&I mortality data were obtained from the vital statistics offices of 122 cities 
throughout the United States (15). These offices reported weekly counts of the total number of 
death certificates received that listed pneumonia or influenza as the underlying or contributing 





Ninth Revision (ICD-9) or Tenth Revision (ICD-10), as appropriate. ICD-9 codes 480-488 and 
ICD-10 codes J09-J18 were used to categorize P&I deaths (16-17). 
Methods used to assess timing of annual influenza waves 
Five methods were used to estimate the time interval of annual influenza epidemics for 
laboratory viral data: (i) Normal Score (total number of positive isolates and percent of positive 
isolates), (ii) 5% moving average, (iii) 10% total tested, (iv) first and last isolate, (v) 5% total 
season (Table 2.1). The normalization method was used to estimate the time interval of influenza 
seasons from mortality data. Human subject review was not required for this study as only 
mortality data and aggregate national data without personal identifiers were used in analyses. 
For each method, the first week, last week, duration, and peak week of each influenza 
season were determined. In addition, the mean start week, end week, season length, peak week, 
and time to peak influenza activity for seasons between 1997-1998 and 2007-2008 were 
calculated for each temporal method. 
The Normalization method used was previously published (18-19). The weekly total of 
positive influenza isolates and the weekly percentage of positive influenza isolates out of the 
total number of isolates tested was reworked as standard Normal scores. A sustained (≥3 
continuous weeks) weekly score in excess of 0.5 standard deviations above the zero mean with 
an additional calendar week at the beginning marked the beginning of an influenza season. Once 
the weekly score was less than 0.5 standard deviations below the zero mean for at least 3 
continuous weeks, with an additional calendar week at the end, marked the end of an influenza 
season. This process was repeated for the P&I mortality data. 
For the 5% moving average method, weeks wherein the three-week moving average of 





10% total tested method refers to an influenza season where the weeks had positive isolates that 
accounted for at least 10 percent of the total respiratory isolates tested in a given week. The first 
and last isolate method refers to the weeks during which at least one positive influenza isolate for 
was identified. The 5% total season method means the number of positive influenza isolates in a 
week was at least 5% of the total number of positive influenza isolates obtained for the entire 
season. It is unlikely that a significant, immediate increase in cases indicates the start of an 
epidemic, therefore a “lead-in” week was added to the beginning of each influenza season for 
each method (except the first/last isolate method) in order to account for the presence of 
influenza that may have been missed due to a lag in viral surveillance or was below the threshold 
of detection (i.e. incubation period). Moreover, a “lead-out” week was added to the end of each 
influenza season for each method (except the first/last isolate method) in order to include the 
week that influenza cases fell below the detectable threshold, but influenza may have still been 
present (i.e. latent period).  
Comparison of the timing of annual influenza waves 
The timing (e.g. start week, end week, peak week of activity, duration of season) of 
annual influenza seasons for each method was compared using Pearson correlations, r, and 95% 
Confidence Interval (CI). Additionally, the difference between the start, end, and peak weeks and 
season lengths of the mortality data and the five methods used on the laboratory data and the 
means of these variables were calculated. ANOVA was used to compare the means of temporal 
variables. A p-value of <0.05 was considered statistically significant. In a second validity 
analysis, the definition of an excellent match was a situation where the start, peak, or end of 
influenza seasons for each timing method (and data source) occurred in the same week, 





difference of two weeks was considered a reasonable or moderate match. A longer period was a 
poor match. The analysis was based on the percentage of influenza seasons fulfilling the criteria 
of a good or moderate match.  
Results 
For the 11 influenza seasons between 1997-98 and 2007-08, the mean start week for the 
viral surveillance data using the five methods of season timing was between the 1
st
 week of the 
surveillance period (calendar week 40) and the 14
th
 surveillance week (calendar week 53/1) 
(Table 2.2). The mean end week for the viral surveillance data was between the 23
rd
 surveillance 
week (calendar week 10) and the 45
th
 surveillance week (calendar week 27). Moreover, the viral 
surveillance data had a mean peak week of activity between week 6 and week 18 of the influenza 
seasons, which corresponded to surveillance week 18 (calendar week 5). The mean duration of 
influenza seasons for the laboratory data was between 10 and 45 weeks. The mean start, end, and 
peak weeks for the mortality data using the Normal score method was surveillance weeks 11, 33 
and 19 (influenza season week 8), respectively. This corresponded to calendar weeks 50, 19, and 
6. The mean length of influenza seasons using the Normal score and mortality data was 22.9 
weeks (Table 2.2). Overall, influenza seasons during this period on average began in mid-
December, peaked in early-February, ended in early-March to early-May, and lasted 
approximately 18 weeks. 
The timing methods used on the viral surveillance data had significantly high Pearson 
correlations (r ≥ 0.84) in terms of their first weeks of influenza activity. However, the first weeks 
of the 11 influenza seasons for the mortality data using the Normal score method was weakly (r 
≥ 0.11) and not significantly correlated, according to their Pearson correlations, with those of the 





agreement (+/- 2 weeks) between the mortality data and three of the six methods (Normalization 
– Percent Positive, Normalization – Total Positive, 10% Total Tested) used on the viral data 
(Table 2.4). The last weeks of the influenza seasons for five of the six methods (Normal Score, 
5% moving average, 10% total tested, 5% total season) used on the viral surveillance data were 
highly (r ≥ 0.88) and significantly correlated. The last week of influenza seasons produced from 
the last/first isolate method did not significantly correlate with the other four methods used on 
the viral surveillance data (r ≥ 0.28). Furthermore, the last weeks of influenza activity produced 
through the Normal score method used on the mortality data did not significantly correlate with 
four of the six methods used on the viral surveillance data (Normal score – Percent of positive 
isolates, 5% moving average, 10% total tested, first/last isolate). The last weeks of influenza 
seasons from the mortality data was positively and significantly correlated with the Normal score 
method (total number of positive isolates) (r = 0.61) and the 5% total season method (r = 0.67) 
(Table 2.4). The mortality data displayed a poor match (>2 weeks difference) for the end of 
influenza seasons with the viral surveillance data (Table 2.4). 
The peak surveillance week of influenza activity was positively (r ≥ 0.98) and 
significantly correlated for all six methods of timing used on the laboratory data (Table 2.5). 
However, although the mortality data had a similar average peak surveillance week as the 
laboratory data (week 19 vs. week 18; calendar week 6 vs. calendar week 5), it had a moderate (r 
≥ 0.27), yet insignificant correlation with laboratory data in terms of its peak week of activity. 
The time to peak flu activity were positively and significantly correlated for four of the six 
timing methods (Normal score – Total Positive Isolates, Normal score – Percent of Positive 





time to peak activity for the mortality data did not correlate significantly with any of the timing 
methods for the laboratory data (r ≥ -0.10).  
All timing methods used on the viral surveillance data, minus the 5% total tested method, 
had high (r ≥ 0.63) and significant correlations in terms of the duration of their identified 
influenza seasons. The season lengths identified with the mortality data through the Normal 
score method did not significantly correlate with any of the timing methods used on the viral 
surveillance data (Table 2.6). 
The ANOVA analysis revealed that the average start week for the Normal score – total 
positive isolates timing method was not significantly different than the average start weeks for 
the influenza seasons identified through the Normal score – percent of positive isolates method, 
the 5% moving average method, or the 10% total tested method used on the laboratory data (p-
value>0.05) (Table 2.7). The average end week for this method was only significantly different 
than the first/last isolate timing method (Table 2.8). The average peak surveillance week of the 
this method was not significantly different than those produced by the other five timing methods 
used on the viral data (Table 2.9). The average time to peak activity identified by this method 
was not significantly different than those produced by three of the five remaining timing methods 
used on the viral data (Table 2.10). The average season lengths produced by the Normal score – 
percent of positive isolates and 10% total tested methods were not significantly different than 
that produced by the Normal score – total positive isolates timing method (Table 2.11). 
The average start week, end week, and season length of the influenza seasons produced 
by the first/last isolate were significantly different than the corresponding figures of the other 
five timing methods used on the viral surveillance data (Tables 2.7, 2.8, and 2.11). The average 





significantly different than those of the other five timing methods used on the laboratory method. 
The mean end week of the seasons produced by the 5% total tested method was significantly 
different than the mean end week of seasons produced by the first/last isolate and 5% moving 
average methods. The mean season length of seasons produced by the 5% moving average was 
significantly different than the mean season length of seasons produced by all of the timing 
methods used on the viral surveillance data, except for the Normal score – percent positive 
method. 
The average start week for the mortality data assessed using the Normal score method 
was significantly different from only the average start weeks of the influenza seasons identified 
using the first/last isolate method on the viral surveillance data (Table 2.7). The average end 
week for the mortality data was significantly different than the average end weeks for the 
influenza seasons identified through all timing methods used on the laboratory data except for 
the 5% moving average method (Table 2.8). The average peak surveillance week of the mortality 
data was not significantly different than those produced by the six timing methods used on the 
viral data (Table 2.9). The average time to peak activity of the mortality data was significantly 
different that those of two of the timing methods used on the viral surveillance data, 5% total 
tested and first/last isolate (Table 2.10). The mean length of influenza seasons produced by the 
Normal score method on the mortality data was significantly different than the average season 
lengths of influenza seasons identified by all of the timing methods used on the laboratory data, 
except for the 5% moving average method (Table 2.11). 
On average, the seasons produced by five of the six timing methods used on the viral 
surveillance data began within two weeks of the average start of the influenza seasons produced 





produced average start weeks that preceded the average start week of seasons produced by the 
mortality data. The average start week for influenza seasons produced by the 5% total tested 
method were about two weeks ahead of the average start week for seasons produced by the 
mortality data. The average influenza season produced by the first/last isolate method began 
approximately eleven weeks prior to the seasons produced by the mortality data. 
The average end of influenza seasons produced by five of the six timing methods used on 
the viral surveillance data was between four and eleven weeks before the end of the average 
influenza season yielded by the mortality data. The average end of seasons generated by the 
first/last isolate method was approximately twelve weeks after the average end of seasons 
generated by the mortality data. All six timing methods used on the viral surveillance data 
produced influenza seasons that, on average, peaked between zero and one calendar week before 
the average peak of seasons produced by the mortality data. However, within an identified 
influenza season, the timing methods used on the laboratory data created influenza seasons that, 
on average, peaked between two weeks before and ten weeks after the average peak of seasons 
created through the mortality data, Normal score method peaked. The average influenza season 
produced by five of the six timing methods used on the laboratory data was between two and 
thirteen weeks shorter than seasons produced by the mortality data. The average influenza season 
identified through the first/last isolate method was about twenty-two weeks longer than the 
average season identified by the mortality data. 
For three of the six timing methods used on the viral surveillance data (e.g. 
Normalization-Total Positive, Normalization-Percent Positive, 10% Total Tested), the mean 
percentage of seasons with an overlap of +/- 2 weeks for the first week of influenza activity with 





+/- 2 weeks and +/- 3 weeks or more for the peak weeks of influenza activity between the 
mortality data and the six timing methods for the viral surveillance data weeks was 39.4% and 
60.6%, respectively. Overall, the mortality data was a poor match with the viral surveillance data, 
although there was a reasonable match between the mortality data and the Normalization-Total 
Positive method used on the laboratory data (Seasons with moderate match: 54.5%) (Table 2.14). 
The mean percentage of seasons with an overlap of +/- 3 weeks or more for the end weeks of 
influenza activity between the mortality data and the viral surveillance data was 89.4% (Table 
2.15). Only the First/Last Isolate timing method displayed a poor match of the first weeks of 
influenza activity with the other five timing methods. The first weeks of an influenza season for 
the 5% Total Season timing method was a poor match for those of the Normalization-Percent 
Positive and 5% Moving Average methods. The 5% Total Season, First/Last Isolate, and 5% 
Moving Average measures were poor matches with the other timing measures in terms of the end 
weeks of influenza activity. When using a match of +/- 1 week, the average percentage of 
seasons with an overlap of first weeks of activity for the influenza isolates data was 40% and 
rose to 52.7% when accepting a 2-week overlap. The average proportion of seasons with an 1-
week or 2-week overlap of peak weeks of activity of for the influenza isolates data was 89.1% 
and 100%, respectively. A match of +/- 1 week for the end weeks of influenza activity yielded an 
18.8% average proportion of seasons with an overlap. The proportion increased to 31.5% when 
accepting a 2-week overlap.  
Discussion 
There was very good agreement in the timing of seasonal influenza between the six 
timing methods using the viral surveillance data. The mortality data did not correlate well with 





beginning weeks of influenza activity. Additionally, the mean start and peak weeks for the 
mortality data was not significantly different than those of the influenza isolates data. 
The 5% total season method using the viral surveillance method was the most 
conservative timing method included in this analysis. The average influenza season lasted only 
ten weeks, which was five weeks shorter than the timing methods with the second lowest mean 
season length, 10% total tested and Normal Score – total positive. The shorter seasons produced 
by the 5% total season method may omit a large number of influenza cases, which would skew 
future analyses. The first/last isolate method was the most liberal approach to determining the 
timing of influenza seasons. The mean start week for influenza seasons using this method was at 
least ten weeks before the other timing methods. Moreover, the average season identified 
through the first/last isolate method was at least 18 weeks longer than the other timing methods.  
The first/last isolate method yielded the largest influenza seasons because it depended on 
the presence of only one positive isolate in a season and only three weeks in the entire study 
period did not contain a positive influenza specimen. This meant that seasons produced by the 
first/last isolate method spanned the entire surveillance period. This also explains why the 
first/last isolate method did not correlate well with the other timing methods using viral 
surveillance data in terms of the first, last, and peak weeks of annual influenza seasons. 
Additionally, because the first/last isolate method created influenza seasons that lasted the entire 
surveillance method, its mean temporal variables (with the exception of the peak surveillance 
week) were significantly different than the temporal variables of the other six timing methods. 
The first/last isolate method will allow for a greater number of influenza cases to be captured, 





meaningless. There is not much value in examining influenza seasons that all have the same 
temporal measures (e.g. start, end, peak, and length). 
Additionally, it was clear from this analysis that the Normal score – total positive isolates 
timing method was a more conservative approach than the Normal score – percent of positive 
isolates method. It yielded influenza seasons that, on average, began later, ended earlier, and 
were shorter than its Normal score lab data counterpart. These differing results were the product 
of the varying sensitivity of each method. The Percent Positive method is affected by both total 
number of isolates received and the total number of positive isolates for a given week, whereas 
the Total Positive Isolates method is only affected by the total number of isolates received for a 
given week. This means that in order to be included in influenza seasons through the Total 
Positive method, the number of positive isolates for a given week needed to be high relative to 
the number of positive isolates recorded in other weeks. A week with a low number of positive 
isolates could have been included in seasons according to the Percent Positive method as long as 
the total isolates submitted for that week was also low. Thus, the greater sensitivity of the 
Percent Positive method meant that weeks had a greater chance of being included in seasons 
according to this method, which created longer influenza seasons. Despite the differences in 
temporal measures between these two timing methods, these two approaches correlated very well 
and were good matches in terms of the start, end, and peak of influenza seasons. 
This study suggests that using mortality data to assess the timing of annual influenza 
seasons is a valid approach. Even though the first week of influenza seasons denoted by the 
Normal score – mortality data method did not correlate well with the first weeks of seasons 
produced by the timing methods used on the viral surveillance data, there was not a significant 





data was within two weeks of the mean first week of the viral surveillance data and the peak 
surveillance/calendar week of seasons produced by the mortality data was only one week after 
the peak surveillance/calendar week of the laboratory data. For the majority of the seasons, there 
was only a two-week difference between the mortality and isolates data. These findings are 
consistent with previous research that reported the peak number of deaths from pneumonia and 
influenza followed the peak of viral activity by two weeks (20). The results of this study also 
suggest that there is approximately one to two weeks’ time between infection with influenza and 
death and this time increases as an influenza season progresses. 
The first weeks of annual influenza seasons identified by the mortality data may not have 
correlated well with those of the viral surveillance data because for three of the eleven seasons, 
the mortality data actually preceded (by 2-4 weeks) seasons identified by five of the six timing 
methods using the laboratory data. The removal of these three influenza seasons (2001-02, 2002-
03, 2006-07) would make the mortality data highly and significantly correlated with the viral 
surveillance data, increasing the Pearson correlation coefficient from a range of 0.11 to 0.38 to 
0.84 to 0.95. Moreover, the mortality data used in this research is from the 122 Cities Mortality 
Data, which tends to overestimate P&I deaths because it relies on the reporting of pneumonia or 
influenza on any part of a death certificate and not as pneumonia or influenza as the primary 
cause of death. This overestimation may lead to artificially early or longer influenza seasons. 
Still, the mortality data was as good of a predictor of the timing of influenza seasons for the 
majority of the eleven seasons compared as the viral surveillance data. Additionally, for all but 
the 5% total tested timing method, the average first week of flu activity for the viral data 





The estimates of the numbers of epidemic weeks (i.e. season length) were less highly 
correlated for the viral surveillance data and not correlated between the viral surveillance and 
mortality data. However, these differences may lead to only small differences in the estimated 
annual number of influenza-associated deaths because the beginning and end of epidemic periods 
are usually associated with small differences between expected mortality and observed mortality 
(21). Moreover, it was not expected that the end and length of influenza seasons identified by the 
mortality data would correlate well with the viral surveillance data. Prior studies have suggested 
that the length of time between infection with influenza and death from influenza is between 7 
and 10 days (22). Furthermore, advanced medical technology may prolong illness from influenza 
without fully resolving it, which may drastically increase the time between viral infection and 
death. It may also be that influenza infections that occur later in the season may be less virulent 
than infections that occurred earlier in the season because influenza type B often dominates the 
latter part of an influenza season. 
P&I mortality data is an important part of influenza surveillance and analysis because it is 
not burdened by some of the limitations of laboratory data. Mortality data is often easier to 
obtain because there are national registries that house them and report them at least annually. 
Mortality data is also easier to use in analyses because its use does not require IRB approval and 
it is not governed by HIPAA. Moreover, mortality data is not burdened by time lags. And, unlike 
laboratory data, mortality data is not hampered by selection bias or lack of generalizability. For 
viral surveillance data, isolates may only be obtained from symptomatic patients of providers 
that are part of the surveillance network. This may lead to underrepresentation of low population 
areas, such as the West and rural areas. Inclusion/testing criteria and data quality may also vary 





Classification of Diseases, regardless of the location of the death and all deaths are included and 
reported. And, as observed in this research, the proportion of influenza-attributable deaths in P&I 
mortality data is unimportant to measure the timing of seasonal influenza. This is most likely due 
to the seasonal pattern of pneumonia deaths, which see a significant increase in the winter 
months because of influenza’s acerbation of existing morbidities despite being recorded year-
round. Finally, mortality data is often preferable for use in temporal analyses of influenza 
seasons compared to viral surveillance data because viral surveillance data may be unavailable. 
This is especially the case in poor regions that may not have access to testing. 
The high correlations observed between five of the six timing methods used on the viral 
surveillance data for each of the temporal measures suggests that there is not a gold standard of a 
lab cutoff procedure. With the exception of the first/last isolate method, all timing methods used 
on the laboratory influenza data were equally good at assessing the timing of annual influenza 
epidemics. The timing measures were consistent for these five methods for all eleven influenza 
seasons in the dataset. The first week of influenza activity for these five methods was within four 
weeks for nine of the eleven seasons and the mean percentage of seasons with a 1-week overlap 
was 57.4%. Removal of the 5% Total method meant that the first week of influenza activity was 
within two weeks for 10 of the 11 seasons with a mean percentage of seasons with a 1-week 
overlap of 71.5%. The peak week of influenza activity for all timing methods on the viral 
surveillance data was the same for 7 of the 11 seasons and within two weeks for the other four 
seasons. The mean percentage of seasons with a 1-week overlap of the peak week of activity was 
89.1%. Indeed, the mean percentage of seasons with an exact match of the peak week of activity 
for the viral surveillance data was 71.5%. The last week of influenza activity for these timing 





the 5% total season method was the most conservative timing method and the first/last isolate 
method was the most liberal approach. However, with the exception of the first/last isolate 
method, each of the timing methods used on the viral surveillance data produced consistently 
similar influenza seasons. This means that there may not be appropriate justification for using 
one method over the other besides personal preference and familiarity. 
This study is limited by the data sources used. For both mortality and virological data, it 
is assumed that every case is an actual influenza case, which may not be true. This is especially a 
concern for P&I mortality data, which has been previously shown to only contain 8.5% 
influenza-associated deaths (23). Furthermore, laboratory viral isolates data may be hampered by 
the differing influenza tests used to assess influenza infection that may vary in sensitivity and by 
location. The efficacy of influenza tests may also be affected by the differing circulating strains 
of influenza virus that have infected a patient and may be more or less sensitive to detection. 
This study lacked the ability to confirm influenza infection and death. Still, the methods 
employed were able to both assess the timing of annual influenza waves and compare the timing 
techniques for the mortality and virologic data.  
In summary, each of the six models used to estimate the timing of annual influenza 
epidemics using viral surveillance data produced similar estimates, with the exception of the 
first/last isolate model. Moreover, the model used to estimate the timing of annual influenza 
seasons using mortality data produced similar estimates in terms of the start and peak of seasons 
compared to the models that used laboratory data. It is therefore reasonable to suggest that 
models that use mortality data to approximate the timing and length of influenza seasons are 
appropriate as long as researchers recognize that mortality data will observe a lag time, which 





infection and death. More importantly, we believe that the Normal score method is a simple, 
robust, and conservative method of assessing the timing of annual influenza epidemics using 
mortality data. This is important for the measurement of the spread of influenza in countries or 
time periods where viral surveillance data are limited. It is also important for historical analyses 
of influenza transmission, where viral surveillance data is most likely unavailable. Research of 
past influenza epidemics and pandemics, such as the 1918 H1N1 pandemic, will mainly, if not 
completely, rely on mortality, whether P&I or all-cause. It is, therefore, crucial for mortality data 
to be confirmed as a sufficient replacement of viral surveillance data because it can closely 
approximate the timing of annual influenza epidemics. Future research should concentrate on 
estimating the time between initial influenza infection and mortality from influenza and how this 
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Tables and Figures 
Table 2.1: Description of methods used to estimate the timing of influenza activity in the United 
States 
 
Timing method Equation Variables Explanation 
Normalization Start: Pr (
    
 
)       
 
End: Pr (
    
 
)       
X = Weekly count (e.g. 
total mortality, total 
positive isolates, percent 
of positive isolates) 
μ = Mean 
σ = Standard deviation 
A sustained (≥3 continuous 
weeks) weekly score in excess 
of 0.5 standard deviations 
above the zero mean marked 
the beginning of an influenza 
season. A sustained weekly 
score less than 0.5 standard 
deviations below the zero mean 
marked the end of an influenza 
season. 
5% Moving Average Start:  
∑   
 
   
 
    
 
End: 
∑   
 
   
 
    
n = 3 weeks 
x = Percent of positive 
isolates 
t = Week 
An influenza season where the 
three-week moving average of 
respiratory specimens tested 
was at least 5 percent positive 
for each week. 
10% Total tested Start: 
  
  





    
x = Number of positive 
isolates 
y = Number of 
specimens 
t = Week 
An influenza season where 
each week had positive isolates 
that accounted for at least 10 
percent of the total respiratory 
isolates tested in a given week. 
First/last isolate n/a n/a An influenza season where at 
least one positive influenza 
isolate was identified in each 
week. 
5% Total season Start: 
  
∑  





   
x = Number of positive 
isolates 
t = Week 
Σxt = Sum of positive 
isolates over all of t 
An influenza season where the 
number of positive influenza 
isolates in each week was at 
least 5% of the total number of 
positive influenza isolates 






Table 2.2: Mean of temporal variables for influenza seasons in the United States, 1997-2008 
 
Timing method First week of 
influenza season 
Peak week of 
influenza season 




Mean (95% Confidence Interval) 


















Normal score – lab data, 









































All analyses were statistically significant at p=0.05 level in two-sided tests. 






Table 2.3: Correlations between seasonal timing methods of the start week of annual influenza 




















Pearson correlation coefficient (95% Confidence Interval) 
Normal 
Score – Total 
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Table 2.4: Correlations between seasonal timing methods of the end week of annual influenza 
seasons in the United States, 1997-2008 
 



















Pearson correlation coefficient (95% Confidence Interval) 
Normal Score – 
Total positive 
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Table 2.5: Correlations between seasonal timing methods of the peak week of annual influenza 
seasons in the United States, 1997-2008 
 
Timing Method Normal 

















Pearson correlation coefficient (95% Confidence Interval) 
Normal Score – 
Total positive 
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Table 2.6: Correlations between seasonal timing methods for the duration of influenza seasons in 
the United States, 1997-2008 
 



















Pearson correlation coefficient (95% Confidence Interval) 
Normal Score – 
Total positive 
1       











1     




















































Table 2.7: Results of generalized linear models for the average start week of influenza seasons in 
the United States for seven timing methods, 1997-2008 
 
Timing method Normal 



















Normal Score – 
Total positive 
---       
Normal Score – 
percent positive 
0.4724 ---      
10% Total 
tested 
1 0.4724 ---     
5% Total 
season 
0.0469 0.0077 0.0469 ---    
First/Last 
isolate 
<0.0001 <0.0001 <0.0001 <0.0001 ---   
5% Moving 
average 
0.3509 0.829 0.3509 0.0042 <0.0001 ---  
Normal Score - 
mortality 







Table 2.8: Results of generalized linear models for the average end week of influenza seasons in 
the United States for seven timing methods, 1997-2008 
 
Timing method Normal 



















Normal Score – 
Total positive ---       
Normal Score – 
percent positive 0.5544 ---      
10% Total 
tested 0.9058 0.6361 ---     
5% Total 
season 0.2713 0.093 0.2237 ---    
First/Last 
isolate <0.0001 <0.0001 <0.0001 <0.0001 ---   
5% Moving 
average 0.0728 0.2237 0.093 0.0046 <0.0001 ---  
Normal Score - 







Table 2.9: Results of generalized linear models for the average peak week of influenza seasons in 
the United States for seven timing methods, 1997-2008 
 



















Normal Score – 
Total positive ---       
Normal Score – 
percent positive 0.7231 ---      
10% Total 
tested 0.7231 1 ---     
5% Total 
season 1 0.7231 0.7231 ---    
First/Last 
isolate 1 0.7231 0.7231 1 ---   
5% Moving 
average 0.7231 1 1 0.7231 0.7231 ---  
Normal Score - 







Table 2.10: Results of generalized linear models for the average time to peak activity of 
influenza seasons in the United States for seven timing methods, 1997-2008 
 
Timing method Normal 



















Normal Score – 
Total positive ---       
Normal Score – 
percent positive 0.7266 ---      
10% Total 
tested 0.6001 0.3831 ---     
5% Total 
season 0.0165 0.0064 0.0576 ---    
First/Last 
isolate <0.0001 <0.0001 <0.0001 <0.0001 ---   
5% Moving 
average 0.541 0.7931 0.2578 0.003 <0.0001 ---  
Normal Score - 






Table 2.11: Results of generalized linear models for the average duration of influenza seasons in 
the United States for seven timing methods, 1997-2008 
 
Timing method Normal 



















Normal Score – 
Total positive ---       
Normal Score – 
percent positive 0.2422 ---      
10% Total 
tested 0.8878 0.3028 ---     
5% Total 
season 0.0102 0.0003 0.0069 ---    
First/Last 
isolate <0.0001 <0.0001 <0.0001 <0.0001 ---   
5% Moving 
average 0.0069 0.1132 0.0102 <0.0001 <0.0001 ---  
Normal Score - 








Table 2.12: Mean difference in temporal variables between mortality data and laboratory data 
using different methods of defining the influenza season in the United States, 1997-2008. 
 
Timing method First week of 
influenza 
Peak week of 
influenza 
Last week of 
influenza 
Duration of influenza 
season 
Mean (95% Confidence Interval) 



























































Table 2.13: Comparison between virological and mortality beginning incidences of influenza 
activity during eleven influenza seasons in the continental United States, 1997-2008 
 
  Normalization 


















– Total Positive 
Exact 
match 
---       
+/- 1 
week 
---       
+/- 2 
weeks 






36% ---      
+/- 1 
week 
82% ---      
+/- 2 
weeks 





55% 45% ---     
+/- 1 
week 
91% 82% ---     
+/- 2 
weeks 





0% 0% 0% ---    
+/- 1 
week 
27% 9% 36% ---    
+/- 2 
weeks 





0% 0% 0% 0% ---   
+/- 1 
week 
0% 9% 9% 0% ---   
+/- 2 
weeks 





18% 55% 18% 0% 0% ---  
+/- 1 
week 
64% 100% 73% 9% 9% ---  
+/- 2 
weeks 
100% 100% 91% 18% 9% ---  
P&I Mortality Exact 
match 
9% 9% 9% 9% 0% 9% --- 
+/- 1 
week 
9% 18% 18% 27% 0% 9% --- 
+/- 2 
weeks 
64% 64% 55% 45% 0% 36% --- 
Exact match: occurrence of beginning incidences are within the same week (excellent match) 
+/- 1 week: occurrence of beginning incidences differ by 1 week (good match) 






Table 2.14: Comparison between virological and mortality peak incidences of influenza activity 
during eleven influenza seasons in the continental United States, 1997-2008 
 
  Normalization 


















– Total Positive 
Exact 
match 
---       
+/- 1 
week 
---       
+/- 2 
weeks 






64% ---      
+/- 1 
week 
82% ---      
+/- 2 
weeks 





64% 100% ---     
+/- 1 
week 
82% 100% ---     
+/- 2 
weeks 





100% 64% 64% ---    
+/- 1 
week 
100% 82% 82% ---    
+/- 2 
weeks 





100% 64% 64% 100% ---   
+/- 1 
week 
100% 82% 82% 100% ---   
+/- 2 
weeks 





64% 100% 100% 64% 64% ---  
+/- 1 
week 
82% 100% 100% 82% 82% ---  
+/- 2 
weeks 
100% 100% 100% 100% 100% ---  
P&I Mortality Exact 
match 
18% 18% 18% 18% 18% 18% --- 
+/- 1 
week 
36% 36% 36% 36% 36% 36% --- 
+/- 2 
weeks 
55% 36% 36% 55% 55% 36% --- 
Exact match: occurrence of beginning incidences are within the same week (excellent match) 
+/- 1 week: occurrence of beginning incidences differ by 1 week (good match) 







Table 2.15: Comparison between virological and mortality end incidences of influenza activity 
during eleven influenza seasons in the continental United States, 1997-2008 
 
  Normalization 


















– Total Positive 
Exact 
match 
---       
+/- 1 
week 
---       
+/- 2 
weeks 






36% ---      
+/- 1 
week 
63% ---      
+/- 2 
weeks 





55% 27% ---     
+/- 1 
week 
82% 73% ---     
+/- 2 
weeks 





0% 0% 9% ---    
+/- 1 
week 
18% 9% 36% ---    
+/- 2 
weeks 





0% 0% 0% 0% ---   
+/- 1 
week 
0% 0% 0% 0% ---   
+/- 2 
weeks 





0% 0% 0% 0% 0% ---  
+/- 1 
week 
0% 0% 0% 0% 0% ---  
+/- 2 
weeks 
18% 45% 0% 0% 0% ---  
P&I Mortality Exact 
match 
0% 0% 0% 0% 9% 9% --- 
+/- 1 
week 
0% 18% 0% 0% 9% 18% --- 
+/- 2 
weeks 
0% 18% 9% 0% 18% 18% --- 
Exact match: occurrence of beginning incidences are within the same week (excellent match) 
+/- 1 week: occurrence of beginning incidences differ by 1 week (good match) 














Although the seasonality of influenza in temperate countries is widely recognized, 
interstate spread of influenza in the United States has not been well characterized. The author 
studied the seasonality of influenza in the United States through the evaluation of the timing, 
velocity, and spatial spread of annual epidemic cycles through the use of monthly pneumonia 
and influenza (P&I) mortality data from 1968 to 2008 for each of the 48 contiguous states of the 
United States and the District of Columbia. The Normal score method was used to identify the 
timing of each seasonal wave. Average start, peak, and end month, as well as the mean velocity 
(average time all deaths are recorded in a location), P&I mortality rate, and season length were 
determined for each State and compared across latitudes and longitudes. These seasonal 
parameters as well as average time to national spread were also determined and compared 
between dominant circulating influenza subtypes and for the national data. Annual influenza 
epidemics lasted an average of 6.7 months and produced a small, but significant southward 
traveling wave of influenza across the United States, originating from northern states in 
September-October and moving toward southern states over a 4-month period. H3N2-prominent 
influenza seasons (N = 25) were, on average, significantly shorter (6.6 vs. 7.4 months, p = 
0.0364) and spread quicker (Average time to death: 3.8 months vs. 4.2 months, p = 0.0263) than 
H1N1-prominent seasons (N = 7). Seasonal parameters on influenza spread vary by influenza 
subtype. The direction of the traveling wave suggests that environmental forces (temperature, 
humidity) play an important role in driving the timing of influenza epidemics across the United 
States. 
 






Influenza is highly seasonally-dependent and most transmission occurs during the winter 
months in temperate regions (1-2). However, despite the regular cyclic nature of influenza, inter-
annual differences in the onset, duration, and magnitude of each transmission period exist. Inter-
annual differences in regional or state-level influenza patterns have not been extensively studied 
or explained despite their potential to improve our understanding of influenza epidemiology and 
enhance epidemic prediction and prevention (3). 
Despite the substantial burden annual influenza epidemics exert on the U.S., the 
transmission dynamics of this virus are unknown (4). Previous efforts to quantify the 
spatiotemporal patterns of influenza have mainly focused on the state or regional-level or in 
small countries over a small timeframe (5-11). There has been no such effort to assess the spread 
pattern of influenza at the state-level of the U.S. over a lengthy time series. Furthermore, no such 
effort has focused on assessing any differences in inter-annual transmission of influenza by 
influenza subtype. Demonstration of state-specific patterns of influenza mortality may be able to 
create an element of predictability, which could improve early warning systems for epidemic 
spread (3). Identification of the main channels of transmission or “epidemic pathways” of 
seasonal influenza in the U.S. through a quantitative understanding of the spread dynamics of 
influenza would increase understanding of how to control the spread of influenza as well as 
greatly aid U.S. influenza control policies (12). 
The present research seeks to identify an underlying wave of influenza mortality in the 
United States by 1) identifying the spatial and temporal patterns of seasonal and pandemic 
influenza in the U.S. from 1968 to 2008 and 2) compare the spatial and temporal patterns of 





determine the pattern of inter-state spread of influenza in the U.S. and how influenza subtype 
may impact this pattern. 
Methods 
Influenza Mortality Data 
Monthly total U.S. pneumonia and influenza (P&I) data for the years 1968 through 2004 
were obtained from the annual Vital Statistics of the United States published by the National 
Center for Health Statistics (NCHS) through the Centers for Disease Control and Prevention 
(CDC) (13). Monthly mortality statistics for the years 2005-2008 were obtained from the CDC 
Wonder Online Data System (14). This dataset only used P&I mortality from the 48 contiguous 
States of the U.S. and the District of Columbia. 
P&I mortality was collected and classified in accordance to the International 
Classification of Diseases, Adapted for Use in the United States (ICDA) in use at the time of 
death. For the years 1968 to 1978, the Eighth Revision of ICDA, ICDA-8, which was based on 
the 1965 Revision of the International Classification of Diseases (ICD), was utilized to classify 
deaths (15). Between 1978 and 1998, the Ninth Revision of ICDA, ICDA-9, was used in death 
classification (16). After 1998, the Tenth Revision of ICDA, ICDA-10, was used to classify 
deaths on certificates. Fetal deaths are not included in this analysis (17).   
Data from the U.S. Census Bureau was used to calculate seasonal and monthly P&I death 
rates for the U.S., each of the 48 contiguous States, and the District of Columbia. Estimated 
population totals of the population at July 1
st
 of the corresponding year (1968-2008) for the 
geographic unit were used, except for the years 1970, 1980, 1990, and 2000. For the years 1970, 
1980, 1990, and 2000, population estimates of the population at April 1 of the corresponding 






Viral Circulation Data 
 Prominent and dominant influenza type and subtype for the seasons 1972-73 through 
1978-79 were determined by Noble (20). The annual dominant and prominent circulating 
influenza types and subtypes for seasons after 1978-79 were based on U.S. surveillance for 
circulating strains. The CDC receives weekly influenza test results by virus type and subtype 
from a network of 80 World Health Organization (WHO) and 70 National Respiratory and 
Enteric Virus Surveillance System (NREVSS) collaborating laboratories in the United States 
(21). Prominent influenza type and subtype were defined as at least 20% of all isolates that were 
tested in that season (4). H3N2 was assumed to be the dominant influenza subtype for seasons 
1968-69 through 1971-72. 
Definition of Influenza Seasons 
An influenza “epidemic period” was defined as a year spanning from September to 
August. Within this epidemic period, a seasonal wave was identified in order to conduct the 
analyses for this research project. Moreover, a seasonal wave was identified because P&I deaths 
are recorded year-round in the U.S., which makes assessment of the timing of a season difficult. 
Identification of a seasonal wave allowed this project to precisely determine the start, peak, and 
length of an influenza season. In North America, influenza typically begins in November and 
ends in April, but the exact start and stop dates vary annually. Because periods of circulating 
influenza are not fixed on both an annual and regional basis, careful definitions of exposure are 
needed when analyzing the impact on outcomes such as hospitalization and deaths (22). 
An annual seasonal influenza wave in the U.S. was calculated by reworking the aggregate 





score in excess of 0.5 standard deviations above the zero mean, with an additional “lead in” 
calendar month at the beginning marked the official beginning of an influenza season. Once the 
monthly Normal score fell below 0.5 standard deviations below the zero mean for two 
consecutive months (or the end of the epidemic period), with a “lead out” month added to the 
end, the end of the influenza season was noted (23). This process was performed to limit the 
“noise” associated with the year-round presence of influenza and establish the time interval when 
there is a significant presence of influenza in the U.S. It was used to identify annual seasonal 
influenza waves for the U.S. as a whole as well as for each of the 48 contiguous States (and the 
District of Columbia) in the dataset for each of the 40 influenza seasons between 1968 and 2008. 
Using the information from the timing of each wave, the study was able to determine the 
start, end, peak, and length of each influenza season for the national data as well as by state and 
by dominant and prominent influenza subtype/type. I was also able to determine the difference in 
epidemic timing between the national start and peak of P&I mortality and the amount of time 
influenza took to spread across the nation (i.e. from the first state of influenza activity to the last 
State of influenza activity).  
Analysis of the spread of seasonal influenza 
As described previously, aggregated monthly counts of P&I deaths were used to 
determine the timing of an influenza season for the United States and for each State for each of 
the 40 influenza seasons between 1968 and 2008. The average first month of seasonal influenza 
was calculated for each State and by subtype. This data was used to construct maps that 
displayed the average wave progression of seasonal influenza in the U.S. over the 40 influenza 
seasons and the average seasonal influenza wave progression for H1N1-prominent and H3N2-





Additionally, the start month of each State was plotted against both the latitude and 
longitude of the States to determine the presence and strength of the East-West and North-South 
movement of influenza in the U.S. This process was performed for each influenza season and the 
mean start month of each State was used to determine the average East-West and North-South 
movement for seasonal influenza in the U.S. The latitude and longitude for the center of each 
State were used in these analyses. Pearson correlation coefficients, r, and 95% Confidence 
Intervals (CI) were calculated for each map in order to determine the strength of the direction of 
influenza in the U.S. ANOVA analyses and generalized linear models were used to assess state 
differences in the mean start, end, peak, and length of annual influenza waves, the mean velocity 
of wave progression, and the mean P&I mortality rate. Generalized linear models were also used 
to analyze differences in the mean temporal variables for dominant circulating influenza 
subtype/type for the national and state-level data. The generalized linear models analyses, under 
the assumption these data were normally-distributed, are made up of three parts: 
Linear predictor: 
                      
A link function that describes how the mean,  (  )    , depends on the linear predictor: 
 (  )     
A variance function that describes how the variance, var(Yi) , depends on the mean: 
 (  )    
where ηi represents the expected mean of a temporal variable (e.g. start, peak, length of season, 
etc.), β0 is the intercept, βi is the coefficient for the linear trend, xi represents the parameter 





To assess the velocity of annual wave progression of each epidemic wave, the average 
time to death from P&I, 
  
t , was assessed for each influenza season and geographical area. It was 
computed as: 
 ̅  
 
 
∑   
 
   
 
where xt is the number of reported P&I deaths in month t and n=xt is the sum of all reported 
P&I deaths for all t (24).  The arithmetic mean,
  
t , indicates the lag in months between the start of 
the epidemic (the month in which the first death was recorded) and the average time at which all 
deaths occurred in that State. A high value of 
  
t indicates a long average time to death and a 
relatively slow moving wave, while a low value of 
  
t  implies a short average time to death and a 
relatively fast moving wave. 
Results 
 Between January 1, 1968 and December 31, 2008, 630,742 deaths from pneumonia and 
influenza were recorded in the 48 contiguous States of the United States and the District of 
Columbia. Figure 3.1 depicts the monthly time series of the death rate from pneumonia and 
influenza for the U.S. The average influenza season during this time began in November, peaked 
in February, and ended in May. During this time, an average of 42,596.3 (95% CI = 40374.0 – 
44772.3) P&I deaths were produced each season, yielding an average rate of 17.1 (95% CI =  
16.3 – 18.0) P&I deaths per 100,000 persons. Moreover, the average influenza season lasted 
approximately 6.7 months (95% CI = 6.4 – 7.0) and had a mean average time to death of 3.8 
months. It took approximately 4.3 months (95% CI = 4.0 – 4.6) for P&I mortality to be recorded 





Analysis of predominant influenza subtype 
 Of the 40 influenza seasons included in this analysis, 25 seasons had an H3N2-prominent 
circulating strain, where either H3N2 was the dominant circulating influenza subtype (N=18) or 
co-dominated with influenza B (N=7) and 7 seasons had an H1N1-prominent circulating strain, 
where H1N1 was the dominant circulating subtype (N=2) or H1N1 co-dominated with influenza 
B (N=5). There were also five seasons where H1N1 and H3N2 co-circulated, which were not 
included in this analysis. There were significant differences in spatiotemporal characteristics 
between H1N1-prominent seasons and H3N2-prominent influenza seasons. An average H1N1-
prominent season began in October, peaked in February, and ceased in May in the U.S. while an 
average H3N2-prominent season began in November, peaked in February, and ended in April in 
the U.S. (p = 0.1662). H3N2-prominent seasons did not only begin later in the year and were 
shorter (p = 0.0203) than H1N1-prominent seasons, but as illustrated in Table 3.1, H3N2-
prominent seasons had shorter, faster waves (p = 0.0364), which allowed them to spread 
throughout the nation quicker than H1N1-prominent influenza waves (p = 0.0263). 
 Table 3.2 displays the mean of temporal variables for the 48 contiguous States and the 
District of Columbia by dominant circulating influenza subtype/type between 1968 and 2008. 
From this table, it can be seen that, on average, States began their seasons significantly later 
(p<0.0001) and ended them significantly earlier (p<0.0001) during H3N2-prominent seasons 
than during H1N1-prominent seasons. Moreover, the average H3N2-prominent season for States 
were significantly shorter (p<0.0001) and faster (p<0.0001) compared to the average H1N1-
prominent season. And, although there was not a significant difference in mortality between 





States during H3N2-prominent seasons was, on average, significantly greater (p<0.0001) than 
that for States in H1N1-prominent seasons. 
Source of influenza spread 
Tables 3.3 and 3.4 show the average of temporal variables for each of the 49 States and 
their rank compared to the rest of the U.S. Delaware was shown to be a possible seed of 
influenza infection in the U.S. It ranked first in the number of times it had the earliest start month 
for an influenza wave (N=21) and also had the lowest mean first month of influenza seasons. 
Indeed, the average first month of an influenza season for Delaware was significantly lower than 
79.2 percent of the country. For H1N1-prominent seasons, Delaware, Iowa, Nebraska, and North 
Dakota initiated five of the seven influenza waves. Delaware, Iowa, and Nebraska were also tied 
for the lowest mean first month of influenza (1.43, 95% CI = 0.70, 2.16). For H3N2-prominent 
seasons, Delaware had the earliest start month for 13 of 25 seasons. The District of Columbia 
initiated 12 of 25 seasons and Idaho 11 of 25 seasons. Delaware also had the lowest mean start 
month of influenza (1.88, 95% CI = 1.43, 2.33), followed by the District of Columbia (2.08, 95% 
CI = 1.58, 2.58) and Idaho (2.16, 95% CI = 1.63, 2.69). The average start month of influenza 
activity for each State for the U.S. for all influenza seasons, for H1N1-prominent seasons, and 
for H3N2-prominent influenza seasons were plotted on maps of the 48 contiguous States of the 
U.S. that are displayed in Figure 3.2. These maps illustrate the average spatial progression of 
seasonal influenza in the U.S. at the start of an influenza season. 
Direction of influenza spread 
 There was a small, but significant North-South spread of influenza in terms of the 
identified first month of influenza seasons (p = 0.0411) (Table 3.5). This indicates that northern 





States. However, despite the earlier start by northern States, influenza seasons in southern States 
were significantly shorter (p<0.0001), faster in velocity (p<0.0001) and ended sooner (p = 
0.0005) than those in northern States. Southern States were also more likely to peak earlier in 
their respective seasons (p = 0.0131), although the actual peak month of influenza activity was 
not significantly different from that seen in northern States (p = 0.2772) (Table 3.5). There was 
not a significant East-West spread of influenza identified in the dataset for any of the temporal 
variables, although peak month of flu activity displayed a significant West-East spread from the 
regression model (p = 0.0445) and a near significant Pearson correlation (p = 0.0561). Moreover, 
with respect to season length, Eastern states had a faster traveling wave compared to Western 
states (Velocity ratio: R
2
 = 0.0043, r = -0.063, 95% CL = -0.10698 to -0.01878).  
Table 3.6 lists the correlation of the identified first month of influenza activity by the 
latitude and longitude of states for each of the 40 influenza seasons included in this research. In 
Figures 3.3 and 3.4, the mean first month of influenza activity for each state included in the 
dataset are plotted against the central latitude and longitude of each state. Additionally, if the 
number of times a state’s influenza season began the earliest compared to the rest of the U.S. was 
plotted against latitude, there would be a fairly strong North-South correlation (R
2
=0.2829; r = -
0.54261; p <0.0001).
 
 The spatial course of seasonal influenza in the U.S. did tend to vary by the 
dominant/prominent circulating influenza subtype (Table 3.7). The initial spread for influenza in 
seasons with H1N1 as the prominent subtype followed significant North-South (p = 0.0098) and 
East-West (p = 0.0173) paths. Spread at the beginning of H3N2-prominent seasons followed 
North-South and West-East trajectories, but was insignificant (p = 0.0797, 0.4686). As with the 





H1N1-prominent seasons, but were also insignificant (p = 0.3125). The path of H3N2-prominent 
seasons at their height were insignificant and North-South (p = 0.9211). The course of influenza 
for H3N2- and H1N1-prominent seasons also differed along longitude. Where H3N2-prominent 
seasons followed a significant West-East trajectory (p = 0.0006) at the height of influenza 
seasons, H1N1-prominent seasons followed an insignificant East-West trajectory (p = 0.2759). 
The North-South and West-East courses of seasonal influenza seen at the height of H3N2-
prominent seasons became South-North and East-West at the end of these annual waves (p = 
0.0016, 0.863). H1N1-prominent seasons, like H3N2-prominent seasons, displayed South-North 
and East-West, but insignificant (p = 0.233, 0.1056), transmission. 
Discussion 
 This quantitative analysis of the seasonal patterns in pneumonia and influenza mortality 
data in the continental U.S. revealed an annual “wave” of influenza traveling southward across 
the U.S. over an approximately 7-month period. This wave began in northern states in October 
and reached southern states a month later. Although this wave was significant, it was also very 
small. Indeed, seasonal influenza in the U.S. did not appear to follow a strict North-South or 
East-West spread. Only 8 of the 40 influenza seasons displayed a significant correlation between 
the start month of influenza spread and latitude (5 of which were North-South spread). Moreover, 
latitude was not a very large contributor to the linear regression model between first month of 
influenza season and latitude (R
2
=0.0024). Longitude was not significantly correlated to the 
initiation of seasonal influenza spread. However, four influenza seasons displayed a significant 
correlation between first month of influenza spread and longitude (2 showed East-West spread 





 Overall, there was an irregular manner by which influenza spread across the U.S. 
Although Delaware initiated influenza spread more often than the rest of the continental States 
(and D.C.), all but four influenza seasons (1972-73, 1975-76, 1977-78, and 2007-08) had at least 
three geographically-distant States identified as possible seed locations of spread. In 1971-72, all 
but two states were identified as possible seed locations. In 1978-79, all but 8 states were 
identified as possible seed locations for influenza spread. This may indicate that pneumonia and 
influenza mortality in the U.S. is geographically widespread at the onset of a wave. It may also 
indicate there is a simultaneous and early introduction of influenza in the U.S., but this may be 
unlikely. 
 The lack of a definitive spatiotemporal pattern in influenza in the U.S. may be due to the 
fairly large temporal basis of the time series. Considering that the U.S. is in a temperate climate, 
influenza, therefore, spreads in a defined season. In tropical climates, where influenza spreads 
throughout the year, it may take several months for influenza to reach different regions of the 
same country (25). However, since there is a definitive time interval for influenza seasons in the 
U.S., there may be only weeks-difference between the initiation of influenza in different regions 
of the U.S. In a prior analysis, I found that less than three weeks separated the start of influenza 
in all nine Census regions of the U.S., although these differences were not significant 
(unpublished findings). Moreover, the close timing of influenza spread in the 48 contiguous 
states of the U.S. and the District of Columbia may be due to a simultaneous introduction of 
influenza into the country. Holmes and colleagues (26) found that within a one-month period, 
there were at least 24 separate introductions of the 2009 H1N1 influenza virus in the University 
of California – San Diego (UCSD) community. Each introduction represented a separate lineage 





strains which leads to geographically-diverse diffusion. Moreover, the authors observed 
extensive spatial mixing of genome sequences, which made the identification of a pattern of 
geographical spread and a point source of outbreak difficult. They concluded that interactions 
outside of school dorms (e.g. classrooms, social gatherings, etc.) were driving influenza 
transmission on the UCSD campus (26). The results of the analysis by Holmes et al (26) may 
explain the results of this analysis. It may be that it takes time for influenza strains to evolve 
locally or regionally. As these strains evolve, infection builds in the surrounding communities 
and once critical mass is reached, influenza spreads to other local or distant communities. 
 Instantaneous global homogenous geographic mixing could also explain the irregular 
manner in which influenza spread initiated in the U.S. However, it is nearly impossible to 
determine if this global mixing did not result from the annual flare-up of an already locally 
circulating infection without knowing the antigenic types of all recorded cases. 
Unlike previous research (27-28), the results of this analysis suggest that air-traffic flow 
may not explain a large part of the geographical pattern of influenza in the U.S. The U.S. is a 
transportation hub for international travel; however, 9 of the 10 busiest airports in the U.S. were 
in States that were in the bottom half of frequency of influenza spread initiation. Indeed, three of 
the five states with the lowest mean start month of influenza spread (California, Texas, and 
Arizona) contain half of the top ten busiest airports in the U.S. These States may simply be way 
stations on the path to travelers’ ultimate destinations. So, instead of fueling influenza 
transmission in the States that house the U.S.’s busiest airports, air travel may fuel transmission 
in States that have the most connections to or receive the most passengers from these hubs. 
 The small, but significant effect of latitude on the spatiotemporal characteristics of 





or humidity, play an important role in driving the timing of influenza epidemics across the U.S. 
Due to the distance from the equator, winter reaches northern States much earlier and has a 
greater impact on that population than in southern States. Previous research has hypothesized 
that physiologic and behavioral characteristics explain the large increase in cases of human 
influenza and other respiratory diseases during colder months in temperate regions. These 
characteristics include confinement in closed spaces, low humidity, and wind chill factors, which 
are caused by low temperatures and may drive viral transmission. Moreover, influenza viral 
transmission is driven by the release of droplets in the environment from nasopharygeal 
secretions and the virus tends to survive longer in cold temperatures (29-30). Extreme climate 
conditions, such as cold weather, may also lower the effectiveness of humans’ immune systems, 
which may make them more susceptible to viral infections, such as influenza (30-31). Low 
absolute humidity, which is associated with the wintertime, has also been shown to predate the 
onset of epidemic influenza in temperate regions (32). Charland et al (33) did not find a 
significant association between cold temperatures and influenza activity. Instead, they observed 
solar radiation was the only environmental factor to be significantly associated with influenza 
spread. This may be true at the peak of influenza activity in the continental U.S.; however it is 
uncertain if the same association (or other associations) holds at the start of influenza seasons. 
 The North-South spread of epidemic influenza seen in this research is also contradictory 
to some earlier research. Previous research have found that the course of influenza in the 
continental United States is from West to East (34-35), with peak activity occurring first in 
Nevada, Utah, and California and ending in Rhode Island, New Hampshire, and Maine. Other 
research has also indicated California is a source of epidemic influenza in the U.S (5). There was 









 lowest mean peak month of 
influenza, they were only significantly lower than the mean peak month of influenza activity of 
four (Michigan, New Hampshire, North Carolina, North Dakota) and five States (Iowa, Michigan, 
New Hampshire, North Carolina, North Dakota), respectively. Moreover, while New Hampshire 
had the 3
rd
 highest average peak month of influenza activity and the highest mean first month of 
epidemic influenza, indicating that it is the end point of epidemic influenza in the U.S., 
California had the 2
nd
 highest mean first month of epidemic influenza and only initiated epidemic 
influenza for 3 seasons, which also indicates this State is one of the last to receive influenza 
during an average season. This research did find a suggested West-East course of influenza 
activity at the start and height of annual waves, but neither of these associations was significant. 
Charland and colleagues (33) reported that epidemic influenza in the U.S. is positively associated 
with latitude, but they found a South-North spread mechanism in terms of peak influenza activity. 
 This prior research used weekly time series of P&I mortality and hospitalization to find 
the timing of peak influenza activity of U.S. States, while my study is based on monthly counts 
of P&I deaths and the start of influenza seasons. Using weekly data, these studies observed 
influenza activity peaked within 4 weeks for all states in the continental U.S. This may explain 
why there was not a significant difference in the average peak month of flu activity in my data. 
However, this does not explain why my research did not find a significant West-East spread, but 
did find a significant, if slight, North-South spread of epidemic influenza. It is doubtful that the 
course of influenza in the continental U.S. would switch from a North-South direction to an East-
West or West-East direction if weekly series of P&I mortality/hospitalization were used instead 
of monthly series data. It is more likely that the methods used to determine the timing of 





specifically, my study’s use of the first month of influenza activity to determine epidemic spread 
compared to the other studies’ use of peak activity. Longitude, with a dominant West-East 
direction, was insignificantly associated with peak month of influenza activity in my data, but 
just barely (p = 0.0561). Moreover, peak activity observed in my study did follow an 
insignificant South-North spread, as was seen in the Charland et al study (33). Perhaps if weekly 
data was used in my study, I would have seen a significant West-East spread of peak influenza 
activity. 
 There are some limitations when using P&I mortality data to analyze the timing of 
influenza activity. Only a fraction of the deaths used in this analysis may be influenza related. 
Although secondary bacterial infection is accountable for most influenza-related deaths, the vast 
majority of deaths classified as caused by pneumonia may be caused by other respiratory 
pathogens besides influenza (4, 35). Moreover, influenza diagnoses are not often confirmed with 
sensitive and specific laboratory diagnostics and even if an influenza infection is confirmed, it is 
rarely reported on death certificates (36). Deaths from pneumonia and influenza can represent a 
lower bound for influenza-associated deaths, especially considering mortality from pneumonia 
and influenza causes are highly correlated with the circulation of influenza (37-39). Furthermore, 
this study was more concerned with the timing of annual influenza epidemics and not the impact 
of these epidemics. Previous studies have also reported that the use of pneumonia and influenza 
mortality data is a reliable proxy for studying the timing and amplitude of influenza activity (5-6, 
40-41). So, the use of P&I mortality in this study was appropriate. Additionally, this study only 
examined two forms of influenza spread, east-west and north-south. There are many other 





 This study examined the spatiotemporal pattern of influenza spread in the United States 
from 1968 to 2008. Additionally, it examined differences in the timing and spread of influenza in 
the U.S. between dominant circulating influenza subtypes. There was a slight North- South 
pattern in the onset of influenza spread and a slight South-North pattern in the cessation of an 
influenza wave, but not a significant pattern in the peak of influenza spread. Moreover, there was 
not a robust traveling wave of influenza in the U.S. Using weekly P&I mortality to approximate 
the timing of annual influenza epidemics may yield more robust results. Still, understanding the 
geographical patterns of influenza spread is essential for predicting influenza spread and 
informing prevention efforts. This research is an important step in deducing the circulation of 
influenza in the U.S. through the study of mortality patterns. 
 Knowledge of the timing of annual influenza epidemics may lead to early identification 
of a novel strain with pandemic potential that has arrived earlier than normal waves. Although a 
universal influenza vaccine may be the most effective method in eventually stemming a 
pandemic, it will likely not be available soon enough to stop or slow a pandemic at its inception. 
However, early identification of this novel strain may provide public health with several weeks 
of pandemic preparation time, especially for States that are affected later in regular influenza 
seasons (42). During this time, non-pharmaceutical interventions (NPIs) can be instituted and 
vaccines for the pandemic seed strain may be developed. A vaccine or NPIs may not be able to 
prevent a pandemic from spreading or mitigate it at the beginning, but they may be able to 
minimize the impact of a second wave of pandemic.    
 Furthermore, enhanced mortality surveillance from the determination of the timing of 
mortality curves from past years is valuable for characterization of the variability in mortality 





prioritization and surge capacity. For example, if it is assumed that the next annual wave of 
influenza will be dominated by the H1N1-subtype, then greater medical surge capacity might be 
required in the Southern and Western sections of the country because, historically, they have 
received influenza later during the year compared to the Northern and Eastern parts of the 
country during such a season. Therefore, the South and West present the best opportunities for 
limiting the impact of this H1N1 wave because it will be almost impossible to stop the virus at its 
introduction in the North and East. 
 Surveillance will be a crucial component to guide the public health response during a 
pandemic. Timely and good surveillance is important for outbreak containment in that it can lead 
to early identification of a novel virus and may lead to a coordinated response. While increased 
surveillance of influenza virus A subtypes and astute clinical diagnoses will be vital during a 
pandemic period, clinicians may become overwhelmed and case reporting may suffer. 
Knowledge of past pandemics and epidemics, such as that presented in this research, may be able 
to fulfill the knowledge gap and provide public health with the necessary tools to estimate 
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Figure 3.1: Monthly pneumonia and influenza (P&I) death rate per 100,000 population, 48 








Table 3.1: Mean seasonal parameters of epidemic influenza in the continental United States, 





























Mean (95% Confidence Interval) 




































































































































*Statistically-significant analyses at p<0.05 level. 






Table 3.2: Mean seasonal parameters of epidemic influenza for the 48 contiguous United States 





First month of 
influenza 
season 
Peak month of 
influenza 
season 












Mean (95% Confidence Interval) 
















































































































All analyses were statistically significant at the p<0.05 level. 





Table 3.3: Mean seasonal parameters for epidemic influenza in the continental United States, 
























United States 2.8 5.65 3.85 8.5 6.7 3.82 17.1 
Alabama 2.63 5.53 3.9 8.4 6.78 3.89 17.0 
Arizona 2.78 5.55 3.78 8.52 6.75 3.85 17.2 
Arkansas 2.7 5.8 4.1 8.7 7 3.98 21.4 
California 2.88 5.33 3.45 8.33 6.45 3.69 16.3 
Colorado 2.6 5.7 4.1 8.95 7.35 4.15 17.2 
Connecticut 2.78 5.6 3.83 8.4 6.63 3.81 18.8 
Delaware 1.88 5.7 4.83 9.23 8.35 4.72 17.0 
District of 
Columbia 
2.15 5.58 4.4 9.18 8 4.50 24.8 
Florida 2.68 5.68 4 8.65 6.98 3.98 15.6 
Georgia 2.6 5.65 4.05 8.4 6.8 3.86 16.7 
Idaho 2.08 5.25 4.18 8.55 7.48 4.23 17.2 
Illinois 2.35 5.55 4.2 8.33 6.98 4.01 18.0 
Indiana 2.38 5.58 4.2 8.53 7.15 4.08 16.9 
Iowa 2.35 5.9 4.55 8.25 6.9 3.98 24.6 
Kansas 2.5 5.6 4.1 8.2 6.7 3.90 20.6 
Kentucky 2.38 5.75 4.38 8.45 7.08 4.06 20.4 
Louisiana 2.55 5.4 3.85 8.48 6.93 3.96 15.0 
Maine 2.75 5.75 4 8.68 6.93 3.97 19.6 
Maryland 2.6 5.6 4 8.38 6.78 3.90 13.8 
Massachusetts 2.68 5.63 3.95 8.4 6.73 3.87 24.8 
Michigan 2.53 5.93 4.4 8.85 7.33 4.15 16.0 
Minnesota 2.25 5.7 4.45 8.45 7.2 4.13 18.9 
Mississippi 2.58 5.4 3.83 8.23 6.65 3.83 17.4 
Missouri 2.68 5.65 3.98 8.18 6.5 3.76 21.1 
Montana 2.4 5.53 4.13 8.83 7.43 4.2 20.0 
Nebraska 2.43 5.55 4.13 8.33 6.9 3.97 22.2 
Nevada 2.65 5.5 3.85 9.13 7.48 4.19 13.6 
New Hampshire 2.85 5.9 4.05 8.7 6.85 3.94 14.9 
New Jersey 2.5 5.35 3.85 8.2 6.7 3.87 15.7 
New Mexico 2.35 5.68 4.33 8.7 7.35 4.19 16.3 
New York 2.63 5.43 3.8 8.45 6.83 3.9 21.0 
North Carolina 2.75 5.9 4.15 8.28 6.53 3.79 16.6 
North Dakota 2.2 5.98 4.78 9.23 8.03 4.51 24.1 
Ohio 2.63 5.83 4.2 8.5 6.88 3.94 16.5 
Oklahoma 2.58  5.73 4.15 8.45 6.88 3.95 20.8 
Oregon 2.83 5.65 3.83 8.58 6.75 3.84 16.6 
Pennsylvania 2.65 5.68 4.03 8.55 6.9 3.94 18.6 
Rhode Island 2.58 5.45 3.88 8.55 6.98 3.96 18.1 
South Carolina 2.45 5.68 4.23 8.18 6.73 3.89 14.3 
South Dakota 2.35 5.48 4.13 8.63 7.28 4.15 24.1 
Tennessee 2.65 5.6 3.95 8.48 6.83 3.89 20.3 
Texas 2.83 5.3 3.48 8.23 6.4 3.68 13.6 
Utah 2.43 5.38 3.95 8.78 7.35 4.16 13.6 
Vermont 2.75 5.65 3.9 8.78 7.03 3.99 19.8 
Virginia 2.6 5.78 4.18 8.38 6.78 3.89 16.0 
Washington 2.55 5.65 4.1 8.68 7.13 4.08 16.3 
West Virginia 2.55 5.78 4.23 8.8 7.25 4.13 22.0 
Wisconsin 2.53 5.55 4.03 8.53 7 4.01 18.6 
Wyoming 2.33 5.53 4.2 8.98 7.65 4.29 18.0 
*Month 1 = September 
†Statistically-significant analyses at p<0.05 level. 





Table 3.4: Frequency of the origination of the start, peak, and end of epidemic influenza in the 




















1 California 1 Delaware (21) 1 District of 
Columbia (14) 
1 New Mexico (8) 
2 New York 2 District of 
Columbia (19) 
2 Wyoming (10)  South Carolina (8) 
3 Texas 3 Idaho (18) 3 Idaho (9) 3 Kansas (7) 
4 Florida 4 North Dakota 
(17) 
 Nevada (9)  New Hampshire 
(7) 
5 Pennsylvania  Wyoming (17)  New Jersey 
(9) 
 Rhode Island (7) 
6 Illinois 6 Minnesota (15)  Rhode Island 
(9) 
 Texas (7) 
7 Ohio  New Mexico 
(15) 
7 Montana (8) 7 Alabama (6) 
8 Michigan  Vermont (15)  Utah (8)  Connecticut (6) 
9 New Jersey 9 Nebraska (14) 9 Colorado (7)  Idaho (6) 
10 North 
Carolina 
 South Dakota 
(14) 
9 Delaware (7)  Illinois (6) 
11 Georgia 11 Montana (13)  New York (7)  Kentucky (6) 
12 Virginia  Rhode Island 
(13) 
13 Arizona (6)  Montana (6) 
13 Massachusetts 13 Indiana (12)  Massachusetts 
(6) 
7 North Carolina (6) 
14 Indiana  Utah (12)  New Mexico 
(6) 
14 District of 
Columbia (5) 
15 Missouri 15 Illinois (11)  South Dakota 
(6) 
 Massachusetts (5) 
16 Tennessee  Iowa (11)  Vermont (6)  Mississippi (5) 
17 Wisconsin  Kansas (11) 17 Connecticut 
(5) 
 Missouri (5) 
18 Washington  Kentucky (11)  Illinois (5)  Nebraska (5) 
19 Maryland  Maine (11)  Maine (5)  New Jersey (5) 
20 Minnesota  South Carolina 
(11) 
 Maryland (5)  South Dakota (5) 
21 Louisiana 21 Maryland (10)  Pennsylvania 
(5) 
 Utah (5) 
22 Alabama  Michigan (10)  Washington 
(5) 
 Wyoming (5) 
23 Arizona  New Jersey 
(10) 
23 California (4) 23 California (4) 
24 Kentucky 24 Arkansas (9)  Nebraska (4)  Delaware (4) 
25 South 
Carolina 
 Washington (9)  Oregon (4)  Georgia (4) 
26 Colorado  West Virginia 
(9) 
 Wisconsin (4)  Indiana (4) 
27 Connecticut  Wisconsin (9) 27 Alabama (3)  Louisiana (4) 
28 Oklahoma 28 Colorado (8)  Georgia (3)  Maryland (4) 
29 Oregon  Connecticut (8)  Iowa (3)  Minnesota (4) 
30 Iowa  Mississippi (8)  Louisiana (3)  New York (4) 
31 Mississippi  New 
Hampshire (8) 
 Michigan (3)  Oklahoma (4) 
32 Kansas  New York (8)  Minnesota (3) 32 Arizona (3) 
33 Arkansas  Ohio (8)  Mississippi (3)  Maine (3) 
34 West Virginia  Virginia (8)  New 
Hampshire (3) 





35 Utah 35 Alabama (7)  North Carolina 
(3) 
 Nevada (3) 
36 Nebraska  Georgia (7)  North Dakota 
(3) 
 North Dakota (3) 
37 New Mexico  Missouri (7)  South Carolina 
(3) 
 Oregon (3) 
38 Nevada 38 Arizona (6)  Tennessee (3)  Pennsylvania (3) 
39 Maine  Florida (6)  Texas (3)  Virginia (3) 





 West Virginia 
(3) 
 West Virginia (3) 
42 Rhode Island  Nevada (6) 42 Arkansas (2)  Wisconsin (3) 
43 Montana  Pennsylvania 
(6) 
 Florida (2) 43 Arkansas (2) 
44 South Dakota  Tennessee (6)  Indiana (2)  Colorado (2) 
45 Delaware 45 Oklahoma (5)  Kansas (2)  Iowa (2) 
46 North Dakota 46 North Carolina 
(4) 
 Kentucky (2)  Tennessee (2) 
47 District of 
Columbia 
 Oregon (4)  Missouri (2)  Vermont (2) 
48 Vermont 48 California (3)  Ohio (2) 48 Florida (1) 







Table 3.5: Correlation between temporal parameters and central latitude and longitude of the 48 
contiguous United States and the District of Columbia, 1968-2008 
 
Variable R2 Pearson correlation – 
latitude 
(95% Confidence Interval) 
Pearson correlation – 
longitude 

































































































Figure 3.2: The average spread of epidemic influenza at the beginning of waves in the continental United 
States, 1968-2008 during: (A) the entire epidemic period, (B) H1N1-prominent influenza seasons (N=7), 
and (C) H3N2-prominent influenza seasons (N=25). States are shaded in varying shades of gray in 
accordance to the average month in which the first pneumonia and influenza deaths were recorded. States 
shaded black represent possible seed locations for epidemic influenza. The first month, 1, of seasonal 

































Table 3.6: Correlation between identified start month of seasonal influenza and latitude and longitude for 



















1968-69 0.2011 0.0674 -0.24355 0.0917 0.12066 0.4089 North-South West-East 
1969-70 0.1716 0.0738 -0.16549 0.2558 -0.2064 0.1548 North-South East-West 
1970-71 0.6357 0.0195 0.06165 0.6739 -0.12837 0.3794 South-North East-West 
1971-72 0.3279 0.0473 0.21717 0.1339 -0.02417 0.8691 South-North East-West 
1972-73 0.5477 0.0258 -0.03127 0.8311 0.15908 0.2749 North-South West-East 
1973-74 0.2152 0.0646 0.23908 0.098 0.07365 0.615 South-North West-East 
1974-75 0.4491 0.0342 0.03675 0.802 -0.18294 0.2083 South-North East-West 
1975-76 0.0054 0.2032 0.43875 0.0016 -0.12641 0.3867 South-
North 
East-West 
1976-77 0.0204 0.1556 -0.28846 0.0444 -0.25358 0.0787 North-
South 
East-West 
1977-78 0.6212 0.0205 0.12354 0.3977 -0.07864 0.5912 South-North East-West 
1978-79 0.3843 0.0407 0.19428 0.181 0.04434 0.7623 South-North West-East 
1979-80 0.1023 0.0944 0.28759 0.0451 0.0927 0.5264 South-
North 
West-East 
1980-81 0.0131 0.1719 -0.33025 0.0205 0.26754 0.0631 North-
South 
West-East 
1981-82 0.1149 0.0898 -0.05061 0.7298 -0.29226 0.0416 North-South East-West 
1982-83 0.6402 0.0192 0.11537 0.4299 0.07059 0.6298 South-North West-East 
1983-84 0.0433 0.1276 -0.20308 0.1617 -0.28286 0.0489 North-South East-West 
1984-85 0.0498 0.1223 -0.34789 0.0143 -0.01759 0.9045 North-
South 
East-West 
1985-86 0.0053 0.2037 -0.11057 0.4495 0.44273 0.0014 North-South West-East 
1986-87 0.0618 0.114 -0.27952 0.0518 -0.17454 0.2303 North-South East-West 
1987-88 0.5331 0.027 0.02471 0.8662 -0.16345 0.2618 South-North East-West 
1988-89 0.5679 0.0243 -0.12314 0.3993 -0.08903 0.543 North-South East-West 
1989-90 0.701 0.0153 0.04558 0.7558 -0.11732 0.4221 South-North East-West 
1990-91 0.7955 0.0099 0.02647 0.8567 0.09437 0.5189 South-North West-East 
1991-92 0.4111 0.0379 0.06839 0.6405 0.17847 0.2198 South-North West-East 
1992-93 0.2609 0.0567 -0.2308 0.1106 0.07095 0.6281 North-South West-East 
1993-94 0.485 0.031 -0.17383 0.2323 -0.01838 0.9003 North-South East-West 
1994-95 0.028 0.144 -0.37888 0.0073 -0.00204 0.9889 North-
South 
East-West 
1995-96 0.0003 0.2994 -0.5129 0.0002 0.21731 0.1336 North-
South 
West-East 
1996-97 0.1859 0.0706 -0.23871 0.0986 -0.10383 0.4777 North-South East-West 
1997-98 0.0205 0.1555 -0.1624 0.2649 0.36738 0.0094 North-South West-East 
1998-99 0.3033 0.0505 -0.1211 0.4072 -0.18281 0.2087 North-South East-West 
1999-00 0.0847 0.1018 -0.21875 0.131 0.24331 0.0921 North-South West-East 
2000-01 0.4376 0.0353 -0.11426 0.4344 0.15489 0.2879 North-South West-East 
2001-02 0.2731 0.0549 -0.18745 0.1971 -0.13043 0.3717 North-South East-West 





2003-04 0.2087 0.0659 -0.19371 0.1823 0.17824 0.2205 North-South West-East 
2004-05 0.438 0.0353 0.17993 0.216 -0.06299 0.6672 South-North East-West 
2005-06 0.0685 0.11 -0.15046 0.3021 0.30305 0.0343 North-South West-East 
2006-07 0.7819 0.0106 0.01404 0.9237 -0.10279 0.4822 South-North East-West 
2007-08 0.007 0.1942 0.41465 0.0031 -0.17055 0.2413 South-
North 
East-West 






Table 3.7: Correlation between identified start, peak, and end month of seasonal influenza and latitude 
and longitude for the continental United States, 1968-2008, by dominant subtype(s) 
 
Variable Subtype(s) R2 Pearson correlation-
latitude 
(95% Confidence Limit) 
Pearson correlation- 
longitude 







All 0.0024 -0.0474 
















































































































































































Figure 3.3: The latitude of 49 States (48 contiguous states and the District of Columbia) correlated against 





























Figure 3.4: The longitude of 49 States (48 contiguous states and the District of Columbia) correlated 
















Understanding the quantitative disease dynamics of influenza is important in developing 
strategies to control its spread. This research sought to determine the dominant spread process of 
epidemic influenza in the continental United States over a 40-year period. Spatial autocorrelation 
and simple correlation were applied to pneumonia and influenza mortality to observe the effect 
of distance and population on the between-state transmission of seasonal influenza. Annual 
influenza epidemics exhibited contagious spatial spread at the peak of activity while there was 
not significant hierarchical spread at any point during annual waves. Moreover, geographically-
close States showed higher correlations in the start, peak, and end of annual epidemics compared 
with geographically-distant States. Despite the lack of contagious diffusion over an entire wave 
in the U.S., significant local clustering was found in the Midwest, Ohio River Valley, and 
Northeastern regions as well as Nevada and Utah at all phases of an epidemic wave. This 
research may be combined with others in order to determine the main epidemic pathways of 








Recurrent epidemics of influenza occur annually during the winter season in temperate 
areas of the world, such as the United States. They are the result of genetic drift in which, in 
order to escape host immunity, the surface antigens of influenza viruses undergo small changes 
(1). These annual influenza epidemics cause considerable morbidity, mortality, and economic 
burden (2). In the U.S. alone, approximately 24,000 deaths a year can be attributed to influenza 
(3).  
It is crucial to understand quantitatively how a disease spreads in modern society. The 
sudden appearance of the 2009 H1N1 pandemic increased interest in the design of efficient 
containment policies and demands for an accurate characterization of spatial and temporal 
epidemic influenza patterns (4-8). One of the most important control strategies that arose out of 
the 2009 pandemic was the need to identify the main channels of transmission or “epidemic 
pathways” of seasonal influenza in the U.S. In fact, identification of these pathways is the first 
clue on how to control influenza’s spread (9). 
While much is understood about the make-up and impact of seasonal influenza in the 
U.S., the spatial pattern of epidemic influenza has been less well characterized.  Prior studies 
have analyzed the spread of influenza, developed unique models to describe and understand this 
disease, and explained the spatial distribution of influenza spread and of annual waves of 
infection in the U.S. (10-14). However, these studies have failed to detect the preferred channels 
of transmission for epidemic influenza in the U.S. 
This study describes the method I used to identify the dominant spreading process in the 
U.S. I combined spatial autocorrelation with simple correlation to illustrate the disease dynamics 





epidemic spread by determining the dominant spread process of epidemic influenza in the 
continental United States over a 40-year period. 
Methods 
 To examine the spatial structure of influenza epidemics in the continental United States 
between 1968 and 2008, I drew on monthly counts of pneumonia and influenza (P&I) mortality 
obtained from the National Centers for Health Statistics (NCHS) and Centers for Disease Control 
and Prevention (CDC) Wonder Online Data System for Multiple Cause of Death (15-16). 
Population estimates used in the calculation of mortality rates were obtained from the Census 
Bureau (17-18). Methods to identify the timing of influenza seasons have been previously 
described (19). 
Spread processes of influenza mortality 
I used a technique of autocorrelation on graphs in order to determine the nature of the 
processes that underlie the spread patterns of epidemic influenza in the U.S. To perform spatial 
autocorrelation analysis, the area in which spread occurs (i.e. United States) was treated as a 
graph consisting of a set of nodes, States, and the links between them. The links were chosen to 
create a graph which corresponds with the hypothetical diffusion process. Analyses examined 
three main types of diffision process for infectious disease: contagious, hierarchical, and mixed 
(20-21). This analysis produced three graphs. 
A contagious process represents a highly localized diffusion process and implies that 
influenza mortality moves in a wave-like pattern from its center of introduction to its closest 
neighbor. A contagious graph represents the simplest network configuration that links all 
geographical units and minimizes the straight-line distance between them. For each month of the 





W if geographical units i and j were linked in the configuration, and ij=0 otherwise. The effect 
of distance on the correlation of P&I mortality between geographic units decreased as distance 
between two geographic units increased. 
A hierarchical, or population-based, process would imply that influenza mortality in the 
U.S. moves progressively from more populuous States to less populous States. In a hierarchical 
graph, ij=1 if geographic unit j was the next larger or the next smaller unit in population size to 
unit i and ij=0 otherwise. A mixed process would imply that influenza mortality in the U.S. 
follows a spread pattern that contains both contagious and hierarchical components. In the mixed 
contagious-hierchical graph, ij=1 if unit j was the geographically nearest unit that was either 
larger or smaller in population size than unit i, and ij=0 otherwise. 
The spatial autocorrelation coefficient, Moran’s I, was computed for each graph and 
month of the 492-month time series of P&I death rates per 100,000 population in order to 
determine the goodness-of-fit between each of the diffusion graphs above and P&I mortality rate. 
It is a weighted correlation coefficient for X, mortality rate, where the weights depend on the 
distance, h, between two regions. Values above z=1.96 mark statistically significant I 
coefficients at the p=0.05 level in a two-tailed test for positive spatial autocorrelation and 
indicate periods when the actual diffusion process corresponded significantly with each diffusion 
graph. The larger the I coefficient, the greater the degree of agreement between a given graph 
and the influenza death rate. Anselin Local Moran’s I Spatial Autocorrelation statistic (LISA) 
was also computed for the P&I mortality rate of each State and each month in the time series in 
order to identify significant local clustering patterns. Unlike Moran’s I, a global statistic, the 
LISA statistic focuses on local patterns of associations (or hotspots) and allows for local 





epidemic months of U.S. influenza seasons as well as for the build-up, peak, and fade-out phases 
of these waves. 
The global mean is the average of all of the analysis field values; the local mean is the 
average analysis field value for a target feature’s neighbors. For each P&I mortality rate in the 
dataset, ArcGIS calculated the z-score, p-value, and local mean, and then for features that were 
statistically significant, determined their outlier classifications. There are four types of outlier 
clustering that can be observed: High-High, High-Low, Low-High, Low-Low. High-High spatial 
clustering indicates that neighboring states share significantly similar high P&I mortality rates at 
a given time. The P&I mortality rate for each State are higher than the global mean. High-Low 
spatial clustering indicates that a State with a high P&I mortality rate at a particular point in time 
is significantly similar to a neighboring state with a low P&I mortality rate. The P&I mortality 
rate for one State is higher than the local mean while the P&I mortality rate for the other State is 
lower than the local mean. Low-High spatial clustering is the opposite of High-Low spatial 
clustering. Low-Low spatial clustering indicates that two neighboring states have significantly 
similar low P&I mortality rates at a given time. The local means for each State are lower than the 
global mean. 
Correlation of seasonal timing between States 
For all pairs of states i and j, I computed Pearson correlation coefficient, rij, for the start, 
peak, and end month of influenza spread over the entire study period. These coeffiecients were 
then plotted against the distance between pairwise states. This allowed for a quantitative estimate 
of the correlations existing between different areas in terms of the beginning, height, and end of 
influenza seasons. This analysis combined with the spatial autocorrelation analysis, allowed me 






 Figure 4.1 plots the monthly values of the spatial autocorrelation coeffiecient for the 
contagious (1A), hierarchical (1B), and mixed contagious-hierarchical (1C) diffusion graphs. 
These graphs also contain a plot of the monthly series of P&I mortality rate for the continental 
United States from January 1968 to December 2008. A vertical dashed line is set at z=1.96 to 
indicate statistically significant I coefficients at the p=0.05 level in a two-tailed test for positive 
spatial autocorrelation. A spatial contagious diffusion process appears to have had the highest 
contribution to the spread of influenza throughout the study period. Out of 492 months, 135 
months demonstrated positive spatial autocorrelation (144 total months demonstrated positive 
and negative spatial autocorrelation) on the contagious graph. In contrast, only 18 months of the 
hierarchical graph (60 total months had spatial autocorrelation) and 26 months of the mixed 
contagious-hierarchical graph (77 total months had spatial autocorrelation) showed positive 
spatial autocorrelation. Of the 268 epidemic influenza months analyzed, 90 months (92 total 
months had spatial autocorrelation) of the contagious model, 9 months (36 total months had 
spatial autocorrelation) of the hierarchical model, and 14 months (42 total months had spatial 
autocorrelation) of the mixed contagious-hierarchical model demonstrated positive spatial 
autocorrelation. 
 The spatial autocorrelation coefficient, Moran’s I, was averaged (Ī ) for the entire study 
period for the build-up, peak, and fade-out of annual epidemics as well as for the entire epidemic 
period. The results presented in Tables 4.1 and 4.2 suggests that neither distance nor population 
played a significant role over an entire epidemic wave. Distance dependence (i.e. contagious 
spread process) is more significantly associated with the spread of influenza in the continental 





periods for the contagious process was not significant. Nevertheless, distance dependence 
appears to play a major role in the vicinity of an epidemic’s peak. Distance did not appear to 
drive influenza spread during the months preceding and following peak activity. Population did 
not significantly drive influenza spread during any part of a season. 
 State pairwise Pearson correlation coefficients were determined for the first, peak, and 
end months of influenza activity. These correlations are plotted against the distance between 
pairs of states and presented in Figures 4.2-4.4. As seen in the spatial autocorrelation analysis, 
distance played a more important role in the peak of epidemic influenza than it did at the 
beginning and end of seasons. Although distance did not explain the total variance in the model  
(R
2
=0.1624), it’s effect on influenza spread was statistically significant (p<.0001), suggesting 
that it is an important factor in influenza spread at the seasonal peak. 
 Significant local clustering was found when LISA analyses were performed even though 
distance did not play a significant part of seasonal influenza in the U.S. over an entire wave or in 
the build-up and fade-out phases of influenza waves. The results presented in Figure 4.5 show 
that significant similarities in high P&I mortality rates (i.e. High-High) were found in States in 
the Midwest (Arkansas, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, 
Oklahoma, and South Dakota), Ohio River Valley (Kentucky, Tennessee, and West Virginia), 
and Northeastern (Connecticut, Massachusetts, New York, and Vermont) regions over an entire 
average influenza wave and at every phase of a season. The western States of Nevada and Utah 
displayed significant similarities in low P&I mortality rates (Low-Low) over all phases of an 
average influenza wave. These results also may explain why distance was not a significant 
contributor to influenza spread over an average wave. While significant clusters were observed 





values during an entire average influenza wave. During the build-up, peak, and fade-out portions 
of an average wave, 20, 40, and 23 States, respectively, had significant average LISA values. 
The high number of States with signficiant average LISA values at the peak of an average 
influenza season corresponds with the significant average global Moran’s I, Ī, statistic observed 
during the spatial autocorrelation analysis for this time period, which was presented earlier. 
Discussion 
 The spread of influenza in the continental U.S. was characterized by reliance on distance 
and close proximity. A clearly defined process of spatial contagion drove the spread of annual 
influenza waves. Hierarchical diffusion played a much smaller role in influenza spread in the 
U.S. and did not appear to influence spread during any part of an annual epidemic wave. 
Although the strength and timing of contagious transmission did vary between the waves, the 
broad findings implicate that spatial proximity is most important at the peak of an epidemic. 
Spatial contagion may be most important at the height of annual influenza spread because local 
dynamical heterogeneities may dominate when an epidemic builds, but there is significantly 
rapid spread of cases to geographically-close States at its peak because the State can no longer 
produce enough new cases to sustain intrastate transmission. An annual epidemic may spread to 
other locales faster than it builds up within a State. Indeed, during the build-up phase of a wave, 
the number of cases in a State increases after it becomes infected and the microscopic spread of 
influenza is more rapid than the macroscopic dynamics, so within-State dynamics dominate. This 
may explain why distance was not observed to be very important in the spread of influenza at the 
beginning of a season. Intrastate transmission, or the neighborhood effect, was enough to create 
and sustain States’ influenza season. It is only at the peak of an influenza season where local 





geographically-close locales. Hierarchical processes may not have been observed in the data 
because the rapidity of epidemic transmission in the U.S. may overwhelm the effects of 
population and population density. 
 As stated previously, although distance did not assert a significant impact on the spread 
of influenza in the continental U.S. as a whole, I did observe significant spatial clustering in parts 
of the U.S. at every phase of an influenza wave. These clusters indicate that distance is important 
to influenza spread in certain parts of the country. The spread of influenza in States in the East 
North Central, Mid-Atlantic, and New England regions tend to be very dependent on spread in 
neighboring States. Nevada and Utah also share a highly dependent connection and exert some 
influence on the spread of influenza in the neighboring States, California, Oregon, and Arizona. 
This analysis also suggests that the spread of influenza in southern and Mountain-region States 
may be dependent on long-distance connections (or other factors) since significant spatial 
clustering in these States were only observed during the peak phase of an average influenza 
wave. The dependence of influenza spread in southern States on long-distance connections may 
also explain why previous research observed that southern States typically receive seasonal 
influenza later than their northern counterparts. Long-distance travel in the U.S. tends to lag in 
the early fall and pick up during the late fall (November and December) around the holidays. 
Therefore, the decreased contact rate and flow of infected persons may delay new influenza 
infections and local spread dynamics are not large enough to create a significant increase in P&I 
mortality in southern States. 
 The results of this analysis are similar to previous research that has also shown spatial 
contagion plays an important role in influenza spread in the U.S (23-24). This research also 





proximity may only be present at the height of an epidemic, although some States are more 
dependent on distance than others. However, this analysis disagrees with a previous French study 
(11) that reported influenza diffusion occurs over long distances before the epidemic builds up in 
communities. Although some distant States in this study did have high synchrony in the timing 
of their annual influenza waves and spread was not dependent on distance at the initiation of 
waves, in general, States that were in close proximity (<500 miles) had the highest correlations 
in their epidemic timing. Additionally, States in certain regions exhibited high spatial synchrony 
during all phases of an influenza wave, indicating geographic heterogeneities played a major role 
here. While other States did not exhibit spatial synchrony until an epidemic’s peak, meaning that 
long distance connections, or global mixing, or local diffusion drove influenza transmission in 
these States before spatial clustering dominated. I found that spatial contagion is the dominant 
spreading process of influenza in the continental United States, but may not be the only 
spreading process. As others have shown, air travel and workflow may make the most 
contribution to the influenza spread process, although this research did not explore these factors 
(23-25). 
 This study suggests that important public health implications can be made by considering 
spatial relation in influenza transmission. Researchers can combine these results with other 
modeling techniques in order to determine the most effective method of allocating resources, 
especially if they are limited. State-level clinical interventions can be enhanced by forecasting 
the expected intensity of disease and the timing of an influenza epidemic wave simply by 
looking at its effect in a neighboring State. Moreover, identifying geographic clusters of strongly 





transmission, which can be helpful in modeling the spread of epidemics and in assessing 
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Figure 4.1: Diffusion of pneumonia and influenza (P&I) mortality in the continental United States, 
1968-2008. Area charts plot the monthly P&I death rate per 100,000 population. Corresponding values 
of the spatial autocorrelation coefficient, Moran’s I, as a standard Normal deviate for different 
diffusion processes are superimposed as line traces. (A) Contagious diffusion. (B) Hierarchical 
diffusion. (C) Mixed contagious-hierarchical diffusion. Dotted horizontal lines at z=1.96 mark the 






Table 4.1: Average monthly values of the z-value of the Moran I statistic, Ī, by diffusion process and 
phase of wave development for influenza in the continental United States, 1968-2008 
 
Wave phase Ī, Contagious Ī, Hierarchical Ī, Mixed 
Entire wave 1.05 -0.11 -0.09 
Build-up 0.84 -0.10 -0.14 
Peak 2.78 -0.22 -0.18 
Fade-out 0.91 -0.14 -0.11 
Values of Ī in excess of z=1.96 in bold font 
 
Table 4.2: Average monthly values of the z-value of the Moran I statistic, Ī, by diffusion process and 
phase development for epidemic influenza in the continental United States, 1968-2008 
 
Wave phase Ī, Contagious Ī, Hierarchical Ī, Mixed 
Entire wave 1.47 -0.25 -0.21 
Build-up 1.19 -0.15 -0.21 
Peak 2.93 -0.31 -0.15 
Fade-out 1.23 -0.33 -0.23 
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Figure 4.2: Correlation of the start month of influenza seasons between continental U.S. States plotted 
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Figure 4.3: Correlation of the peak month of influenza seasons between continental U.S. States plotted 




































Figure 4.4: Correlation of the end month of influenza seasons between continental U.S. States plotted 

























Figure 4.2: Average local spatial clustering of monthly P&I mortality rates in the continental United States, 1968-2008, for A) All 
epidemic influenza months, B) Build-up phase of annual influenza waves, C) Peak phase of annual influenza waves, D) Fade-out 
phase of annual influenza waves; NS=Not Significant 
 
































































































Assessing the impact of pandemic influenza on the spatial and temporal dynamics of epidemic 








Although pandemic and epidemic influenza cause considerable morbidity and mortality and differ in 
many aspects, the effect of pandemic strains on spatial and temporal patterns of influenza spread has 
not been assessed. This research examined the effect of the introduction of the 1968-69 H3N2 
pandemic strain and reintroduction of H1N1 during the 1977-78 influenza season on the State-specific 
timing and spread of successive epidemics in the U.S. Using pneumonia and influenza mortality for 48 
continental U.S. States and the District of Columbia for the years 1968 to 1972 and 1974 to 1981, this 
research analyzed differences in the epidemic timing (start, peak, and end) and spatial spread of 
influenza between novel viral seasons and preceding and succeeding waves. Generalized linear models 
were used to determine significant differences between each time period and epidemic timing. As 
hypothesized, successive waves of novel viral seasons were observed to be significantly longer (1968-
69 vs. later waves: 5.6 vs. 7.1 months, p<.0001; 1977-78 vs. later waves: 5.9 vs. 6.9 months; 
p=0.0002) and slower in progression (Average time to death, 1968-69/later waves: 3.2 vs. 4.1 months; 
p<0.0001; 1977-78/later waves: 3.4 vs. 4.0 months; p<.0001) on the State-level. Successive waves also 
began earlier and ended later than either the 1968-69 pandemic season or the 1977-78 epidemic season 
(p<0.05). Assessing the effect of the introduction of pandemic influenza strains on the spatiotemporal 







Annual influenza epidemics are caused by antigenic drift in influenza viruses, which has 
allowed this disease to persist for several millennia (1). Influenza pandemics, which occur every 10-40 
years, are instead caused by antigenic shift, a sudden or total change in either or both of the surface 
antigens, hemagglutinin and neuraminidase. This produces a “new” virus in which the population has 
little to no immunity (2). The low population immunity to this “new” virus is why pandemic influenza 
strains usually cause significant excess mortality compared to seasonal epidemic strains (3). 
In the fall of 1968, the H3N2 Hong Kong influenza pandemic arrived in the United States and 
immediately caused high influenza attack rates, however its impact on excess mortality was less than 
what was observed in earlier pandemics (4-5). Still, although estimated numbers of deaths in the 1968-
69 influenza pandemic (between 34,000 – 51,000) were similar to annual estimates of deaths attributed 
to seasonal influenza epidemics (between 33,000 – 51,000), excess mortality during this pandemic was 
significantly higher than these epidemic seasons (5-6). In 1977, the H1N1 influenza virus was 
reintroduced into the population after a 20-year absence. This was an unusual situation considering 
circulating influenza A subtypes are always completely replaced by pandemic influenza subtypes (i.e. 
H1N1 was replaced by H2N2 in 1957; H2N2 was replaced by H3N2 in 1968) and never return to 
circulation in a significant capacity (3). 
Although we know that pandemic and seasonal epidemics vary greatly in their severity, 
preexisting immunity to the specific influenza viruses, and viral make-up, not much is known about the 
variations in spatial, temporal, and spatiotemporal characteristics. We also do not know how the 
reintroduction of a prior influenza strain, one which preexisting immunity at the population level is still 
relatively high, affects the spatial and temporal dynamics of seasonal influenza in the U.S. This 
research investigated the effect of the introduction or reintroduction of a novel influenza virus subtype 





hypothesized that, considering the rapid nature of pandemic influenza spread, influenza waves that 
followed the 1968-69 pandemic and the 1977-78 reintroduction of H1N1 influenza seasons will be 
longer and slower in progression than the prior season that introduced or reintroduced the virus. 
However, I do not foresee a change in the spatial spread of epidemic influenza. Understanding the 
impact of previous influenza pandemics on successive influenza epidemics may provide useful 
information for preparing for future influenza pandemics. It will also aid the U.S. government in 
allocating resources and planning intervention and containment strategies for future pandemics. 
Methods 
Monthly pneumonia and influenza (P&I) data for the years 1968 to 1972 and 1974 to 1981 in 
the 48 continental states and the District of Columbia were obtained from the annual Vital Statistics of 
the United States published by the National Center for Health Statistics (NCHS) through the Centers 





Census Year 1970) for each State, which form the basis of the mortality rates used in this analysis, 
were obtained from the Census Bureau (8-9). P&I mortality for years 1968 to 1972 and 1974 to 1977 
were collected and classified as 470-474 (influenza) and 480-486 (pneumonia) in accordance to the 
Eighth Revision of the International Classification of Diseases, Adapted for Use in the United States 
(ICDA-8) (10). Codes 480-488 from the Ninth Revision of ICD, ICD-9, were used to classify P&I 
deaths for the years 1978 to 1981 (11). 
Methods to identify annual seasonal influenza waves have been previously described (12). 
Wave velocity or average time to death, 
  
t , was assessed for each state and the U.S. as a whole and for 
each influenza season. The following formula was used: 
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where xt is the number of reported P&I deaths in month t and n=xt is the sum of all reported P&I 
deaths for all t (13).  Average time to death indicates the average amount of time in months all P&I 
deaths were recorded in a state in an influenza season. Higher values indicate relatively slow moving 
waves and lower values indicate relatively fast moving waves. 
For the 1968-69 pandemic, I examined the immediate effect it exerted on the spatiotemporal 
dynamics of seasonal influenza in the continental United States. Successive waves of this pandemic 
were defined as influenza seasons 1969-70, 1970-71, and 1971-72.  For the 1977-78 reintroduction of 
H1N1, I examined the change in the spatio-temporal dynamics of seasonal influenza in the U.S. 
between the three preceding waves (1974-75, 1975-76, and 1976-77) and the 1977-78 influenza season 
and the immediate effect the reintroduction of H1N1 had on the spatiotemporal characteristics of 
successive waves (1978-79, 1979-80, and 1980-81) of epidemic influenza in the U.S.  
In order to examine the difference in the timing of influenza waves in the three seasons that 
followed the 1968-69 pandemic and 1968-69, the State-specific first, peak, and end months of 
influenza waves, wave velocity, and season length were averaged for the successive waves. 
Generalized linear models were then used to compare State temporal measures seen during the 1968-
69 pandemic with the average temporal measures seen during the three succeeding waves. State-level 
mean total seasonal P&I mortality and mean seasonal P&I mortality rate for the influenza seasons 
1969-70, 1970-71, and 1971-72 were also compared with total seasonal P&I mortality and seasonal 
P&I mortality rate of the 1968-69 pandemic. Temporal measures were then plotted against the central 
latitude and longitude of States through linear regression and correlation analyses in order to determine 
if the 1968 pandemic exhibited a significant effect on the spatial spread of influenza in latter seasons 
and the strength of this association. Pearson correlation coefficients, r, and 95% confidence intervals 
(CI) were assessed for each chart. Generalized linear models were also used to compare mean temporal 





pandemic for the U.S. as a whole. These analyses were repeated for the 1977-78 reintroduction of 
H1N1 to assess its deviation from the spatiotemporal spread of previous influenza waves and impact 
on the spatiotemporal spread of subsequent waves. 
Results 
The 1968-69 pandemic began its spread in the continental United States in November 1968 and 
ended in April 1969, although some individual states saw the novel H3N2 virus as early as September 
1968. During this time, the 1968 H3N2 pandemic reached its height in January 1969, three months 
after it began, and caused 49,603 P&I deaths (24.5 P&I deaths per 100,000 persons). The 1977-78 
influenza season lasted between November 1977 (only two states received influenza prior to this, 
Rhode Island and Wyoming, in October 1977) and April 1978, with peak P&I mortality observed 
during January 1978. There were 36,811 P&I deaths (16.5 P&I deaths per 100,000 persons) reported 
during this time where H1N1 was reintroduced. 
Effect of 1968-69 pandemic on successive waves 
Table 5.1 displays the mean temporal measures of States in 1968-69 and the three succeeding 
waves of 1968-69. States observed significantly earlier and later-ending influenza waves immediately 
following the 1968-69 pandemic (p<0.0001; p = 0.0017) compared to the pandemic season. Moreover, 
States observed longer and slower influenza waves in successive seasons of the 1968 pandemic 
(p<0.0001; p<0.0001) compared to the pandemic season. The average peak month of influenza activity 
for States in the years 1969-70, 1970-71, and 1971-72 was about 0.5 months later than what was seen 
in those same States during the 1968-69 pandemic. The States in the 1968-69 successive influenza 
seasons also took longer to achieve peak P&I mortality, approximately 1.5 months later, compared to 
States in the 1968-69 pandemic (p<0.0001). Both mean total P&I mortality and mean mortality rate for 
States during the waves following the 1968-69 pandemic were significantly lower than what was seen 





mortality differed between the 1968-69 pandemic and the three subsequent waves (3 months vs. 4 
months; p<0.0001). This was most likely due to the low data counts (N=4). 
Maps of the spread of influenza in the 1968-69 pandemic and the average spread of influenza in 
the three waves following 1968-69 are displayed in Figure 5.1. There was not a significant spatial trend 
found for either the 1968-69 pandemic or the three waves following this pandemic. Nevertheless, the 
first month of influenza spread for 1968-69 suggested a North-South and West-East spread whereas the 
average first month of influenza spread for the three successive waves suggested a South-North and 
East-West spread (Table 5.2). In 1968-69, influenza began in the Mountain region and then spread to 
the rest of the continental U.S., whereas in the following seasons, early season initiation was observed 
in four distinct corners of the U.S. and then later initiation was found in the rest of the States. The 
1968-69 data did observe a significant North-South spread of peak influenza activity (r = -0.32503; 
95% CI = -0.55546, -0.04824). And, while the P&I mortality data for the successive waves of the 
1968-69 data also showed a North-South spread of peak influenza activity, it was insignificant (r = -
0.07113; 95% CI = -0.23014, 0.09206). 
Difference between the 1977-78 H1N1 reintroduction season and preceding waves 
Table 5.3 displays the mean temporal measures of States in 1977-78 and the three preceding 
and three succeeding waves of 1977-78. There was not a significant difference between the start month 
of State-specific influenza spread in the three seasons preceding the 1977-78 influenza wave than in 
the wave were H1N1 was reintroduced in the population (p = 0.2741). These preceding waves did end 
approximately ½ month later (p = 0.0017) and, therefore, lasted significantly longer than the 1977-78 
influenza wave (p = 0.0115). The peak month and time to peak P&I mortality for the three seasons 
preceding the 1977-78 H1N1 reintroduction season were also significantly later than the 1977-78 
season (p<0.0001; p<0.0001), which corresponds with the slower moving wave observed in these 





higher mean P&I mortality compared to the 1977-78 wave (741.6 vs. 719), although this figure was 
not significant (p = 0.3052). The mean P&I mortality rate for States in the preceding waves were, 
however, significantly higher than seen during the 1977-78 season (p = 0.0208). There was not a 
significant difference observed between mean national temporal measures in the seasons 1974-75, 
1975-76, and 1976-77 and those seen during the 1977-78 influenza season. 
Effect of the 1977-78 H1N1 reintroduction on successive waves 
Successive waves of the 1977-78 influenza season began significantly earlier on the State level 
than the 1977-78 season (p<0.0001), however these seasons ended around the same time as the 1977-
78 season at the State level (p = 0.942). States in the three seasons immediately following the 
reintroduction of H1N1 in 1977-78 observed longer and slower influenza waves (p = 0.0002; 
p<0.0001) than the novel-H1N1 season. Although preceding waves of the 1977-78 wave were slower 
than the 1977-78 season, States during these seasons peaked at around the same time (January) as was 
shown during the 1977-78 season (p = 0.9703), but peaked later in their respective seasons than was 
seen during the 1977-78 season (p<0.0001). There was not a significant difference in total P&I 
mortality between 1977-78 and successive waves (p = 0.3522), however States exhibited lower mean 
P&I mortality rates in succeeding waves than in 1977-78 (p = 0.0059). No significant differences were 
shown in temporal measures on the national level for these two time periods. 
Figure 5.2 displays maps of the spread of the 1977-78 influenza wave, the average spread of 
influenza during the three waves prior to 1977-78, and the average spread of influenza during the three 
waves following 1977-78. The first month of influenza for 1977-78 and the average first months of 
influenza during the preceding and successive waves did not display significant correlation with either 
latitude or longitude, but had a slight South-North direction of spread (Table 5.2). Influenza during the 
1977-78 wave and the three seasons preceding this wave also displayed general East-West spread, 





previously, this spread direction was insignificant. Instead, seasons prior to 1977-78 on average began 
in the District of Columbia, expanded to a cluster of states around D.C. (Maryland, Virginia, Delaware, 
New Jersey), and then spread to the remaining continental States. Spread during the 1977-78 wave and 
average spread between 1978 and 1981 was more diffuse at the beginning of the waves. Spread at the 
end of an influenza wave was significantly associated with latitude and longitude during 1977-78 (r = 
0.40252, 95% CI = 0.136808, 0.614197; -0.32519, 95% CI = -0.55559, -0.04843) and latitude during 
the preceding waves (r = 0.19936, 95% CI = 0.038717, 0.349959). States in the South ended their 
seasons earlier than northern states for 1977-78 and preceding waves and States in the East ended their 
seasons earlier than western states during 1977-78. 
Difference between preceding and following waves of 1977-78 
The average start month for States during the three influenza seasons that followed the 1977-78 
H1N1 reintroduction season was significantly earlier than the same measures seen in the three seasons 
that preceded 1977-78 (p<0.0001) (Table 5.3). These successive seasons also terminated and peaked 
significantly earlier (p = 0.0004; p<0.0001) than the 1974-77 preceding waves, although there was not 
a significant difference between the average length of seasons (p = 0.0851). There was not a significant 
difference between these two time periods in terms of time to peak mortality (p = 0.6726) or wave 
velocity (p = 0.0775). Furthermore, average P&I mortality and P&I mortality rate was significantly 
greater in seasons preceding the 1977-78 season than in seasons following 1977-78 (p = 0.006; 
p<0.0001). There was not a significant difference in any of the national measures between the two time 
periods (1974-77 and 1978-81). 
Discussion 
This study found that seasons where a novel influenza virus was introduced (or reintroduced) 
into the population had distinct temporal characteristics compared to surrounding seasons. As 





than their counterparts in seasons that followed them. It was also clear from this study that the spatial 
composition of seasonal influenza in the U.S. did not change despite the introduction of a novel virus. 
These findings are consistent with reports that pandemic influenza tends to spread quickly. 
Perhaps surprisingly, these results indicate that the introduction of a novel virus does not 
necessarily impact P&I mortality. While 1968-69 produced significantly higher P&I mortality (and 
P&I mortality rates) in States compared to the seasons that followed them, there was not a significant 
difference in P&I mortality between 1977-78 and the three successive influenza seasons (although 
average State P&I mortality rates were higher during 1977-78 than in the later waves). Moreover, 
average State P&I mortality rates were actually higher in seasons preceding 1977-78 than in the season 
that reintroduced H1N1. This difference may be a function of the novel virus having a differential 
effect on the populations of some States compared to others. On the national scale, P&I mortality and 
P&I mortality rate was only slightly, yet insignificantly, elevated in seasons preceding 1977-78 
compared to the novel H1N1 season (37505 vs. 36811; p = 0.8329). The elevated P&I mortality may 
also be a function of the longer seasons seen during the preceding waves than during 1977-78. 
However, P&I mortality and P&I mortality rate were also higher in seasons preceding 1977-78 than in 
seasons following it. This discrepancy may be the result of different subtypes of influenza circulating 
during these periods. H3N2 was the prominent circulating influenza strain between 1974 and 1977 
while H1N1 was the prominent circulating influenza strain between 1978 and 1981. As has been noted 
previously, H3N2-prominent seasons are usually more severe than H1N1-prominent seasons (6). It 
may also be possible that the novel influenza virus exhausted the pool of susceptibles. With fewer 
people to infect, there would then be fewer deaths as a result of influenza infection. It may take a few 
seasons for the susceptible pool to build-up to and for P&I mortality to return to pre-pandemic levels. 
This study also found that novel influenza seasons began later than surrounding seasons, which 





fall, which is characteristic of typical influenza seasons (14-16). Moreover, while I fully expected the 
introduction/reintroduction of a novel virus into the population of the U.S. would not have a significant 
impact on the spatial spread of influenza, I was surprised by the lack of a significant and definitive 
spatial spread (along latitude and longitude) during any of the time periods (pandemic or non-
pandemic) I analyzed in this research. The most significant spatial composition of influenza came 
during the time period before 1977-78 where there was a clearly defined cluster of states that initiated 
influenza early in the season. This may indicate an extensive seeding of the influenza virus in the U.S. 
Such a notion was illustrated during both the 1957-58 and 1968-69 pandemics where sporadic 
outbreaks in the civilian population developed in geographically-scattered States of the continental U.S. 
Furthermore, while scattered outbreaks occurred during the summers of 1957 and 1968, widespread 
community transmission did not begin until the fall (4, 14, 17). This may also explain why this 
research did not find early transmission of the 1968-69 pandemic. 
This study was the first to examine the difference between seasons driven by a novel influenza 
virus and the seasons that surrounded them. I found that the introduction of a novel virus may 
significantly alter some temporal characteristics of successive influenza waves. Although the temporal 
measures of the 1968-69 pandemic were completely unique compared to successive waves, the 1977-
78 H1N1 reintroduction season was similar to succeeding seasons in its epidemiology and disease 
course. Indeed, in many aspects, successive waves of 1977-78 were more similar to that wave than 
they were to previous waves of 1977-78. This similarity may be the direct result of the prominent 
presence of H1N1 in 1977-78 and following waves as well as the limited impact of H1N1’s 
reintroduction on P&I mortality. Differences observed between the 1968-69 pandemic and successive 
waves may be the result of influenza exhaustion and carry-over immunity to H3N2. 
Knowledge of the spatiotemporal characteristics of pandemic and seasonal influenza may better 





be able to recognize and inform locations when they are in imminent danger of the introduction of 
pandemic influenza into their population.  This will allow these cities to respond more quickly and 
aggressively because they will have many weeks’ notice of the severity of the pandemic (18). Properly 
implemented nonpharmaceutical interventions (NPIs)  may not be able to prevent a pandemic or 
change a population’s susceptibility to the pandemic virus, but it could delay the temporal effect of a 
pandemic, reduce the attack rate and cumulative deaths, and provide valuable time for the production 
and distribution of a vaccine and antiviral medication (i.e. PIs) for the pandemic-strain (19). In order to 
plan effective countermeasures against a possible future pandemic, it is crucial public health has a 
comprehensive understanding of the spatiotemporal patterns of past pandemics because they will offer 
insight into control strategies and what, how, and when we should prepare for a pandemic at the 
national, community, and individual level. This research also shows that the introduction of a novel 
virus may not alter the spatiotemporal aspects of seasonal influenza in the U.S. So, while intervention 
strategies may need to be altered to address a pandemic situation; these strategies may remain the same 
for the seasons following this pandemic. Influenza interventions that were effective on epidemic 
influenza prior to the introduction of a novel virus will most likely also be effective on epidemic 
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Tables and Figures 
Table 5.1: Mean temporal characteristics of States during the 1968-69 pandemic influenza wave 































































P&I = pneumonia and influenza 
All analyses are statistically significant at p=0.05 level for two-tailed tests. 






Table 5.2: Correlation between temporal measures and latitude and longitude for the continental 
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Figure 5.1: The spread of influenza at the beginning of A) the 1968-69 pandemic and B) the 

















Table 5.3: Mean temporal characteristics of States during the 1977-78 H1N1 reintroduction 
influenza wave vs. the three preceding and successive epidemic influenza waves of 1977-78 in 














































































(14.9, 16.2)  
P&I = pneumonia and influenza 
*Statistically significant at p=0.05 level for two-tailed tests. 















Figure 5.2: The spread of influenza at the beginning of waves for A) the average wave 
between 1974 and 1977, B) the 1977-78 season, C) the average between 1978 and 1981; 

































Because of the high mortality and morbidity associated with annual influenza epidemics, 
it is prudent to focus on influenza as a yearly event as well as a future disaster event.  Moreover, 
as the population ages, deaths associated with viral respiratory infections, such as influenza, will 
continue to increase. This will further burden hospital systems that already struggle to handle 
wintertime surges in patient visits during influenza seasons (1). Determining the transmission 
dynamics of influenza and quantitatively how it spreads in the U.S. is a crucial component in the 
design of efficient containment and intervention policies (2-6). Through the use of retrospective 
mortality data, this research sought to accurately characterize the spatial and temporal epidemic 
influenza patterns in the U.S. between 1968 and 2008, whether these characteristics change with 
dominant influenza type or subtype or the introduction of a novel influenza subtype, and what 
U.S. States are more likely to initiate the spread of influenza throughout the U.S. This conclusion 
synthesizes the findings presented in Chapters 2, 3, 4, and 5 in order to summarize the 
conclusions from this dissertation as a whole, reflect on the overall findings, offer public health 
implications, and suggest future research directions. 
Summary of findings 
 The analyses performed in Chapter 2 examined the reliability of nationally-collected 
mortality data as a proxy for nationally-collected viral surveillance data to estimate influenza 
activity in the U.S. as well as the similarities in temporal measures between different timing 
methods used on viral surveillance data. Mortality data was a moderate match for laboratory data 
in terms of the start and peak of seasons and, therefore, is a reasonable replacement for influenza 
viral data to approximate the timing and length of annual influenza epidemics as long as 
researchers recognize the two week time difference between influenza infection and death. 





viral surveillance data produced similar estimates. Future research should concentrate on 
estimating the time between initial influenza infection and mortality from influenza and how this 
time interval may vary by influenza type or subtype and the period of the influenza season. This 
study found that P&I mortality statistics lagged behind influenza isolates data by approximately 
one to two weeks; however, it was unable to determine exact time between infection and death 
from influenza because viral surveillance and mortality data were not linked. Further knowledge 
of this phenomenon may allow public health officials to accurately determine the effectiveness 
of influenza interventions to decrease mortality from influenza infections. It may also provide 
public health officials with an accurate assessment of the allowable time between infection and 
death interventions may have to take effect. Due to the rare availability of viral surveillance data 
compared to mortality data, especially at the State level, it was important for this research to 
confirm mortality patterns. The results of Chapter 2 indicated that P&I mortality is very adequate 
in estimating influenza activity in a country. 
 In Chapter 3, this research used pneumonia and influenza mortality to examine the 
spatiotemporal pattern of influenza spread in the United States from 1968 to 2008 and the 
differences in the timing and spread of influenza in the U.S. between dominant circulating 
influenza subtypes. A typical influenza season in the U.S. lasts approximately seven months, 
from November to May, with a peak in February. It takes approximately four months for 
epidemic influenza to spread to all 49 States of the continental U.S. Furthermore, there is a slight, 
but significant, North-South pattern in the onset of influenza spread and a slight South-North 
pattern in the cessation of an influenza wave, but not a significant pattern in the peak of influenza 
spread. For the most part, the direction of influenza transmission varied from season-to-season. 





time period. Additionally, this researched observed that Delaware was the strongest potential 
source of influenza transmission in the U.S. It had the lowest mean first month of influenza 
activity and the highest frequency of flu season initiation. However, influenza tended to be 
geographically disperse at the beginning of annual waves. 
 The finding of Delaware as a potential seeding location of influenza transmission in the 
U.S. was particularly surprising since it did not appear to have any special relation to 
neighboring States. Indeed, Delaware did not exhibit any significant spatial clustering with 
neighboring States during the build-up phase of its annual influenza waves. Instead, it began its 
average influenza wave more than half a month earlier than its neighbors Maryland (0.72 months 
later than Delaware’s average season), New Jersey (0.62 months later), and Pennsylvania (0.77 
months later). A similar finding was had for District of Columbia whose average influenza 
season began at least .4 months before its neighboring States (Maryland [0.4 months], Virginia 
[0.45 months], and West Virginia [0.4 months]). Delaware as a potential source of influenza 
transmission was also in contrast to an earlier study by Viboud and colleagues (7), which 
suggested that California was influenza’s starting point in the U.S. There may indeed be several 
reasons why Delaware is a seeding location of influenza in the nation, but may not be a source of 
influenza transmission. There may also be several reasons why California may not be a source of 
influenza transmission nor a seeding location for influenza in the U.S. 
A possible explanation is that Delaware’s early start is an artifact of its small population 
size. However, several lines of evidence suggest that this explanation is unlikely. There was not a 
significant association between population size and any spatiotemporal measure, including flu 
season initiation (see Appendix 2). Indeed, the start of influenza seasons for Delaware was 





Maine, and Nevada, but was not significantly earlier than some States with large populations, 
such as New Jersey, Michigan, and Illinois. Moreover, if the state population of Delaware was 
applied to another State, whether that State be a neighbor such as New Jersey or at a distance like 
California, that State would have the same temporal measures as it does with its own population. 
This is because the method used to determine the timing of annual influenza epidemics (i.e. 
Normal scores) does not depend on a denominator, the size of the susceptible pool, or absolute 
numbers. Instead, this method depends on the relation of monthly numbers (e.g. monthly totals 
of P&I mortalities, P&I rates) to other monthly numbers within a season for a geographic unit.  
An influenza season is determined by the identification of significant increases in 
monthly numbers, such as P&I mortality, within a season for a given geographic unit. The 
significant increases shown during Delaware’s epidemic periods would result in the same timing 
measures for its influenza seasons no matter the size of its population. Delaware was seen as an 
early initiator of seasonal influenza because significant increases in P&I mortality within the 
State occurred earlier than they did in other States and not because it has a small population size. 
It is possible there are other sources of transmission in the U.S. or sociodemographic and 
environmental factors that account for the observed early starts of Delaware’s influenza seasons. 
However, these factors remain unknown. Another possible explanation is that the influenza virus 
that circulates in Delaware may not be the same influenza virus that spreads in the U.S. during 
any given year. And this influenza virus may harbor unique spatiotemporal characteristics or 
reactions to the Delaware environment which allows for early person-to-person transmission. 
This may also be the reason why Delaware does not have any significant clustering of P&I 
mortality rates with neighboring States. For whatever reason, the neighborhood effect (i.e. 





This combined with Delaware’s early seasonal start possibly prevents Delaware’s flu season to 
significantly impact bordering States. 
Early introduction of influenza activity for Idaho, North Dakota, Minnesota and 
Wyoming may be partially due to the early arrival of low temperatures for these States. Using 
data on the normal mean daily temperatures of States, 1971-2000, from the National Oceanic and 
Atmospheric Administration (8), lower mean temperatures for November and December were 
significantly associated with earlier mean starts of influenza seasons (R
2
 = 0.1043, r = 0.323, p-
value=0.0236; R
2
 = 0.1121, r = 0.3347, p-value=0.0187). Wyoming had the sixth lowest mean 





 on the list. Moreover, North Dakota and Minnesota, which had the fourth and fifth 




 lowest mean temperatures in 
November and December. This may explain the early initiation of influenza in the Midwest and 
the significant clustering of mortality in this region. This also strengthens the case for North 
Dakota as a seed location for influenza in the U.S.  
The significant association between mean daily temperatures and seasonal influenza 
timing continued throughout the season, but in an opposite direction. Higher temperatures for the 
months of January and February were significantly associated with early mortality peaks (R
2
 = 
0.0965, r = -0.3107, p=0.0298; R
2 
= 0.1041, r = 0.3226; p=0.0238). Higher temperatures for the 
months of March through May were significantly associated with early season termination 
(March: R
2
 = 0.1155, r = -0.3398, p-value=0.016889; April: R
2
 = 0.1469, r = -0.3833, p=0.0066; 
May: R
2
 = 0.161, r = -0.4013, p=0.0043). These results are in line with the results seen in 
Chapter 3. Specifically, the slight North-South trend of flu initiation may be the result of earlier 





research observed the spread of influenza switched from North-South at the beginning of a 
season to South-North at a season’s peak and end. Southern States may experience shorter and 
earlier terminating seasons because warmer temperatures return to this area sooner than they 
return to the northern U.S. 
 
California may not initiate flu spread in the United States because, for one, it is 
surrounded by States with relatively low P&I mortality rates that did not significantly contribute 
to any phase of its epidemic. Secondly, intrastate transmission may not be enough to initiate or 
sustain early transmission. Thirdly, long-distance or foreign connections may be needed to 
initiate or sustain transmission in California. This is problematic since the highest international 
travel months to California are between Memorial Day (late May) and Labor Day (early 
September) and travel drops off from late September to early December. Moreover, the typical 
flu season in China, which has been the initiator of previous influenza pandemics, is from 
November to March (9). Typical flu seasons in Asian countries begin in late October and peak in 
December, although the dominant circulating virus subtype may not be the same in all Asian 
countries (10). The lack of convergence between months of high international travel and the 
Chinese influenza season may mean that transmission in Asia has very little impact on the 
influenza season in the U.S., particularly California. Indeed, China may have initiated some flu 
pandemics (e.g. 1957, 1968), but it does not appear to be a source of global epidemic flu spread 
(11).  
It is also likely that increased foreign visitors to California over the years may have 
increased the synchrony between California and China. This may have eliminated the time lag 
between the two countries and limited the effect of travel on epidemic timing (12). Southeast 





conditions in the State, such as high winter temperatures and absolute humidity, may not be 
conducive to viral transmission (13). California also had high correlations of its months of 
influenza season initiation with distant States, such as Arizona (r = 0.74925), Florida (r = 
0.626864), Massachusetts (r = 0.668397), North Carolina (r = 0.6), and Texas (r = 0.762118), 
which may prevent early initiation of its influenza epidemics. 
Whatever the reasons for the early introduction of influenza in the States of Delaware, 
D.C., Idaho, and North Dakota and not California, it is unlikely that these results can be 
attributed to the methodology used. The presence of these States as possible seeding locations for 
seasonal influenza in the U.S. spanned across all four decades included in these analyses. 
Therefore, any State differences in medical services (e.g. likelihood for hospitalization, 
likelihood to die from influenza infections) or demographics (e.g. race, age) would have had to 
be present throughout the 40-year time period of this study, which is improbable. Indeed, 
although the age distribution of mortality within the elderly has changed over time, data for all 
States within an age group has trended in the same direction. The age structure within the elderly 
has not varied in any meaningful way across the U.S. It is, therefore, reasonable to assume that 
differences in mortality patterns across States cannot be attributable to differences in the age 
structure of the population (14).  
The steady change in the age structure of State’s population is also a reason why crude 
P&I mortality rates were used in this dissertation research instead of age-adjusted P&I mortality 
rates. Indeed, there was only an average of 0.65 percent change between annual crude P&I and 
age-adjusted P&I mortality rates for States between 1999 and 2010 when a standard 2000 U.S. 
population was used (Appendix 1). Furthermore, comparison of the timing of annual epidemics 





demography, healthcare, and socioeconomic status that may affect influenza deaths. There may 
be slight variations in the timing of epidemics by age group, but these variations should 
disappear once deaths are aggregated. Usage of age-adjusted rates also would have yielded the 
same temporal measures for States as the crude rates produced. As previously explained, the 
timing of influenza seasons are based on the relationship of monthly numbers within a season 
and geographic unit. Because all months within an epidemic period and geographic unit would 
have the same denominator when adjusted for age, monthly age-adjusted rates would have the 
same relationship to each other as the current crude rates have to each other. The same 
significant increase in monthly numbers seen using crude rates (and P&I death totals) would be 
observed if age-adjusted rates were used. The only measure that would change from usage of 
age-adjusted rates in these analyses would be seasonal P&I rates and that change would most 
likely be insignificant. 
Because the spatiotemporal characteristics are based on mortality data, early recognition 
of influenza circulation will not affect the results of this dissertation. Influenza activity is 
determined by actual date of death from pneumonia or influenza and is unaffected by when the 
person may have become infected with influenza or when his death was reported. State 
differences in influenza recognition or death reporting would not impact the results of this 
research. Theoretically, classification and ICD coding rules should generally be applied 
uniformly regardless of demographic characteristics. There may be some demographic and 
geographic variation in coding due to degree of difficulty of diagnosis in certain age groups, 
differences in training of clinical codes, hospital funding of codes, and annual audits of coding 
accuracy. However, it is not expected that these variations will be sufficient to produce 





The results of this research also suggest that there are several points of introduction for 
influenza in the U.S. Results of the temporal measures observed in Chapter 3 combined with 
results observed in Chapter 4 indicate that there may be as many as three seeding locations for 
influenza transmission in the U.S. The most significant seeding location in the U.S. appears to be 
North Dakota, which was seen to have a large and significant impact on States in the Midwest. 
North Dakota had the fourth highest number of seasons for flu season initiation (N = 17) and the 
fourth lowest mean first flu month. It also exhibited significant spatial clustering with bordering 
States during the build-up phase of its respective and U.S. epidemic waves. From North Dakota, 
this research observed a southern trail of flu transmission so that influenza during an average 
season appeared to initiate from North Dakota, travel to Minnesota, then Iowa and South Dakota, 
Nebraska, Kansas, Oklahoma, Missouri, and terminating in Arkansas. Early spread in North 
Dakota may be due to early spread in the Canadian territories. Although Schanzer and colleagues 
(16) found that peak activity occurred first equally in Canada and the continental U.S. in six 
influenza seasons, peak activity occurred first in two Canadian provinces (Manitoba and 
Saskatchewan) that border North Dakota for two of the six seasons. New York appeared to 
initiate late-season flu transmission in the Northeast, with subsequent transmission to 
Massachusetts, Vermont, and Connecticut. These results also suggested Kentucky may be a 
seeding location for mid-season influenza in the Ohio River Valley region, significantly 
impacting spread in West Virginia then Tennessee. 
 This dissertation also found that the timing and spread of influenza in the U.S. varied by 
dominant influenza subtype. Seasons where H1N1 dominated or co-dominated with B (H1N1-
prominent), on average, began earlier than seasons where H3N2 dominated or co-dominated with 





Overall, H3N2-prominent seasons had shorter, faster traveling waves of P&I mortality than 
H1N1-prominent seasons, as hypothesized. There was a significant North-South and East-West 
direction of influenza spread at the beginning of H1N1-prominent seasons while the direction of 
spread at the beginning of H3N2-prominent seasons was insignificant, North-South, and West-
East. H3N2-prominent seasons had significant West-East spread at the peak of influenza activity 
whereas H1N1-prominent seasons had insignificant East-West spread. Both H1N1-prominent 
and H3N2-prominent seasons followed a South-North and East-West direction of spread at the 
end of seasons, although only the South-North spread of H3N2-prominent seasons was 
significant. Delaware was found to be the potential seeding location of influenza transmission for 
both H1N1-prominent and H3N2-prominent seasons. 
 It is uncertain if influenza immunization had a significant impact on the timing of 
influenza epidemics or if it can explain some of the State-level variation seen in the results of 
this dissertation. Influenza vaccination is a relatively new phenomenon and, more importantly, is 
not widely used in the United States. Vaccination coverage and match also tends to vary season-
to-season. Moreover, as influenza immunization can decrease morbidity and mortality from 
influenza, its effect on the temporal progression of influenza waves depends on the timing of 
vaccinations. Institution of vaccinations prior to an influenza season’s peak would likely shorten 
the season due to early exhaustion of the susceptible pool and delay the peak of the season, but 
these vaccinations would have to occur nearly three months prior to the season’s peak (17). Yoo 
and colleagues (18) found the majority of flu vaccinations in Medicare recipients occurred before 
the national epidemic start of seasons between 2000-01 and 2004-05 (September to December); 





 Additional analyses for this dissertation found that high flu vaccination coverage in 
persons aged 65 years and older was not significantly associated with delayed starts of influenza 
seasons (p=0.20) and was only barely significantly associated with later peaks (p=0.047). High 
State-level flu vaccination coverage was associated with later-ending, faster, smaller waves 
(p=0.0007, 0.0007, 0.0149). This was in contrast to an analysis of temporal measures between 
influenza seasons that had available immunization data (1995-96, 1997-98, 1998-99, 2001-02 to 
2007-08) and those seasons without this data. The latter seasons began significantly earlier, 
peaked later, and were longer and slower than seasons without vaccination data. It is unlikely 
that these differences were caused by the presence of immunization in the older population.  
 Monthly temporal resolution was used to generate analyses; repeating these using weekly 
data would help to determine what lag time might be best used to anticipate seasonal influenza 
activity across the U.S. In addition, repeating these analyses on the county or city-level may help 
to determine what spatial scale is best to examine influenza activity in the nation. It will also 
allow researchers to determine between-county/city spatiotemporal differences.  
 Observations in Chapter 3 were built upon in Chapter 4 through the characterization of 
the dominant spreading process of influenza in the U.S. Although it was hypothesized that 
seasonal influenza in the U.S. would observe a dominant contagious diffusion process, where 
influenza spreads from its center of introduction to geographically close locales, spatial 
contagion was only significant at the height of influenza seasons. Distance did not contribute 
much to the model of correlations of temporal characteristics between States; however 
correlation coefficients were highest for States less than 500 miles between their geographic 
centers and for the peak of influenza activity. Hierarchical, population-based, diffusion did not 





influenza transmission was only dependent on distance at the peak of seasons, significant local 
clustering was seen in many parts of the country. In particular, States in the Midwest, Ohio River 
Valley, and Northeast regions tended to be very dependent on spread in neighboring States. 
Nevada and Utah also shared a highly dependent connection and appeared to exert some 
influence on the spread of influenza in the neighboring States, California, Oregon, and Arizona. 
Future research can expand on these analyses and examine within-State spatial clustering. Such 
research may clarify the urban-suburban relationship in influenza transmission. 
 This research suggests that there is not an urban-suburban hierarchical interstate spread. 
Past research has also suggested that hierarchical spread is insignificant in influenza transmission 
within a State (19). Synchronized epidemics were observed to occur among the most populated 
counties of Pennsylvania, although adjacent counties had a high mean correlation in peak activity. 
This distance-based synchrony declined with distance (≥127 km) as was seen in this research. It 
was also evident from this past research that workflow patterns did not drive local epidemics as 
influenza spread did not follow an urban-suburban spread. Instead, non-routine and leisure 
travels were the catalyst for local epidemics within a State (19). 
 Chapter 5 of this dissertation expanded on the analyses used in Chapter 3 and explored 
the impact of the introduction (or reintroduction) of a novel influenza A virus in the U.S. 
population on the spatiotemporal aspects of epidemic influenza. The novel seasons, 1968-69 and 
1977-78, had distinct temporal characteristics compared to surrounding seasons. For one, as 
hypothesized, States during these two time periods had shorter and faster moving waves than 
their counterparts in seasons that followed them. Yet, the spatial composition of seasonal 
influenza in the U.S. did not change despite the introduction of a novel virus. Moreover, the 





influenza to become more similar to the novel season, but other aspects returned to pre-pandemic 
levels. Novel virus introduction also appeared to alter some spatiotemporal characteristics of 
succeeding seasons, in which they were unique from both pre-pandemic and pandemic waves. 
Influenza activity for States peaked and ended earlier during the post-novel waves, 1978-81, than 
during the earlier, pre-novel waves, 1974-77, which was a signature of the 1977-78 wave. The 
mean velocity and season duration between the pre-novel and post-novel season periods were not 
significantly different. However, in the three seasons between 1978 and 1981, States began their 
waves significantly earlier than the seasons between 1974 and 1977 and were also significantly 
earlier than the 1977-78 season. P&I mortality rates were significantly less after a novel wave 
than before it. All temporal measures for successive seasons of the 1968 pandemic were 
significantly different than those of the 1968-69 pandemic wave in that during these succeeding 
waves State-level seasons began earlier, peaked and ended later, and were shorter and faster in 
velocity. Future research may focus on examining the impact of earlier pandemic strains (i.e. 
1918, 1957) on the spatial and temporal characteristics of epidemic influenza. This may assess if 
earlier pandemics were similarly distinct from surrounding seasons and what, if any, impact they 
exerted on following seasons. 
Implications of the findings 
 The strength of this dissertation lies in the novel approach used to examine seasonal 
variation and temporal trends in pneumonia and influenza mortality, investigate the existence of 
State-level spatial variation of pneumonia and influenza mortality, understand the role of viral 
subtype in determining the spatial and temporal variation, and to investigate the existence of 
spatial-temporal variation of pneumonia and influenza mortality. These patterns were examined 





influenza epidemics varied season-to-season, but patterns existed by circulating subtype. 
Moreover, distance was not a dominant factor in the overall spread of influenza, but played a 
major role in certain phases and regions of the U.S. Knowing these patterns presents a great 
opportunity to improve current influenza surveillance methods, early warning systems, and 
models of transmission and impact. 
The spatiotemporal analytical tools presented in this dissertation work could be applied to 
improve understanding of other infectious diseases. The sensitivity analyses used in Chapter 2 
could be applied to other data sources to verify their reliability. For instance, data regarding 
influenza-like illness or hospitalizations may be tested against the gold standard, influenza 
isolates data, to investigate how well they approximate the timing of influenza seasons. This will 
show how appropriate these data sources are for use in research when viral surveillance data is 
unavailable. Viral surveillance data may also be unrepresentative of the population, therefore 
researchers may feel the need to use other more generalizable data. They need to be confident in 
the reliability of these alternative data sources before they engage in any time series analyses. 
These sensitivity analyses may also be utilized for testing two different data sources for other 
diseases and for ensuring the quality of historical data. Certain high-quality data may not be 
available for earlier time periods, but sensitivity analyses of their modern counterpart and the 
gold standard may ensure that the historical data is of sufficient quality to properly answer the 
requested research questions. 
The temporal autocorrelation analyses presented in Chapter 3 can be combined with maps 
of cumulative incidence to describe when demographic subgroups and counties may be at high 
risk for disease. Spatial autocorrelation, which was used in Chapter 4, could be used to determine 





clustering about disease foci, and to suggest a scale for control efforts (20). Furthermore, the 
space-time correlograms presented in Chapter 4 could be used to develop a function of disease 
correlation vs. distance, which could then be incorporated into a public health system to detect 
active surveillance and forecast short-term disease spread. 
An important finding in Chapter 4 of this dissertation is the nonexistent role of density-
dependence, or population, in the role of influenza spread. Indeed, there was not a dominant 
spreading process observed in the data, although distance was an important factor at the peak of 
annual epidemics. Prior research suggested that influenza spread follows an urban hierarchy and 
local dynamics of an epidemic are dependent on population density (21-24). This research found 
that not only did seasonal influenza not spread from urban centers to less populous centers, but 
the neighborhood effect most likely dominated at the introduction of influenza into several States 
of the country and was only superseded at the height of annual epidemics by distance. Some 
local epidemics peaked before spreading across the country, although some regions underwent 
homogenous mixing at the beginning of waves. This finding has several implications for public 
health. For one, local public health interventions may have as much, or more, effect on 
decreasing seasonal influenza incidence in a neighboring State than it does on decreasing 
incidence within a State. This is because decreasing the incidence of influenza within a State will 
prevent the build-up of cases necessary for distance-dependence diffusion to dominate local 
diffusion and drive influenza to neighboring States. Secondly, other factors likely dominate the 
diffusion process of influenza in the nation and interventions and preventatives may need to be 
altered to address these factors on the local or State-level.  
These other factors may also explain why spatial waves of influenza epidemics rarely 





Instead, there appeared to be separate, geographically-distant points of introduction for influenza 
in the U.S. Delaware and Idaho had the highest frequencies of initiation of influenza spread and 
Washington D.C. and North Dakota followed quickly behind. Moreover, at least three States 
were identified as the source of influenza epidemics in the nation. This may indicate that 
different strains of influenza are introduced into the country simultaneously or strains have 
differing effects on different populations. As previously stated, targeted interventions may need 
to be developed to address this finding.  
Ascertaining the appropriate timing configuration is critical for achieving optimal or near 
optimal performance in mitigating the spread of influenza epidemics. Influenza interventions, 
such as vaccination campaigns, would need to be instituted before local epidemics peak in order 
to have a maximum impact (29). Beginning an intervention during the fadeout phase of an 
epidemic wave will have little effect on influenza infection prevalence because peak infection 
usually occurs when herd immunity is reached and intervention is no longer warranted (30-31). 
Delayed distribution of vaccines may have little impact on the prevalence of influenza infection 
because it results in a smaller proportion of the population seeking the vaccine (31). This 
research identified the three different waves of influenza seasons for each State in the nation, 
which will allow public health officials to know when an intervention will have maximum 
impact in that State.  
Indeed, a preventative strategy may not have to be very effective.  Even a low efficacy 
intervention, such as handwashing, will decrease an outbreak enough in order to prevent a 
second outbreak from occurring, as long as it is instituted early enough and lasts long enough (6-
8 weeks) (32-33). Moreover, high efficacy interventions (e.g. school/airport closure, workforce 





long as it begins somewhat before the peak of the season. Later starts may also be needed for 
high efficacy interventions due to their high costs and the difficulty of implementing them for 
long periods of time (32). Current CDC policy advocates the delivery of vaccines over time 
relative to a State’s population size (31). This most likely will not significantly reduce the 
national number of infections because, as seen in this dissertation, initiation or peak of influenza 
seasons does not follow hierarchical spread. Indeed, many of the least populated States exhibited 
early influenza seasons compared to the rest of the U.S. Vaccine distribution would be better 
utilized if it adhered to a schedule that accounted for the general timing of State-level epidemics. 
The results presented in Chapter 5 highlight an important finding in pandemic vs. non-
pandemic influenza research. It was previously believed that smaller, later epidemics would most 
likely follow a pandemic season due to the exhaustion of the susceptible population (34) And, 
while influenza seasons succeeding pandemics produced less P&I mortality, on average, they 
were significantly earlier than what was seen during the pandemic wave. This was despite the 
dominant circulating influenza subtype being the same (or co-dominating) in successive seasons 
as it was during the pandemic. Additional analyses (Appendix 5) also found that earlier influenza 
waves were significantly, although weakly, associated with later successive waves and high P&I 
mortality rates significantly lead to earlier successive waves. This suggests that influenza 
interventions would need to either carry over from those used during the pandemic or be 
instituted much earlier than usual. It is also possible that the pandemic strains produced a small, 
but significant, rapid genetic drift in the novel influenza subtype. Due to immunity carry-over, 
most of the population would be immune (or partially-immune) to this new variant, but a small 





produce an early wave of influenza. However, partial immunity may prevent the new variant 
from being as severe as the pandemic strain. 
As previously stated, significant clusters of similar P&I rates in the Midwest (Arkansas, 
Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, Oklahoma, and South Dakota), 
Northeast (Connecticut, Massachusetts, New York, and Vermont), and Ohio River Valley 
(Kentucky, Tennessee, and West Virginia). Targeted interventions to these sections of the U.S. 
may greatly aid the efficacy of influenza policy in the country because they will be able to 
capture the flow of residents and the spread of disease. Indeed, interventions targeted to these 
States that displayed significant synchronous disease spread might be more efficient than 
nationwide campaigns and may provide greater public health value (19). 
The earlier, less virulent influenza seasons which followed pandemic seasons are also in 
contrast to the theory that large, full-scale epidemics begin earlier in the season and create 
shorter, smaller subsequent waves due to the exhaustion of the susceptible pool and vice versa 
(35). This research did find that early entry of infected individuals into a susceptible population 
(i.e. early start of an influenza season) is correlated with high P&I mortality rates, or the impact 
of an epidemic, (R
2
 = 0.0452; r = -0.21261, 95% Confidence Interval = -0.254488, -0.169931). 
However, not only did the large outbreaks of novel seasons begin later in their seasons, but they 
produced successive epidemic waves that began earlier and were longer and less intense than the 
novel seasons. Indeed, the three seasons that followed the 1977-78 novel H1N1 season began 
earlier and had less of an impact than the three seasons that preceded the novel season. This 
research also found that the level of P&I mortality rates at the State-level in prior waves did not 
significantly impact the length of successive seasons, but it did significantly affect the start of 





significantly likely to have similar high P&I mortality rates in later seasons (Appendix 5). We 
can therefore assume that pandemics, unlike epidemics, are able to reach large-scale levels 
despite late starts and may also produce longer, yet earlier and smaller subsequent epidemics. 
In addition, this research found that despite H3N2-prominent seasons, on average, 
beginning later in the year and being shorter than H1N1-prominent seasons, they had a higher 
average P&I mortality rate at the State-level. This is despite the start of influenza seasons having 
a significant impact on P&I mortality within these two subtypes (H3N2-prominent seasons: R
2
 = 
0.0366, r = -0.1912, 95% confidence interval = -0.244594, -0.136659; H1N1-prominent seasons: 
R
2
 = 0.0568, r = -0.23794, 95% CI = -0.335381, -0.135454). The entry of infected individuals 
into the susceptible population appears to have a limited impact on the severity of an influenza 
season. Other factors, most likely the virulence of an influenza strain, may be driving the impact 
of annual influenza waves. Models of the impact of influenza (e.g. mortality, economic) would 
need to take influenza subtype into account. It was also evident that the spatial dynamics of 
influenza spread varied by dominant subtype. Due to this finding, models of the transmission of 
future influenza pandemics and epidemics would need to account for influenza subtype in order 
to more accurately predict influenza spread. 
Although temporal dynamics differed between influenza subtypes, certain temporal 
measures for subsequent seasons could be predicted by measures in the previous season 
(Appendix 5). A finding that it is contrast to past studies (36) that indicated the shape of 
influenza seasons could not be predicted by past epidemics. This relationship was strengthened 
in certain aspects by the prediction of measures within a dominant circulating subtype. For 
instance, early influenza seasons significantly produced later starting seasons (R
2
 = 0.0064, r = -







 = 0.0033, r = -0.0576, 95% CI = -0.1022, -0.0128) and longer seasons significantly 
produced subsequent shorter seasons (R
2
 = 0.0022, r = -0.0471, 95% CI = -0.0917, -0.0022), 
regardless of influenza subtype. Furthermore, seasons with high P&I mortality rates significantly 
produced earlier succeeding influenza waves (R
2
 = 0.0115, r = -0.1072, 95% CI = -0.1513, -
0.0627). For H3N2-prominent seasons, the next season that followed one with relatively high 
P&I mortality rates was significantly likely to start early in the year (R
2
 = 0.0227, r = -0.1507, 
95% CI = -0.2061 to -0.0944). This relationship did not hold for H1N1-prominent seasons. Wave 
velocity and season duration for H3N2-prominent influenza seasons also significantly impacted 
the start of subsequent H3N2-prominent seasons even though this relationship did not hold for all 
of the seasons. For H1N1-prominent seasons, short past seasons lead to short and faster moving 
waves. This was in contrast to all of the influenza waves, in which shorter past seasons produced 
longer and slower moving waves. 
This research indicates that temporal dynamics of subsequent seasons may be predicted 
by the temporal dynamics of past seasons, a finding that can greatly aid public health 
interventions. As previously mentioned, knowledge of the appropriate timing of interventions 
would make them more effective. Therefore, the temporal measures detailed in this dissertation 
can be used to dictate when and where influenza interventions will produce the best effect. This 
research also suggests that influenza interventions can be implemented in accordance to the 
temporal dynamics or severity of the past season, but may be strengthened by knowledge of the 
dominant circulating subtype of the current season.  
 Strengthening our understanding of the relationship between space, time, and influenza 
could allow public health practitioners to incorporate new information that would potentially be 





large. What is certain is that every year is an influenza year that will cause considerable 
morbidity and mortality. Indeed, cumulative mortality from an annual epidemic caused by 
antigenic drift variants may be greater than mortality caused by a novel pandemic virus (37). The 
findings of this dissertation have significant implications for policy development and resource 
planning by contributing to the effective allocation of resources and services based on seasonal 
and geographic specific demands. Additionally, they could aid the development of more focused 
preventive strategies. 
Limitations 
 A major limitation of this study is that results may have been obscured due to a violation 
of the independence assumption of generalized modeling (see Appendix 6). It appears that the 
temporal measures are very much spatially correlated, which may be tempering some significant 
observations. This spatial correlation may be due to the seasonality of seasonal influenza and the 
limited range temporal measures can adhere to. For instance, the start month of State-level 
influenza seasons mostly stayed between influenza months 1 and 4 (September to December) 
(N=1924, 98.1%) and the majority of peak months of State-level seasons landed between 
influenza months 4 (December) and 7 (March) (N=1864, 95.1%), with the plurality of seasonal 
peaks occurring in January (N=832, 42.4%). Despite these violations, significant findings 
between States and, especially, between influenza subtypes/types were found. This suggests that 
the findings of this dissertation are correct, however, other significant findings may be 
discovered through the use of different analytical models. 
 For this study, only the underlying cause of death was extracted from the multiple cause-
of death data files, not the immediate or intermediate causes. This may have excluded relevant 





of U.S. deaths had more than one cause identified, therefore a large number of deaths certificates 
that may have listed pneumonia or influenza were not included in these analyses because those 
conditions were not listed as underlying. In 1979, P&I was listed as the underlying cause of 
death for 2.4% of all deaths, but was identified on 7.7% of deaths as a multiple cause. These 
differences may be the result of pneumonia often being listed as the immediate cause of death 
and not the underlying cause of death (38). 





 ICD revisions, most deaths attributed to solids and liquids, aspiration pneumonia, and 
other alveolar and parietoalveolar pneumopathy, and other acute interstitial pneumonia 
transferred from ICDA-8 classification of “Pneumonia” to non-pneumonia ICD-9 categories (39). 
The change from ICD-9 to ICD-10 in January 1999 lead to an approximately 30 percent decrease 
in “Pneumonia” (and P&I) cause-of-death classifications. “Influenza” cause-of-death 
classifications remained relatively the same. This decline was due to the broadened application 
of the direct sequel rule to pneumonia. It states that if pneumonia and another cause were listed 
on the death certificate and pneumonia was obviously a direct consequence (or sequel) of that 
other cause, then the other cause was selected as the underlying cause of death. Therefore, deaths 
that were classified as pneumonia as the underlying cause under ICD-9 are classified in ICD-10 
to many other causes. Most of these former pneumonia deaths were classified as diseases of the 
heart, cerebrovascular diseases, malignant neoplasms, chronic lower respiratory diseases, 
septicaemia, malnutrition and chronic liver disease and cirrhosis (40). It is unlikely that these 
coding changes had a strong impact on this study. New revisions often affect the profiles of 
health problems and disease burden. Moreover, changes to ICD codes were probably instituted 





these potential limitations, the underlying cause of death is conceptually easy to understand and 
is a well-accepted measurement of mortality that is useful for trend analysis (38). These NCHS 
mortality data have been used by many others to study time series of mortality (1, 41-43).  
Influenza-related deaths are difficult to ascertain completely. A complete diagnosis of an 
influenza-related death would require agreement of clinical symptoms, epidemic reporting, 
immunoassays, and viral cultures (44). Verification for each U.S. death through these means was, 
of course, infeasible.   
This was a study of mortality rather than infection and did not allow consideration of how 
infected and susceptible people interact in the community. P&I mortality is a reflection of 
infection as well as many other factors that make individuals more likely to die, such as the 
presence of comorbidities and lack of access to care. Infection data are not available for the 
entire country during these four decades. This study did, however, analyze infection data as a 
complement to mortality data for more recent years. It found that mortality may follow infection 
within 1 or 2 weeks, although regional and age-specific variations were not examined. The 
aggregation of P&I mortality data to the spatial level of State and the temporal resolution of 
month resulted in the loss of one or more layers of detail (45). Local or county-level mortality 
was not the subject of these analyses, but the identification of broad patterns motivates further 
research within each State. Moreover, aggregation of the data to the month level may have 
resulted in the loss of some minor variations in the timing of annual epidemics. Previous studies 
have shown continental States’ influenza seasons tended to peak within four weeks of each other 
(46). This pattern is most likely also at the beginning and end of seasons. Finer differences 
between States in the peak of influenza activity may have allowed this research to observe a 





height of seasons. Finer temporal resolution may have also allowed this research to determine if 
Delaware remains the earliest initiator of influenza spread and if its mean start week significantly 
differed from the means of other early initiators, such as Idaho, North Dakota, District of 
Columbia, Minnesota, and Wyoming. This research did not find significant differences in the 
means of start months between these early initiators. 
Caution must also be taken in interpreting the spatial patterns of influenza epidemics. 
States that recorded P&I deaths prior to the national start of an influenza season may represent 
possible “seed” locations and an instance of early introduction of an influenza virus to these 
locations for the corresponding waves. Yet, the appearance of several seed locations during one 
season may reflect the geographically widespread nature of influenza mortality at the onset of the 
corresponding wave, rather than an apparently simultaneous introduction of influenza into the 
country. This situation is more the case for subsequent waves of pandemic influenza rather than 
the waves of subsequent influenza epidemics (47). Nevertheless, it is expected that the continued 
presence of reported P&I deaths for a State prior to the national start of multiple epidemic 
seasons may signal it is a “true” seed location for seasonal influenza in the U.S. It is also 
understood that the liberal use of the word ‘spread’ assumes that the sequence of activity across 
the contiguous United States parallels the actual spread of influenza. As there is not a clear 
insight into the dynamics of influenza between States which informs this dissertation, ‘spread’ 
should be interpreted cautiously and used in a very general context. The spread of influenza 
depends on many factors, therefore, a particular pattern may not be observed, as was with most 
of the influenza seasons included in these analyses.  
This research also assumed that seasonal epidemics are the consequence of new 





in temperate regions (48). Other important factors of epidemic timing, such as absolute humidity 
(49), could help to synchronize epidemics. Indeed, the variation in epidemic timing between the 
Northern Hemisphere and the Southern Hemisphere may signal climate factors as a critical 
contributor to general seasonal patterns. Some combination of environmental conditions and 
seeding of the virus via international travel likely influences the observed timing of epidemics 
(50). 
Finally, this research chose to use the Pearson correlation coefficient to quantify the 
degree of association between temporal measures and central latitude and longitude instead of 
the Spearman coefficient. Pearson correlation was used because the dataset contained few 
outliers and, therefore, Spearman’s rank correlation would have been nearly identical to the 
Pearson’s correlation. Moreover, the temporal measures met the assumption of linearity, which is 
what the Pearson’s correlation requires. The data used in this research were also normally 
distributed and the temporal measures represent intervals (weeks or months), not ordinals. 
Therefore, Pearson’s was appropriate to use for the analyses in this dissertation (51). 
Suggestions for Future Research 
 The findings of this dissertation suggest that other factors besides influenza subtype and 
distance play a major role in the spread of influenza in the U.S. The spatiotemporal patterns of 
mortality reported in Chapters 2 to 5 would be well served by models that include sociological 
variables. There may be differences in P&I mortality by sex, race, and age group which merit 
further investigation. Additionally, vaccination rates and access to care may vary by subgroup 
and could partially explain some differences in the timing of influenza epidemics as well as the 
geographic make-up of annual waves. Previous research has shown that living conditions, such 





influenza are higher in disadvantaged classes possibly due to the inability of these individuals 
and families in cold-weather climates to pay their energy bills (52). A study of spatiotemporal 
patterns of influenza that includes these demographic and sociological variables, ideally using 
individual-level data, would be an interesting addition to this research. 
 Future research may also concentrate on modeling immunity to accurately capture long-
term trends in influenza epidemic patterns. Antigenic drift and progressive loss of individual 
immunity may be modeled as a continuous flow that approximates the actual evolution of 
portions of the influenza virus that are important to pathogenesis. This type of information may 
be informative in future computer models in order to explain the differences in the rate of 
influenza progression in different regions of the country. It may also explain the seasonal 
variation in the timing of annual epidemics. 
 Inclusion of environmental factors into these spatiotemporal models is also fervent 
ground for future research. Climate could affect influenza seasonality, activation of latent 
infection, cessation of transmission, patterns of contagion, apparent inter-epidemic virus 
disappearance, and regional synchrony of disease transmission (53). Climate might also alter 
virus transmissibility, human immunity, disease expression, human-to-human contact patterns, 
and non-human host abundance and behavior (53). Identification of the primary mechanisms by 
which climate exerts its effect may lead to the development of efforts designed to ameliorate 
such effects. 
 Ultimately, the goal of influenza research is to develop an early-warning system. This 
could be used to alert vulnerable populations to impending disease outbreaks. Understanding the 
relationships between specific factors and influenza morbidity and/or mortality can lead to an 





efforts to anticipate and diminish disease outbreaks. Anticipation of these disease outbreaks 
would lessen a population’s vulnerability to them. An early warning system may have a 
significant and positive effect on the number of cases, hospital admissions, length of hospital 
stay, days of sickness, social class distribution of illness, and/or crude and case fatality. 
Moreover, an early warning system would be particularly effective in locations with limited 
public health infrastructures. The ability to remotely detect phenomena that may constitute a 
harbinger of increased activity could permit researchers from outside the area to identify 
potential risks and ship in resources before the situation becomes dire. Anticipating the 
magnitude of influenza epidemics could also increase the effectiveness and acceptance of 
vaccination and allow schools and businesses to anticipate absenteeism and hospitals to expect 
elevated need for services (53). A temporally and spatially nuanced understanding of influenza 
activity could enable action to meaningfully reduce the burden of disease locally and across the 
globe. 
The data analysis combined with mathematical modeling provided a better understanding 
of the spatio-temporal and synchronization dynamics of influenza in Israel and between Israel 
and France. Altogether, we show that despite major differences in demography and weather 
conditions intra-annual influenza epidemics are tightly synchronized in both their timing and 
magnitude, while they may vary greatly between years. The predominance of a similar main 
strain of influenza, combined with population mixing serve to enhance local and global influenza 
synchronization within an influenza season. 
Predictive modeling was beyond the scope of this dissertation research. Moreover, 





contribution to the model was minimal. These two factors may not provide a very informative 
predictive model. 
Conclusion 
 This dissertation furthered our understanding of the spatiotemporal characteristics of 
seasonal influenza in the U.S. First, it confirmed the reasonable use of pneumonia and influenza 
mortality as a proxy for viral isolates data in research. Second, this work summarized what is 
known about the geography of influenza and how influenza subtype affects it. Seasonal and 
subtype variation was found in the timing and direction of epidemic influenza. Moreover, these 
analyses identified significant global and local clustering of pneumonia and influenza mortality, 
which suggests distance plays a significant role in the geographic spread of annual waves, 
especially at their peak. Lastly, this research observed differences in spatiotemporal 
characteristics between novel subtype influenza waves and the seasons that surround them. The 
findings of this research suggest that space and time need to be accounted for in models of 
disease transmission and planning of intervention strategies for influenza. This work is a great 
step forward in the identification of characteristics that control the spread of influenza. Future 
spatiotemporal analyses should include demographic, sociological, and environmental variables 
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Appendix 1: Classifications of pneumonia and influenza deaths and dominant circulating 
influenza subtype 
 
Table 6.1.1: ICD codes used to classify pneumonia and influenza deaths 
 
Years ICD Manual ICD codes for 
influenza 




 470-474 480-486 
1979-1998 ICD-9
b
 487 480-486 
1999-2008 ICDA-10
c
 J09-J11 J12-J18 
aNational Center for Health Statistics. Eighth Revision International Classification of Diseases. Adapted for Use in the United 
States. Washington, DC: U.S. Government Printing Office, 1967. 
 
bWorld Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. 
Based on Recommendations of the Ninth Revision Conference, 1975, and adopted by the Twenty-Ninth World Health Assembly. 
Geneva, Switzerland: WHO, 1977. 
 
cWorld Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems: tenth 







Table 6.1.2: Characteristics of annual influenza epidemics in the continental United States, by 




































1968-69 H3N2 3 5 8 6 3.23 49603 24.5 3 
1969-70 H3N2 3 6 8 6 3.48 39330 19.2 4 
1970-71 H3N2 2 5 9 8 4.49 42165 20.3 4 
1971-72 H3N2 1 4 7 7 3.93 30936 14.7 3 
1972-73 H3N2 4 5 8 5 2.93 31661 14.9 3 
1973-74 B 3 7 9 7 3.99 35978 16.8 7 
1974-75 H3N2 3 5 8 6 3.48 35964 16.7 4 
1975-76 H3N2 4 7 9 6 3.48 40180 18.4 6 
1976-77 B/H3N2 2 7 9 8 4.52 36371 16.5 4 
1977-78 H1N1/H3N2 3 5 8 6 3.46 36811 16.5 3 
1978-79 H1N1 1 5 9 9 4.96 36970 16.4 7 
1979-80 B 3 6 8 6 3.65 31505 13.9 5 
1980-81 H1N1/H3N2 3 5 8 6 3.31 36274 15.8 4 
1981-82 B/H1N1 1 7 9 9 5.16 38601 16.7 5 
1982-83 H3N2 3 7 9 7 4.06 35964 15.4 4 
1983-84 B/H1N1 3 7 9 7 4.03 37944 16.1 4 
1984-85 H3N2 3 6 8 6 3.56 40423 17.0 4 
1985-86 B/H3N2 3 6 8 6 3.59 41225 17.2 5 
1986-87 H1N1 3 5 9 7 3.92 43967 18.1 4 
1987-88 H3N2 3 6 9 7 4.00 51625 21.1 4 
1988-89 B/H1N1 3 6 8 6 3.55 45042 18.2 4 
1989-90 H3N2 3 5 8 6 3.43 48872 19.6 4 
1990-91 B 3 5 9 7 3.96 49039 19.4 5 
1991-92 H1N1/H3N2 3 5 8 6 3.36 47124 18.4 4 
1992-93 B/H3N2 3 7 9 7 4.05 53059 20.4 5 
1993-94 H3N2 3 5 8 6 3.37 50801 19.3 4 
1994-95 B/H3N2 3 5 9 7 4.00 53040 19.9 4 
1995-96 H1N1/H3N2 3 5 9 7 3.85 54946 20.4 3 
1996-97 B/H3N2 3 5 8 6 3.43 53704 19.7 3 
1997-98 H3N2 3 5 8 6 3.48 57022 20.7 4 
1998-99 B/H3N2 1 7 8 8 4.59 55851 20.0 4 
1999-00 H3N2 3 5 8 6 3.36 41232 14.6 4 
2000-01 B/H1N1 3 5 9 7 3.91 40882 14.3 5 
2001-02 H3N2 3 7 9 7 4.01 43728 15.2 4 
2002-03 B/H1N1 3 5 9 7 3.92 39524 13.6 5 
2003-04 H3N2 3 4 8 6 3.27 41087 14.0 3 
2004-05 B/H3N2 3 7 9 7 4.06 42993 14.5 4 
2005-06 H3N2 3 5 9 7 3.94 37822 12.7 6 
2006-07 H1N1/H3N2 3 5 9 7 3.95 35031 11.6 4 
2007-08 H3N2 3 7 9 7 4.04 38630 12.7 5 
*Month 1 = September 






Table 6.1.3: Mean difference between crude and age-adjusted pneumonia and influenza (P&I) 









between crude and 
age-adjusted P&I rates 
Alabama 22.7 22.6 -0.2 
Arizona 20.0 20.5 0.5 
Arkansas 28.0 25.6 -2.4 
California 20.0 22.7 2.7 
Colorado 14.5 18.0 3.5 
Connecticut  23.3 19.0 -4.2 
Delaware 18.3 18.3 0.0 
District of Columbia 15.3 15.6 0.3 
Florida 16.3 12.5 -3.8 
Georgia 17.9 23.5 5.6 
Idaho 17.8 19.1 1.3 
Illinois 21.7 21.4 -0.3 
Indiana 19.8 19.6 -0.2 
Iowa 28.8 21.7 -7.1 
Kansas 23.8 20.6 -3.2 
Kentucky 24.9 25.4 0.5 
Louisiana 20.6 22.6 2.0 
Maine 22.0 18.3 -3.7 
Maryland 19.3 20.7 1.5 
Massachusetts 27.6 23.6 -4.1 
Michigan 18.9 18.5 -0.4 
Minnesota 15.2 14.0 -1.2 
Mississippi 23.5 24.6 1.1 
Missouri 25.5 23.1 -2.4 
Montana 21.4 18.8 -2.6 
Nebraska 20.6 17.4 -3.2 
Nevada 17.4 21.8 4.3 
New Hampshire 16.8 16.6 -0.3 
New Jersey 19.0 17.5 -1.5 
New Mexico 17.9 19.2 1.3 
New York 26.4 24.3 -2.1 
North Carolina 20.7 22.2 1.4 
North Dakota 23.7 17.7 -6.0 
Ohio 19.5 18.1 -1.5 
Oklahoma 25.1 24.2 -0.9 
Oregon 15.9 14.4 -1.4 
Pennsylvania 22.6 17.7 -4.9 
Rhode Island 25.2 19.9 -5.3 
South Carolina 18.4 19.6 1.2 
South Dakota 25.8 20.2 -5.5 
Tennessee 26.2 26.9 0.8 
Texas  15.3 19.6 4.3 





Vermont 15.3 14.1 -1.2 
Virginia 18.7 21.1 2.4 
Washington 14.1 14.7 0.6 
West Virginia 25.4 21.4 -4.0 
Wisconsin 20.9 18.5 -2.5 
Wyoming  23.8 25.4 1.6 








Appendix 2: Additional analyses and maps for Chapter 3 
 
Table 6.2.1: Correlation between central latitude and longitude of 49 continental U.S. States and 



































































































































































































Table 6.2.2: Correlation between central latitude and longitude of 49 continental U.S. States and 





































































































































































































Table 6.2.3: Correlation between central latitude and longitude of 49 continental U.S. States and 





































































































































































































Table 6.2.4: Correlation between central latitude and longitude of 49 continental U.S. States and 





































































































































































































Table 6.2.5: Correlation between central latitude and longitude of 49 continental U.S. States and 





































































































































































































Table 6.2.6: Correlation between central latitude and longitude of 49 continental U.S. States and 





































































































































































































Figure 6.2.11: Mean and 95% confidence intervals of the start month of influenza seasons for 

































































































































































































































































































































































































































































































































































































































































  Appendix 3: Additional analyses, maps, and equations of the spatial spread of seasonal influenza for Chapter 4 
 
Table 6.3.1: Matrix of distances (in miles) between central latitude and longitude of the 49 continental U.S. States 
 
STATE AL AZ AR CA CO CT DE DC FL GA ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT 
AL 0 1431 355 1872 1130 986 771 696 396 199 1691 524 495 740 761 342 319 1305 713 1062 837 1015 164 500 1553 
AZ 1431 0 1092 491 473 2165 2025 1940 1765 1628 715 1301 1448 1123 794 1490 1177 2381 1958 2230 1559 1238 1270 1105 893 
AR 355 1092 0 1521 776 1163 981 897 739 542 1343 402 484 498 413 439 281 1445 916 1237 775 794 221 238 1225 
CA 1872 491 1521 0 775 2494 2385 2303 2228 2063 557 1649 1802 1425 1159 1876 1644 2664 2320 2552 1835 1446 1718 1481 851 
CO 1130 473 776 775 0 1730 1611 1529 1510 1312 596 876 1028 667 386 1102 958 1925 1546 1792 1097 765 989 707 594 
CT 986 2165 1163 2494 1730 0 228 292 1056 852 2108 865 719 1069 1371 725 1292 334 276 76 689 1115 1114 1068 1850 
DE 771 2025 981 2385 1611 228 0 85 829 627 2040 736 583 972 1237 545 1083 562 67 301 663 1077 908 920 1803 
DC 696 1940 897 2303 1529 292 85 0 784 563 1964 653 501 894 1153 460 1005 620 19 367 605 1012 828 835 1732 
FL 396 1765 739 2228 1510 1056 829 784 0 294 2081 890 819 1126 1151 648 589 1390 795 1126 1144 1389 521 895 1949 
GA 199 1628 542 2063 1312 852 627 563 294 0 1858 606 526 854 933 354 508 1182 577 927 851 1104 363 644 1700 
ID 1691 715 1343 557 596 2108 2040 1964 2081 1858 0 1332 1479 1074 931 1594 1549 2227 1980 2156 1421 1001 1562 1218 306 
IL 524 1301 402 1649 876 865 736 653 890 606 1332 0 153 264 507 273 655 1101 671 931 373 499 512 215 1130 
IN 495 1448 484 1802 1028 719 583 501 819 526 1479 153 0 405 656 172 697 972 518 788 342 596 532 349 1268 
IA 740 1123 498 1425 667 1069 972 894 1126 854 1074 264 405 0 357 537 779 1259 910 1128 438 295 681 262 866 
KS 761 794 413 1159 386 1371 1237 1153 1151 933 931 507 656 357 0 717 646 1594 1171 1437 789 580 634 322 821 
KY 342 1490 439 1876 1102 725 545 460 648 354 1594 273 172 537 717 0 592 1017 479 799 505 759 416 395 1402 
LA 319 1177 281 1644 958 1292 1083 1005 589 508 1549 655 697 779 646 592 0 1601 1022 1368 1021 1074 178 518 1466 
ME 1305 2381 1445 2664 1925 334 562 620 1390 1182 2227 1101 972 1259 1594 1017 1601 0 606 264 831 1229 1423 1314 1946 
MD 713 1958 916 2320 1546 276 67 19 795 577 1980 671 518 910 1171 479 1022 606 0 351 616 1025 846 854 1747 
MA 1062 2230 1237 2552 1792 76 301 367 1126 927 2156 931 788 1128 1437 799 1368 264 351 0 735 1159 1190 1136 1893 
MI 837 1559 775 1835 1097 689 663 605 1144 851 1421 373 342 438 789 505 1021 831 616 735 0 426 866 569 1161 
MN 1015 1238 794 1446 765 1115 1077 1012 1389 1104 1001 499 596 295 580 759 1074 1229 1025 1159 426 0 971 557 734 
MS 164 1270 221 1718 989 1114 908 828 521 363 1562 512 532 681 634 416 178 1423 846 1190 866 971 0 421 1445 
MO 500 1105 238 1481 707 1068 920 835 895 644 1218 215 349 262 322 395 518 1314 854 1136 569 557 421 0 1057 
MT 1553 893 1225 851 594 1850 1803 1732 1949 1700 306 1130 1268 866 821 1402 1466 1946 1747 1893 1161 734 1445 1057 0 
NE 937 819 609 1097 349 1397 1296 1216 1333 1092 773 567 719 328 223 822 861 1579 1233 1456 749 432 828 448 617 
NV 1720 450 1365 219 597 2293 2192 2111 2089 1905 359 1459 1611 1225 983 1696 1516 2454 2129 2349 1626 1232 1572 1301 639 
NH 1119 2229 1267 2534 1781 156 380 434 1209 996 2120 937 801 1115 1437 835 1416 187 420 105 702 1119 1237 1148 1849 
NJ 847 2064 1039 2411 1641 143 87 151 916 710 2049 767 616 990 1273 600 1155 476 134 218 649 1072 978 961 1803 
NM 1117 314 780 776 316 1875 1724 1639 1457 1314 817 1012 1156 865 514 1185 870 2107 1658 1943 1301 1031 957 808 890 
NY 932 2024 1061 2338 1580 173 270 287 1067 828 1941 729 592 915 1231 633 1220 385 280 216 520 945 1041 939 1679 
NC 482 1839 754 2240 1468 541 313 260 525 318 1962 632 494 895 1082 369 801 874 271 615 728 1081 634 762 1760 
ND 1241 1082 960 1203 636 1420 1383 1316 1631 1358 715 758 879 505 626 1030 1233 1516 1330 1461 732 307 1166 747 432 
OH 577 1640 655 1987 1216 527 400 321 825 538 1644 341 192 573 847 243 833 790 337 596 340 707 658 541 1415 
OK 640 807 289 1232 500 1396 1234 1149 1011 831 1086 552 681 496 207 691 463 1651 1168 1467 892 760 491 337 1010 
OR 1974 829 1622 474 855 2406 2340 2265 2360 2146 301 1631 1779 1374 1214 1891 1812 2517 2281 2453 1719 1296 1840 1511 574 
PA 752 1899 898 2238 1470 269 183 145 896 649 1874 598 451 816 1105 463 1044 557 148 340 481 900 865 799 1629 
RI 1041 2228 1224 2556 1793 63 274 345 1094 901 2167 928 782 1131 1434 786 1348 299 328 39 747 1172 1171 1131 1907 
SC 355 1758 666 2178 1414 692 464 407 384 172 1935 628 513 891 1029 355 673 1025 420 766 799 1109 516 718 1754 
SD 1083 931 778 1127 465 1400 1331 1256 1478 1218 710 642 781 378 422 914 1044 1541 1272 1451 718 321 992 583 488 
TN 217 1433 351 1841 1074 833 637 555 560 279 1597 330 279 576 688 130 467 1135 573 909 621 829 289 379 1426 
TX 735 742 462 1222 629 1626 1441 1357 1032 934 1216 824 934 800 490 901 445 1904 1376 1699 1182 1062 571 614 1210 
UT 1457 354 1102 455 331 2040 1932 1851 1830 1641 375 1197 1350 971 717 1431 1264 2214 1868 2098 1383 1007 1311 1036 542 
VT 1093 2177 1227 2477 1727 171 378 421 1204 979 2060 889 756 1060 1386 799 1385 218 409 144 644 1060 1207 1101 1789 
VA 568 1854 790 2233 1458 422 203 131 661 432 1922 593 443 848 1076 364 880 751 146 498 622 1002 706 755 1704 
WA 2033 1025 1690 710 956 2361 2319 2248 2427 2192 361 1640 1780 1377 1277 1909 1905 2440 2263 2402 1673 1247 1911 1549 516 
WV 537 1746 705 2114 1339 463 280 195 710 444 1793 468 316 719 961 266 832 771 214 539 500 871 653 642 1573 
WI 835 1368 687 1635 902 882 832 765 1186 894 1226 314 370 260 617 541 957 1030 778 931 200 247 824 456 974 











Table 6.3.1: Matrix of distance (in miles) between central latitude and longitude of the 49 continental U.S. States (continued) 
 
STATE NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY 
AL 937 1720 1119 847 1117 932 482 1241 577 640 1974 752 1041 355 1083 217 735 1457 1093 568 2033 537 835 1329 
AZ 819 450 2229 2064 314 2024 1839 1082 1640 807 829 1899 2228 1758 931 1433 742 354 2177 1854 1025 1746 1368 645 
AR 609 1365 1267 1039 780 1061 754 960 655 289 1622 898 1224 666 778 351 462 1102 1227 790 1690 705 687 984 
CA 1097 219 2534 2411 776 2338 2240 1203 1987 1232 474 2238 2556 2178 1127 1841 1222 455 2477 2233 710 2114 1635 752 
CO 349 597 1781 1641 316 1580 1468 636 1216 500 855 1470 1793 1414 465 1074 629 331 1727 1458 956 1339 902 296 
CT 1397 2293 156 143 1875 173 541 1420 527 1396 2406 269 63 692 1400 833 1626 2040 171 422 2361 463 882 1774 
DE 1296 2192 380 87 1724 270 313 1383 400 1234 2340 183 274 464 1331 637 1441 1932 378 203 2319 280 832 1691 
DC 1216 2111 434 151 1639 287 260 1316 321 1149 2265 145 345 407 1256 555 1357 1851 421 131 2248 195 765 1613 
FL 1333 2089 1209 916 1457 1067 525 1631 825 1011 2360 896 1094 384 1478 560 1032 1830 1204 661 2427 710 1186 1721 
GA 1092 1905 996 710 1314 828 318 1358 538 831 2146 649 901 172 1218 279 934 1641 979 432 2192 444 894 1493 
ID 773 359 2120 2049 817 1941 1962 715 1644 1086 301 1874 2167 1935 710 1597 1216 375 2060 1922 361 1793 1226 365 
IL 567 1459 937 767 1012 729 632 758 341 552 1631 598 928 628 642 330 824 1197 889 593 1640 468 314 972 
IN 719 1611 801 616 1156 592 494 879 192 681 1779 451 782 513 781 279 934 1350 756 443 1780 316 370 1121 
IA 328 1225 1115 990 865 915 895 505 573 496 1374 816 1131 891 378 576 800 971 1060 848 1377 719 260 719 
KS 223 983 1437 1273 514 1231 1082 626 847 207 1214 1105 1434 1029 422 688 490 717 1386 1076 1277 961 617 572 
KY 822 1696 835 600 1185 633 369 1030 243 691 1891 463 786 355 914 130 901 1431 799 364 1909 266 541 1231 
LA 861 1516 1416 1155 870 1220 801 1233 833 463 1812 1044 1348 673 1044 467 445 1264 1385 880 1905 832 957 1204 
ME 1579 2454 187 476 2107 385 874 1516 790 1651 2517 557 299 1025 1541 1135 1904 2214 218 751 2440 771 1030 1920 
MD 1233 2129 420 134 1658 280 271 1330 337 1168 2281 148 328 420 1272 573 1376 1868 409 146 2263 214 778 1629 
MA 1456 2349 105 218 1943 216 615 1461 596 1467 2453 340 39 766 1451 909 1699 2098 144 498 2402 539 931 1826 
MI 749 1626 702 649 1301 520 728 732 340 892 1719 481 747 799 718 621 1182 1383 644 622 1673 500 200 1096 
MN 432 1232 1119 1072 1031 945 1081 307 707 760 1296 900 1172 1109 321 829 1062 1007 1060 1002 1247 871 247 696 
MS 828 1572 1237 978 957 1041 634 1166 658 491 1840 865 1171 516 992 289 571 1311 1207 706 1911 653 824 1205 
MO 448 1301 1148 961 808 939 762 747 541 337 1511 799 1131 718 583 379 614 1036 1101 755 1549 642 456 853 
MT 617 639 1849 1803 890 1679 1760 432 1415 1010 574 1629 1907 1754 488 1426 1210 542 1789 1704 516 1573 974 299 
NE 0 898 1440 1317 599 1242 1191 409 896 430 1069 1143 1460 1162 202 825 698 642 1384 1160 1101 1034 553 409 
NV 898 0 2327 2215 671 2134 2063 985 1793 1081 382 2041 2355 2010 914 1670 1117 266 2269 2048 593 1926 1426 536 
NH 1440 2327 0 293 1948 209 690 1417 615 1483 2415 373 143 840 1421 951 1728 2080 61 564 2353 585 902 1799 
NJ 1317 2215 293 0 1768 200 399 1379 426 1283 2349 176 194 549 1339 701 1501 1958 291 280 2318 334 830 1705 
NM 599 671 1948 1768 0 1741 1529 945 1348 497 1016 1607 1938 1445 759 1123 448 456 1898 1548 1169 1444 1121 595 
NY 1242 2134 209 200 1741 0 543 1248 407 1274 2238 180 228 685 1235 753 1520 1884 167 406 2190 395 715 1610 
NC 1191 2063 690 399 1529 543 0 1371 389 1033 2260 377 586 151 1272 407 1195 1798 681 139 2272 230 840 1599 
ND 409 985 1417 1379 945 1248 1371 0 1007 832 1002 1206 1476 1385 207 1080 1106 793 1356 1301 942 1169 552 462 
OH 896 1793 615 426 1348 407 389 1007 0 871 1944 259 590 463 936 372 1114 1534 573 295 1931 166 461 1292 
OK 430 1081 1483 1283 497 1274 1033 832 871 0 1355 1127 1459 953 628 626 305 820 1437 1054 1442 954 747 742 
OR 1069 382 2415 2349 1016 2238 2260 1002 1944 1355 0 2174 2465 2229 1010 1890 1447 563 2355 2222 238 2093 1525 660 
PA 1143 2041 373 176 1607 180 377 1206 259 1127 2174 0 332 512 1163 578 1360 1784 342 238 2145 215 656 1530 
RI 1460 2355 143 194 1938 228 586 1476 590 1459 2465 332 0 737 1460 892 1687 2102 180 474 2417 523 941 1834 
SC 1162 2010 840 549 1445 685 151 1385 463 953 2229 512 737 0 1266 341 1086 1745 829 280 2258 329 880 1570 
SD 202 914 1421 1339 759 1235 1272 207 936 628 1010 1163 1460 1266 0 942 899 686 1362 1220 1000 1090 520 379 
TN 825 1670 951 701 1123 753 407 1080 372 626 1890 578 892 341 942 0 805 1405 919 442 1925 370 631 1232 
TX 698 1117 1728 1501 448 1520 1195 1106 1114 305 1447 1360 1687 1086 899 805 0 885 1686 1246 1577 1166 1048 917 
UT 642 266 2080 1958 456 1884 1798 793 1534 820 563 1784 2102 1745 686 1405 885 0 2024 1785 716 1664 1184 331 
VT 1384 2269 61 291 1898 167 681 1356 573 1437 2355 342 180 829 1362 919 1686 2024 0 550 2293 557 844 1740 
VA 1160 2048 564 280 1548 406 139 1301 295 1054 2222 238 474 280 1220 442 1246 1785 550 0 2219 132 756 1564 
WA 1101 593 2353 2318 1169 2190 2272 942 1931 1442 238 2145 2417 2258 1000 1925 1577 716 2293 2219 0 2088 1489 706 
WV 1034 1926 585 334 1444 395 230 1169 166 954 2093 215 523 329 1090 370 1166 1664 557 132 2088 0 626 1437 
WI 553 1426 902 830 1121 715 840 552 461 747 1525 656 941 880 520 631 1048 1184 844 756 1489 626 0 897 






How Spatial Autocorrelation (Global Moran’s I) works 
 
The Spatial Autocorrelation (Global Moran's I) statistic assess the overall pattern and 
trend of data.  It quantifies the similarity of outcome values among locations that are considered 
spatially related and evaluates whether the pattern expressed is clustered, dispersed, or random. 














where zi could be the mortality rate of an area, wij is the spatial weight between location i and j, 
and n is equal to the total number of areas. A weights matrix is used to define the spatial 
relationships so that locations close in space are given greater weight when calculating the I 
statistic than more distant locations.  
The z-score and p-value evaluates the statistical significance of the Moran’s I statistic. 
















A Moran’s I of zero means the null hypothesis is correct and there is no spatial clustering 
in the data (i.e. the attribute is randomly distributed among the locations in the study area). A 
positive Moran’s I indicates positive spatial autocorrelation (i.e. neighboring locations have 
similar attribute values). A negative Moran’s I indicates negative spatial autocorrelation (i.e. 
neighboring areas have dissimilar attribute values or the attribute values are spatially dispersed). 





How Cluster and Outlier Analysis: Anselin Local Moran's I (Spatial Statistics) works 
The Cluster and Outlier Analysis tool of ArcGIS identifies clusters of features with values 
similar in magnitude when given a set of weighted features. It also identifies spatial outliers. The 
tool calculates a Local Moran's I value, a Z score, a p-value, and a code representing the cluster 
type for each feature. The Z score and p-value represent the statistical significance of the 
computed index value.  



















where xi is the P&I mortality rate for State i,  ̅ is the mean of the corresponding P&I mortality 

















with n equating to the number of States. 
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Source: Anselin L. Local Indicators of Spatial Association—LISA. Geographical Analysis 1995;27(2): 93–115. Mitchell A.  





Table 6.3.2: Average global clustering of monthly P&I mortality rates in the United States over 
an entire epidemic wave, 1968-2008, by season 
 
Influenza season Ī, Contagious Ī, Hierarchical Ī, Mixed 
1968-69 -0.04732 0.293383 0.158583 
1969-70 1.857375 -0.95082 -0.05283 
1970-71 -0.97 -1.622 -0.613 
1971-72 0.681571 -1.32614 -0.47316 
1972-73 0.119696 0.0488 -0.54 
1973-74 1.829143 0.347296 0.250286 
1974-75 2.236167 -0.45267 -0.43832 
1975-76 3.04955 -0.48983 0.431867 
1976-77 0.422375 -1.3755 0.048138 
1977-78 1.238033 -0.33295 0.2345 
1978-79 0.310633 0.094222 -0.68728 
1979-80 0.709733 0.32905 -0.89983 
1980-81 2.694 -0.27991 0.241167 
1981-82 0.880811 -0.50473 -0.49367 
1982-83 1.759714 -0.71759 -0.51986 
1983-84 0.851857 -0.61071 -0.57231 
1984-85 1.621067 0.482033 0.094833 
1985-86 2.115 0.119033 -0.62755 
1986-87 1.573557 -0.71247 -1.43886 
1987-88 1.982857 -0.20336 -1.76571 
1988-89 1.32875 0.190833 -1.83367 
1989-90 1.716833 0.1322 -0.4535 
1990-91 2.461714 -0.14689 -0.04057 
1991-92 2.070937 0.00925 -0.34748 
1992-93 1.860714 -0.47809 -0.19048 
1993-94 2.087583 -0.861 -0.26472 
1994-95 1.260571 -0.76123 -0.21343 
1995-96 1.037 0.304986 0.484986 
1996-97 1.220383 -0.60352 -0.44117 
1997-98 1.756167 0.3185 0.114833 
1998-99 1.578481 0.118613 0.092625 
1999-00 2.071167 -0.66935 0.394917 
2000-01 0.856571 -0.79657 -1.30257 
2001-02 1.373857 -0.23223 0.096143 
2002-03 1.032043 0.125714 -1.29593 
2003-04 2.3475 0.532667 0.166883 
2004-05 2.422286 -0.06256 0.1621 
2005-06 1.721343 0.423129 1.219429 
2006-07 1.435571 0.617071 0.9182 
2007-08 3.393 0.342814 2.186886 







Table 6.3.3: Average global clustering of monthly P&I mortality rates in the United States during 
the build-up phase of an epidemic wave, 1968-2008, by season 
 
Influenza season Ī, Contagious Ī, Hierarchical Ī, Mixed 
1968-69 -0.5655 0.65915 0.9105 
1969-70 2.76775 -0.81063 0.406 
1970-71 -0.94367 -0.44533 -0.79133 
1971-72 -0.76667 -3.03 -1.31967 
1972-73 -1.23 0.244 0.343 
1973-74 0.4175 0.274518 -0.68525 
1974-75 1.455 -0.3715 -1.4175 
1975-76 2.107767 0.399667 0.8014 
1976-77 0.896 -0.7982 0.09422 
1977-78 1.14985 -1.726 0.051 
1978-79 0.105925 -0.15125 -0.534 
1979-80 -0.9322 0.514667 -0.78933 
1980-81 2.037 -0.01069 -0.8295 
1981-82 0.59255 -0.22333 -0.76467 
1982-83 1.84275 -1.38828 -0.81673 
1983-84 1.04075 -0.41375 -0.2143 
1984-85 1.6808 0.565333 -0.69 
1985-86 1.288667 -0.43473 -1.679 
1986-87 1.2095 1.0565 -1.0255 
1987-88 2.439 -0.54067 -1.371 
1988-89 1.3425 0.661 -1.71133 
1989-90 0.997 0.489 -0.6125 
1990-91 0.7305 0.0918 -0.193 
1991-92 3.9 0.30675 -0.15145 
1992-93 0.25575 -0.27165 -0.21891 
1993-94 2.03925 -2.136 -0.1095 
1994-95 0.6885 -1.4595 0.11 
1995-96 -0.7855 1.9719 1.085 
1996-97 2.331 -0.29555 1.3175 
1997-98 1.4425 1.099 0.4475 
1998-99 1.004642 0.39545 -0.18 
1999-00 3.3195 -0.10605 0.607 
2000-01 0.8225 -1.225 -1.537 
2001-02 1.19275 -0.63375 -0.39025 
2002-03 0.89365 -0.02 -0.38945 
2003-04 2.22 -0.17 -1.61 
2004-05 3.01475 0.351025 0.449675 
2005-06 1.3 1.209 1.3439 
2006-07 1.458 1.03 1.7527 
2007-08 3.26 0.697675 2.8448 






Table 6.3.4: Average global clustering of monthly P&I mortality rates in the United States at the 
peak of an epidemic wave, 1968-2008, by season 
 
Influenza season Ī, Contagious Ī, Hierarchical Ī, Mixed 
1968-69 3.2161 -0.53 -0.0612 
1969-70 4.66 -1.74 -0.765 
1970-71 -0.999 -1.88 -1.14 
1971-72 -0.531 -0.252 1.45 
1972-73 0.00648 0.336 -1.28 
1973-74 3.672 -0.604 -0.988 
1974-75 7.7 -0.648 -0.699 
1975-76 8.62 -2.58 0.409 
1976-77 2.109 -2.64 1.067 
1977-78 2.94 0.766 1.337 
1978-79 -0.524 -0.928 0.363 
1979-80 1.92 0.292 -1.2 
1980-81 5.01 0.0139 1.181 
1981-82 1.69 -0.368 -0.681 
1982-83 4.43 1.207 0.0829 
1983-84 1.77 0.34 0.741 
1984-85 1.89 -0.242 -1.96 
1985-86 1.844 0.348 0.0567 
1986-87 -0.2071 -3.07 -3.74 
1987-88 3.86 0.0475 -2.38 
1988-89 1.58 -0.189 -1.41 
1989-90 2.574 -0.384 -0.27 
1990-91 5.39 0.345 -0.222 
1991-92 2.61 -0.775 0.52 
1992-93 8.47 0.297 -0.187 
1993-94 6.75 0.84 0.646 
1994-95 2.23 -0.237 1.201 
1995-96 0.519 -0.686 -0.576 
1996-97 0.795 -0.413 0.11 
1997-98 0.925 -0.135 0.354 
1998-99 4.26 -1.37 -0.858 
1999-00 4.05 0.486 0.0995 
2000-01 2.085 0.9 -0.435 
2001-02 3.687 0.0524 0.831 
2002-03 2.08 1.291 -0.142 
2003-04 4.44 2.665 -0.846 
2004-05 3.3 -0.886 0.741 
2005-06 3.09 -0.614 2.18 
2006-07 1.66 0.1815 1.176 
2007-08 3.52 -1.45 -0.601 






Table 6.3.5: Average global clustering of monthly P&I mortality rates in the United States during 
the fade-out of an epidemic wave, 1968-2008, by season 
 
Influenza season Ī, Contagious Ī, Hierarchical Ī, Mixed 
1968-69 -0.78967 0.324 -0.26943 
1969-70 -0.9095 -0.7665 -0.385 
1970-71 -0.9825 -2.44 -0.3475 
1971-72 2.534 0.019667 -0.2677 
1972-73 0.607333 -0.112 -0.58767 
1973-74 3.731 0.9685 2.7405 
1974-75 0.935667 -0.44167 0.301367 
1975-76 1.677 -0.779 -0.111 
1976-77 -1.605 -2.1865 -0.5765 
1977-78 0.7295 0.229433 -0.01067 
1978-79 0.724 0.59525 -1.10313 
1979-80 2.5675 0.06915 -0.9155 
1980-81 2.36 -0.55733 0.641667 
1981-82 1.341 -1.4173 0.413 
1982-83 0.2585 -0.3385 -0.2275 
1983-84 0.015 -1.48 -1.945 
1984-85 1.397 0.7191 2.2995 
1985-86 3.49 0.8352 0.6075 
1986-87 2.20075 -1.00758 -1.07025 
1987-88 0.901 0.050333 -1.95567 
1988-89 1.1825 -0.3245 -2.229 
1989-90 1.911 0.0664 -0.40867 
1990-91 2.59525 -0.3892 0.081 
1991-92 0.671873 0.072333 -0.76733 
1992-93 1.766 -1.2785 -0.13535 
1993-94 0.565667 -0.578 -0.67177 
1994-95 1.30425 -0.54315 -0.72875 
1995-96 2.07775 -0.28073 0.450225 
1996-97 0.621767 -0.87233 -1.79733 
1997-98 2.242333 -0.05067 -0.18667 
1998-99 2.34 -0.0538 2.679 
1999-00 0.579333 -1.43 0.352 
2000-01 0.5665 -1.0065 -1.40225 
2001-02 0.5795 0.4285 0.7015 
2002-03 0.83925 -0.09275 -2.03765 
2003-04 1.85625 0.17525 0.864325 
2004-05 0.7985 -0.478 -0.7025 
2005-06 1.58985 0.289475 0.91705 
2006-07 1.36825 0.5195 0.4365 
2007-08 3.5955 0.5295 2.265 






Table 6.3.6: Average local clustering of monthly P&I mortality rates for the 49 continental States 
in the U.S. during their respective epidemic waves, 1968-2008, by State 
 
State No. of Epidemic Months Local Mean I Z Score Most Frequent Cluster Outlier Type 
Alabama 271 -0.10276 HH 
Arizona 270 -3.05634 HL 
Arkansas 280 9.465341 HH 
California 258 -2.73565 HL 
Colorado 294 -0.9708 HL 
Connecticut 265 5.992496 HH 
Delaware 334 0.232458 LL 
District of Columbia 320 2.426485 HH 
Florida 279 -0.46791 LL 
Georgia 272 -1.1958 HL 
Idaho 299 -1.57146 LL 
Illinois 279 2.515796 HH 
Indiana 286 0.268972 HH 
Iowa 276 25.50848 HH 
Kansas 268 9.929096 HH 
Kentucky 283 4.534188 HH 
Louisiana 277 0.276044 LL 
Maine 277 3.314648 HH 
Maryland 271 -0.35619 HH 
Massachusetts 269 14.71444 HH 
Michigan 293 -0.06295 HL 
Minnesota 288 3.003304 HH 
Mississippi 266 0.369967 HH 
Missouri 260 16.11052 HH 
Montana 297 -0.62061 HL 
Nebraska 276 14.22643 HH 
Nevada 299 5.207704 LL 
New Hampshire 274 0.0804 LH 
New Jersey 268 0.030682 HL 
New Mexico 294 -0.5913 LL 
New York 273 9.072649 HH 
North Carolina 261 -1.00864 HL 
North Dakota 321 10.41732 HH 
Ohio 275 0.096928 HH 
Oklahoma 275 7.598664 HH 
Oregon 270 -2.23156 HL 
Pennsylvania 276 2.48143 HH 
Rhode Island 279 4.533145 HH 
South Carolina 269 0.058196 LL 
South Dakota 291 17.66372 HH 
Tennessee 273 6.013476 HH 
Texas 256 0.071648 LL 
Utah 294 4.218239 LL 
Vermont 281 3.54011 HH 
Virginia 271 0.049846 HL 
Washington 285 -1.04541 LL 
West Virginia 290 4.950152 HH 
Wisconsin 280 2.350125 HH 
Wyoming 306 -0.82991 HL 
Bold indicates significant average local Moran’s I, Ī, at z=1.96. 





Table 6.3.7: Average local clustering of monthly P&I mortality rates for the 49 continental States 
in the U.S. during the build-up of their respective epidemic waves, 1968-2008, by State 
 
State No. of Epidemic Months Local Mean I Z Score Most Frequent Cluster Outlier Type 
Alabama 116 0.058371 HH 
Arizona 111 -1.4163 HL 
Arkansas 124 6.847576 HH 
California 98 -1.376 HL 
Colorado 124 0.596782 LL 
Connecticut 113 3.272705 HH 
Delaware 153 0.609751 LL 
District of Columbia 136 1.652842 HH 
Florida 120 0.423415 LL 
Georgia 122 -0.43063 HL 
Idaho 127 0.728677 LL 
Illinois 128 1.505804 HH 
Indiana 128 0.10263 HH 
Iowa 142 19.45422 HH 
Kansas 124 6.014426 HH 
Kentucky 135 3.181769 HH 
Louisiana 114 1.285806 LL 
Maine 120 1.468498 HH 
Maryland 120 -0.67057 LH 
Massachusetts 118 11.22781 HH 
Michigan 136 0.314939 LL 
Minnesota 138 1.540207 HH 
Mississippi 113 0.267096 HH 
Missouri 119 11.13216 HH 
Montana 125 -0.29 HL 
Nebraska 125 9.333399 HH 
Nevada 114 9.112378 LL 
New Hampshire 122 -1.53459 LH 
New Jersey 114 0.034783 NS 
New Mexico 133 1.350922 LL 
New York 112 6.644582 HH 
North Carolina 126 -0.37856 HL 
North Dakota 151 6.719631 HH 
Ohio 128 0.026159 NS 
Oklahoma 126 5.478293 HH 
Oregon 113 -1.34803 HL 
Pennsylvania 121 1.476878 HH 
Rhode Island 115 1.039413 HH 
South Carolina 129 1.548028 LL 
South Dakota 125 11.87696 HH 
Tennessee 118 4.43609 HH 
Texas 99 1.427182 LL 
Utah 118 7.407706 LL 
Vermont 116 1.579058 HH 
Virginia 127 0.008899 NS 
Washington 124 0.890025 LL 
West Virginia 129 3.113303 HH 
Wisconsin 121 1.203028 HH 
Wyoming 128 0.640232 LL 
Bold indicates significant average local Moran’s I, Ī, at z=1.96. 





Table 6.3.8: Average local clustering of monthly P&I mortality rates for the 49 continental States 
in the U.S. at the peak of their respective epidemic waves, 1968-2008, by State 
 
State No. of Epidemic Months Local Mean I Z Score Most Frequent Cluster Outlier Type 
Alabama 40 -0.83407 HL 
Arizona 40 -12.1686 HL 
Arkansas 40 26.56748 HH 
California 40 -11.4821 HL 
Colorado 40 -8.23587 HL 
Connecticut 40 19.46004 HH 
Delaware 40 -2.24079 HL 
District of Columbia 40 5.686953 HH 
Florida 40 -6.30543 HL 
Georgia 40 -6.08381 HL 
Idaho 40 -17.2204 HL 
Illinois 40 8.344411 HH 
Indiana 40 1.681148 HH 
Iowa 40 62.92845 HH 
Kansas 40 30.42728 HH 
Kentucky 40 13.41632 HH 
Louisiana 40 -4.55199 HL 
Maine 40 12.88246 HH 
Maryland 40 0.98691 HH 
Massachusetts 40 32.26768 HH 
Michigan 40 -2.3294 HL 
Minnesota 40 10.35257 HH 
Mississippi 40 1.148253 HH 
Missouri 40 41.09643 HH 
Montana 40 -2.77568 HL 
Nebraska 40 39.24081 HH 
Nevada 40 -10.7067 HL 
New Hampshire 40 9.081441 HH 
New Jersey 40 0.01231 HL 
New Mexico 40 -12.2366 HL 
New York 40 20.56649 HH 
North Carolina 40 -4.41707 HL 
North Dakota 40 35.03099 HH 
Ohio 40 0.626397 HH 
Oklahoma 40 21.03874 HH 
Oregon 40 -11.6884 HL 
Pennsylvania 40 7.704878 HH 
Rhode Island 40 21.14004 HH 
South Carolina 40 -8.24422 HL 
South Dakota 40 49.31588 HH 
Tennessee 40 16.77877 HH 
Texas 40 -7.27125 HL 
Utah 40 -12.4567 HL 
Vermont 40 13.75295 HH 
Virginia 40 0.296437 HL 
Washington 40 -11.4803 HL 
West Virginia 40 14.66413 HH 
Wisconsin 40 8.387018 HH 
Wyoming 40 -9.09137 HL 
Bold indicates significant average local Moran’s I, Ī, at z=1.96. 





Table 6.3.9: Average local clustering of monthly P&I mortality rates for the 49 continental States 
in the U.S. during the fade-out phase of their respective epidemic waves, 1968-2008, by State 
 
State No. of Epidemic Months Local Mean I Z Score Most Frequent Cluster Outlier Type 
Alabama 115 -0.01092 HH 
Arizona 119 -1.52317 HH 
Arkansas 116 6.366352 HH 
California 120 -0.93054 HL 
Colorado 130 -0.23063 LL 
Connecticut 112 3.926733 HH 
Delaware 141 0.524685 LL 
District of Columbia 144 2.251461 HH 
Florida 119 0.595472 LL 
Georgia 110 -0.26699 HL 
Idaho 132 0.957646 LL 
Illinois 111 1.58007 HH 
Indiana 118 -0.02929 NS 
Iowa 94 18.73087 HH 
Kansas 104 6.712673 HH 
Kentucky 108 2.935034 HH 
Louisiana 123 0.910258 LL 
Maine 117 1.937087 HH 
Maryland 111 -0.50031 LH 
Massachusetts 111 12.09547 HH 
Michigan 117 0.272656 LL 
Minnesota 110 2.166364 HH 
Mississippi 113 0.197338 HH 
Missouri 101 12.0807 HH 
Montana 132 -0.28065 HL 
Nebraska 111 10.72242 HH 
Nevada 145 6.528003 LL 
New Hampshire 112 -1.37507 LH 
New Jersey 114 0.033027 NS 
New Mexico 121 1.12354 LL 
New York 121 7.5205 HH 
North Carolina 95 -0.4092 HL 
North Dakota 130 7.138902 HH 
Ohio 107 -0.01635 NS 
Oklahoma 109 5.117597 HH 
Oregon 117 0.148227 LL 
Pennsylvania 115 1.721542 HH 
Rhode Island 124 2.416239 HH 
South Carolina 100 1.457277 LL 
South Dakota 126 13.35625 HH 
Tennessee 115 3.88756 HH 
Texas 117 1.435051 LL 
Utah 136 6.355308 LL 
Vermont 125 2.091857 HH 
Virginia 104 0.005007 NS 
Washington 121 0.420729 LL 
West Virginia 121 3.697213 HH 
Wisconsin 119 1.487293 HH 
Wyoming 138 0.201102 LL 
Bold indicates significant average local Moran’s I, Ī, at z=1.96. 





Table 6.3.10: Average local clustering of monthly P&I mortality rates for the 49 continental 
States in the U.S. for the entire U.S. epidemic waves, 1968-2008, by State (N=268) 
 
State Local Mean I Z Score Most Frequent Cluster Outlier Type 
Alabama -0.12439 HH 
Arizona -3.19077 HL 
Arkansas 9.770479 HH 
California -2.57712 HL 
Colorado -1.3242 HL 
Connecticut 5.795078 HH 
Delaware 0.059278 HL 
District of Columbia 2.724236 HH 
Florida -0.60658 LL 
Georgia -1.19683 HL 
Idaho -2.09508 HL 
Illinois 2.569976 HH 
Indiana 0.29514 HH 
Iowa 25.72887 HH 
Kansas 9.804926 HH 
Kentucky 4.799929 HH 
Louisiana 0.196585 LL 
Maine 3.412686 HH 
Maryland -0.3093 HH 
Massachusetts 14.58306 HH 
Michigan -0.18925 HL 
Minnesota 3.188254 HH 
Mississippi 0.353496 HH 
Missouri 15.74583 HH 
Montana -0.66376 HL 
Nebraska 14.3358 HH 
Nevada 4.26551 LL 
New Hampshire 0.270809 LH 
New Jersey 0.018459 HL 
New Mexico -1.05166 LL 
New York 9.136022 HH 
North Carolina -0.96306 HL 
North Dakota 11.85962 HH 
Ohio 0.102371 HH 
Oklahoma 7.805809 HH 
Oregon -2.44999 HL 
Pennsylvania 2.531537 HH 
Rhode Island 4.249707 HH 
South Carolina 0.113355 LL 
South Dakota 18.59303 HH 
Tennessee 6.185619 HH 
Texas 0.321934 LL 
Utah 3.566273 LL 
Vermont 3.736359 HH 
Virginia 0.057419 HL 
Washington -1.32046 HL 
West Virginia 5.345992 HH 
Wisconsin 2.42506 HH 
Wyoming -1.14208 HL 
Bold indicates significant average local Moran’s I, Ī, at z=1.96. 





Table 6.3.11: Average local clustering of monthly P&I mortality rates for the 49 continental 
States in the U.S. at the build-up of U.S. epidemic waves, 1968-2008, by State, (N=114) 
 
State Local Mean I Z Score Most Frequent Cluster Outlier Type 
Alabama 0.091305 HH 
Arizona -2.223 HL 
Arkansas 6.574406 HH 
California -1.44437 HL 
Colorado -0.35359 LL 
Connecticut 3.8496 HH 
Delaware 0.268787 LL 
District of Columbia 2.426982 HH 
Florida 0.392507 LL 
Georgia -0.53692 HL 
Idaho -0.62606 LL 
Illinois 1.840342 HH 
Indiana 0.103203 HH 
Iowa 19.82194 HH 
Kansas 6.600047 HH 
Kentucky 3.393239 HH 
Louisiana 1.076555 LL 
Maine 1.650226 HH 
Maryland -0.56979 HL 
Massachusetts 11.9377 HH 
Michigan 0.291219 HL 
Minnesota 2.285095 HH 
Mississippi 0.430834 HH 
Missouri 11.80829 HH 
Montana -0.39244 HL 
Nebraska 10.64517 HH 
Nevada 6.208658 LL 
New Hampshire -1.01357 LH 
New Jersey -0.00384 HL 
New Mexico 0.407331 LL 
New York 8.075365 HH 
North Carolina -0.22674 HL 
North Dakota 7.382774 HH 
Ohio 0.014533 NS 
Oklahoma 6.094724 HH 
Oregon -1.37075 HL 
Pennsylvania 1.369673 HH 
Rhode Island 1.72263 HH 
South Carolina 1.251665 LL 
South Dakota 14.70595 HH 
Tennessee 4.4345 HH 
Texas 0.967995 LL 
Utah 5.072609 LL 
Vermont 2.724187 HH 
Virginia -0.00584 NS 
Washington 0.186837 LL 
West Virginia 3.059724 HH 
Wisconsin 1.430912 HH 
Wyoming -0.13119 LL 
Bold indicates significant average local Moran’s I, Ī, at z=1.96. 





Table 6.3.12: Average local clustering of monthly P&I mortality rates for the 49 continental 
States in the U.S. at the peak of U.S. epidemic waves, 1968-2008, by State (N=40) 
 
State Local Mean I Z Score Most Frequent Cluster Outlier Type 
Alabama -0.83233 HL 
Arizona -11.0764 HL 
Arkansas 23.92952 HH 
California -10.2531 HL 
Colorado -6.99228 HL 
Connecticut 16.43679 HH 
Delaware -1.01928 HL 
District of Columbia 4.904718 HH 
Florida -5.69241 HL 
Georgia -5.80181 HL 
Idaho -12.9193 HL 
Illinois 7.883831 HH 
Indiana 1.51802 HH 
Iowa 58.68112 HH 
Kansas 29.41125 HH 
Kentucky 12.59407 HH 
Louisiana -4.13868 HL 
Maine 9.286504 HH 
Maryland 0.863741 HH 
Massachusetts 27.38594 HH 
Michigan -2.02639 HL 
Minnesota 9.04511 HH 
Mississippi 0.970083 HH 
Missouri 38.41002 HH 
Montana -1.87894 HL 
Nebraska 36.26607 HH 
Nevada -4.55964 HL 
New Hampshire 5.608564 HH 
New Jersey 0.039818 NS 
New Mexico -9.93716 HL 
New York 18.08755 HH 
North Carolina -4.18349 HL 
North Dakota 27.53897 HH 
Ohio 0.548118 HH 
Oklahoma 18.45425 HH 
Oregon -9.4052 HL 
Pennsylvania 7.349891 HH 
Rhode Island 15.40149 HH 
South Carolina -7.31096 HL 
South Dakota 42.20164 HH 
Tennessee 16.16698 HH 
Texas -6.45448 HL 
Utah -7.4106 HL 
Vermont 10.09292 HH 
Virginia 0.303377 HL 
Washington -8.5573 HL 
West Virginia 12.90799 HH 
Wisconsin 7.827049 HH 
Wyoming -6.36523 HL 
Bold indicates significant average local Moran’s I, Ī, at z=1.96. 





Table 6.3.13: Average local clustering of monthly P&I mortality rates for the 49 continental 
States in the U.S. during the fade-out of U.S. epidemic waves, 1968-2008, by State (N=114) 
 
State Local Mean I Z Score Most Frequent Cluster Outlier Type 
Alabama -0.09168 HH 
Arizona -1.39164 HL 
Arkansas 7.998467 HH 
California -1.01656 HL 
Colorado -0.30601 LL 
Connecticut 4.00662 HH 
Delaware 0.228211 HL 
District of Columbia 2.256408 HH 
Florida 0.178839 LL 
Georgia -0.24096 HL 
Idaho 0.233866 LL 
Illinois 1.435099 HH 
Indiana 0.057998 HH 
Iowa 20.07361 HH 
Kansas 6.130393 HH 
Kentucky 3.471834 HH 
Louisiana 0.837763 LL 
Maine 3.114158 HH 
Maryland -0.4604 LH 
Massachusetts 12.73619 HH 
Michigan -0.0251 HL 
Minnesota 2.036376 HH 
Mississippi 0.059812 HH 
Missouri 11.73102 HH 
Montana -0.50871 HL 
Nebraska 10.33161 HH 
Nevada 5.418905 LL 
New Hampshire -0.31771 LH 
New Jersey 0.033266 NS 
New Mexico 0.607074 LL 
New York 7.055793 HH 
North Carolina -0.56941 HL 
North Dakota 10.83494 HH 
Ohio 0.033806 NS 
Oklahoma 5.780599 HH 
Oregon -1.08882 HL 
Pennsylvania 2.00275 HH 
Rhode Island 2.863879 HH 
South Carolina 1.580067 LL 
South Dakota 14.19639 HH 
Tennessee 4.434506 HH 
Texas 2.053563 LL 
Utah 5.911472 LL 
Vermont 2.518157 HH 
Virginia 0.034378 NS 
Washington -0.28852 LL 
West Virginia 4.978929 HH 
Wisconsin 1.523773 HH 
Wyoming -0.3203 LL 
Bold indicates significant average local Moran’s I, Ī, at z=1.96. 








Figure 6.3.1: Correlation of the start month of influenza seasons between continental U.S. States 
plotted as a function of the difference in mean population size between States, 1968-2008 
  

















































Figure 6.3.2: Correlation of the peak month of influenza seasons between continental U.S. States 
plotted as a function of the difference in mean population size between States, 1968-2008 
  














































Figure 6.3.3: Correlation of the end month of influenza seasons between continental U.S. States 
plotted as a function of the difference in mean population size between States, 1968-2008  













































Appendix 4: Additional analyses for Chapter 5 
 
Table 6.4.1: Mean temporal characteristics of the U.S. during the 1968-69 pandemic influenza 





























Mean (95% Confidence Interval) 
























Table 6.4.2: Mean temporal characteristics of the continental U.S. during the 1977-78 H1N1 
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Appendix 5: Analyses of the effect of temporal variables in prior seasons on the temporal 
variables of succeeding seasons (Chapter 6) 
 
Immunity from prior the circulating strains of influenza in prior seasons may carryover to 
successive seasons. To examine whether these possible immunization effects had any impact on 
the differential rates and variables of wave propagation observed in this analysis, the regression 
model 
 ̅                  
was postulated. Here,  ̅   is the dependent variable in State i for time t, xit-l, is the independent 
variable in State i for the prior time period, e is the error term, b0 is the intercept, and b1 is a 
parameter to be estimated. 
I looked at the predictive properties of four season characteristics: first month of 
influenza activity, average time to death (wave velocity), P&I mortality rate per 100,000, and 
season length. Sixteen models where analyzed from these four seasonal variables. 
Some findings emerge from the table: 
1. There were statistically significant and negative associations between the first month of a 
season, average time of death, and season length of a prior wave and the corresponding 
season characteristics of a succeeding wave. The negative associations indicate that a season 
that starts later in the year is associated with an earlier starting wave in the next season, a 
slower moving preceding wave produces a faster moving succeeding wave, and a longer 
prior season is associated with a shorter following season. However, these associations were 
very weak and these temporal characteristics did not account for a lot of the variation in their 
respective models (Models 1-2, 4). P&I mortality rate of a successive wave had a positive 
and significant association with P&I mortality rate of a prior wave. Therefore, high mortality 





mortality rate of a prior season did account for a lot of the variation in the model (R
2
=0.46) 
(Model 4).  
2. Model 6 shows that the initiation of influenza waves was significantly and negatively 
associated with the levels of pneumonia and influenza mortality in the previous wave. High 
P&I mortality rates in the prior season produced earlier waves in the following season. This 
association was not very large. 
3. Models 8 and 10 show that the velocity of successive seasons had a significant and positive 
association with the start of influenza seasons and a significant and negative association with 
the length of prior waves. Smaller prior waves often produced slower moving successive 
waves while earlier starting waves produced faster moving successive waves. 
4. Models 12 and 13 show that the levels of P&I mortality in successive seasons had significant 
and negative associations with velocity and length of prior seasons. Faster moving and 
shorter prior waves resulted in high P&I mortality rates in future waves. 
5. Models 14 and 15 show that the length of following seasons had a significant and positive 
association with wave initiation and a significant and negative association with wave velocity 
of prior seasons. Earlier starting waves produced smaller successive waves while faster 
moving waves produced longer successive waves. 
Many of the models analyzed showed significant associations between seasonal variables 
of one season with seasonal variables of preceding seasons. However, these associations were 
very weak, except for P&I mortality with prior P&I mortality. Seasonal variables in prior seasons 
appear to somewhat drive seasonal influenza transmission in successive seasons, but they are not 
dominant factors.






















Table 6.5.1: Results of regressions relating season characteristics in one epidemic wave to season characteristics of preceding waves 
Model Dependent variable Independent variable F value Linear regression 
p-value 






1 First month of 
season 
First month of season, 
prior season 
12.2 0.0005 0.0064 -3.49 -0.07967 -0.12407 -0.03495 
2 Average time to 
death 
Average time to death, 
prior season 
6.36 0.0118 0.0033 -2.52 -0.0576 -0.10218 -0.0128 
3 P&I mortality rate P&I mortality rate of 
prior season 
1633.12 <0.0001 0.4611 40.41 0.67892 0.653985 0.702374 
4 Season length Season length, prior 
season 
4.24 0.0396 0.0022 -2.06 -0.04706 -0.09171 -0.00222 
5 First month of 
influenza activity 
Average time to death of 
prior season 
1.18 0.2773 0.0006 1.09 0.02486 -0.02001 0.069618 
6 First month of 
season 
P&I mortality rate, prior 
season 
22.21 <0.0001 0.0115 -4.71 -0.10722 -0.15133 -0.06268 
7 First month of 
season 
Season length, prior 
season 
0.98 0.3234 0.0005 0.99 0.02259 -0.02227 0.067365 
8 Average time to 
death 
First month of season, 
prior season 
24.53 <0.0001 0.0127 4.95 0.11261 0.068118 0.156663 
9 Average time to 
death 
P&I mortality rate, prior 
season 
0.38 0.5384 0.0002 0.62 0.01408 -0.03078 0.058881 
10 Average time to 
death 
Season length, prior 
season 
5.05 0.0248 0.0026 -2.25 -0.05134 -0.09596 -0.00652 
11 P&I mortality rate First month of season, 
prior season 
2.55 0.1105 0.0013 1.6 0.03651 -0.00835 0.081213 
12 P&I mortality rate Average time to death, 
prior season 
4.71 0.03 0.0025 -2.17 -0.04962 -0.09425 -0.00479 
13 P&I mortality rate Season length, prior 
season 
4.03 0.0449 0.0021 -2.01 -0.04586 -0.09052 -0.00103 
14 Season length First month of season, 
prior season 
22.39 <0.0001 0.0116 4.73 0.10763 0.063097 0.15174 
15 Season length Average time to death, 
prior season 
5.18 0.023 0.0027 -2.28 -0.052 -0.09662 -0.00718 
16 Season length P&I mortality rate, prior 
season 
0.26 0.6074 0.0001 0.51 0.01176 -0.0331 0.056567 
Bold indicates significant Pearson correlations at p = 0.05. 
CI = Confidence Interval 








Table 6.5.2: Results of regressions relating season characteristics in one epidemic wave to season characteristics of preceding waves, 
H3N2-prominent seasons 
 
Model Dependent variable Independent variable F value Linear regression 
p-value 






1 First month of 
season 
First month of season, 
prior season 
1.67 0.1969 0.0014 -1.29 -0.0377 -0.0946 0.0196 
2 Average time to 
death 
Average time to death, 
prior season 
926.4 <0.0001 0.4411 30.44 0.6641 0.6309 0.6949 
3 P&I mortality rate P&I mortality rate of 
prior season 
0.02 0.8942 <0.0001 0.13 0.0039 -0.0533 0.061 
4 Season length Season length, prior 
season 
0.43 0.5141 0.0004 0.65 0.0190 -0.0382 0.0761 
5 First month of 
influenza activity 
Average time to death 
of prior season 
8.06 0.0046 0.0068 -2.84 -0.0826 -0.1391 -0.0255 
6 First month of 
season 
P&I mortality rate, prior 
season 
27.3 <0.0001 0.0227 -5.22 -0.1507 -0.2061 -0.0944 
7 First month of 
season 
Season length, prior 
season 
8.61 0.0034 0.0073 -2.93 -0.0853 -0.1418 -0.0283 
8 Average time to 
death 
First month of season, 
prior season 
6.62 0.0102 0.0056 2.57 0.0749 0.0178 0.1315 
9 Average time to 
death 
P&I mortality rate, prior 
season 
2.09 0.1484 0.0018 1.45 0.0422 -0.015 0.0991 
10 Average time to 
death 
Season length, prior 
season 
0.09 0.7608 <0.0001 0.30 0.0089 -0.0483 0.066 
11 P&I mortality rate First month of season, 
prior season 
3.53 0.0605 0.003 1.88 0.0548 -0.0024 0.1116 
12 P&I mortality rate Average time to death, 
prior season 
2.68 0.1017 0.0023 -1.64 -0.0477 -0.1046 0.0094 
13 P&I mortality rate Season length, prior 
season 
2.81 0.0938 0.0024 -1.68 -0.0489 -0.1058 0.0083 
14 Season length First month of season, 
prior season 
4.67 0.0308 0.004 2.16 0.0630 0.0058 0.1197 
15 Season length Average time to death, 
prior season 
0.31 0.5779 0.0003 0.56 0.0162 -0.041 0.0733 
16 Season length P&I mortality rate, prior 
season 
1.44 0.2306 0.0012 1.20 0.0350 -0.0222 0.092 
Bold indicates significant Pearson correlations at p = 0.05. 
CI = Confidence Interval 








Table 6.5.3: Results of regressions relating season characteristics in one epidemic wave to season characteristics of preceding waves, 
H1N1-prominent seasons 
 
Model Dependent variable Independent variable F value Linear regression 
p-value 






1 First month of 
season 
First month of season, 
prior season 
0.20 0.6527 0.0007 0.45 0.0264 -0.0883 0.1403 
2 Average time to 
death 
Average time to death, 
prior season 
109.62 0.0000 0.2730 10.47 0.5224 0.434 0.6009 
3 P&I mortality rate P&I mortality rate of 
prior season 
3.73 0.0545 0.0126 1.93 0.1123 -0.0022 0.2238 
4 Season length Season length, prior 
season 
5.27 0.0225 0.0177 2.29 0.1331 0.019 0.2438 
5 First month of 
influenza activity 
Average time to death 
of prior season 
0.00 0.9671 0.0000 -0.04 -0.0024 -0.1168 0.112 
6 First month of 
season 
P&I mortality rate, prior 
season 
0.01 0.9213 0.0000 0.10 0.0058 -0.1087 0.1201 
7 First month of 
season 
Season length, prior 
season 
0.03 0.8660 0.0001 -0.17 -0.0099 -0.1241 0.1046 
8 Average time to 
death 
First month of season, 
prior season 
3.43 0.0649 0.0116 -1.85 -0.1078 -0.2195 0.0067 
9 Average time to 
death 
P&I mortality rate, prior 
season 
1.27 0.2606 0.0043 -1.13 -0.0658 -0.1789 0.0489 
10 Average time to 
death 
Season length, prior 
season 
5.37 0.0211 0.0181 2.32 0.1344 0.0204 0.2451 
11 P&I mortality rate First month of season, 
prior season 
0.37 0.5408 0.0013 -0.61 -0.0358 -0.1496 0.0789 
12 P&I mortality rate Average time to death, 
prior season 
1.67 0.1975 0.0057 1.29 0.0754 -0.0394 0.1881 
13 P&I mortality rate Season length, prior 
season 
1.91 0.1685 0.0065 1.38 0.0805 -0.0342 0.1931 
14 Season length First month of season, 
prior season 
3.67 0.0564 0.0124 -1.92 -0.1114 -0.2229 0.003 
15 Season length Average time to death, 
prior season 
3.72 0.0547 0.0126 1.93 0.1122 -0.0023 0.2237 
16 Season length P&I mortality rate, prior 
season 
0.61 0.4346 0.0021 -0.78 -0.0457 -0.1593 0.069 
Bold indicates significant Pearson correlations at p = 0.05. 





Appendix 6: Regression diagnostics 
 
First month of influenza season vs. latitude 
 







Test of independence 
 
Pearson's Chi-squared test 








Peak month of influenza season vs. latitude 
 






Test of independence 
 
Pearson's Chi-squared test 








Last month of influenza season vs. latitude 
 





Test of independence 
 
Pearson's Chi-squared test 








P&I mortality rate vs. latitude 
 





Test of independence 
 
Pearson's Chi-squared test 







Season length vs. latitude 
 





Test of independence 
 
Pearson's Chi-squared test 








Average time to death vs. latitude 
 







Test of independence 
 
Pearson's Chi-squared test 
X-squared = 93149, df = 92976, p-value = 0.3437 
 
 
